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ABSTRACT 
Characterizing early predictors of autism facilitates earlier identification, diagnosis and 
treatment. Although aberrant visual attention is one of the earliest identified predictors of 
autism and may play an integral role in developmental cascades that contribute to 
associated impairments, the emergence of atypical attention in infancy is poorly 
understood. The present dissertation includes three related manuscripts examining early 
patterns of visual attention in two infant samples at elevated risk for autism: infant 
siblings of children with autism (ASIBs) and infants with fragile X syndrome (FXS). 
Together, these manuscripts identify patterns of abnormal heart defined attention among 
ASIBs (Study 1), investigate the association between abnormal heart defined attention 
and attention orienting in ASIBs (Study 2), and examine the generalizability of these 
patterns to infants with FXS (Study 3).  Together, findings provide novel evidence of 
atypical heart-defined and associated behavioral attention in ASIBs and FXS, with 
abnormalities emerging as early as 6 months of age in ASIBs. Importantly, Study 3 
revealed diverging patterns of attention-arousal relationships in infants with FXS, 
suggesting potentially unique biological pathways subserving similar patterns of 
abnormal behavior across two infant samples at high risk for autism. These findings 
provide evidence of both shared and diverging endophenotypic features of autism in 
infants at high genetic risk, potentially informing early detection and interventions that 
target mechanisms, rather than symptoms, of impairment.  
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CHAPTER 1 
BIOBEHAVIORAL ATTENTION IN INFANTS AT RISK FOR AUTISM:  
AN INTRODUCTION 
Over the past decade, over 100 studies have investigated the early emergence of ASD in 
infant siblings of children with autism (ASIBs) as a means to better understand the 
genetic and experiential factors associated with autism spectrum disorder (ASD). This 
high number reflects both the urgency and utility of exploring ASD risk factors in 
infancy. Rates of ASD in the general population continue to increase, with recent 
estimates suggesting 1 in 68 children in the United States meet ASD criteria (Centers for 
Disease Control, 2014). Characterizing ASD emergence in infancy offers opportunity for 
earlier detection and treatment, potentially altering early brain development and 
preventing ASD symptoms from emerging (Dawson, 2008; Rogers et al., 2014a). 
Furthermore, early intervention reduces the public health costs associated with ASD by 
up to 65% (Järbrink & Knapp, 2001). Thus, understanding early predictors of ASD is of 
importance for both individual well-being and public health.  
The high number of studies investigating prodromal ASD features in ASIBs also 
reflects increased recognition of the utility of examining prospective ASIB cohorts to 
better understand ASD. Infant siblings are at 18-20 times higher risk for ASD  than the 
general population (Ozonoff et al., 2011), thus exploring emerging ASD symptomatology 
in this group offers an efficient framework for engaging in 
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prospective, theory-driven investigations of ASD. As the natural history of ASD 
among ASIBs continues to unfold, however, it has become clear that ASIBs face elevated 
risk for a number of additional developmental and socio-communicative 
outcomes beyond ASD (Messinger, Young, & Ozonoff, 2013; Ozonoff et al., 2014; Toth, 
Dawson, & Meltzoff, 2007). In addition, ASIBs and other family members of individuals 
with ASD exhibit higher rates of subthreshold symptoms, a phenomena termed the 
broader autism phenotype (Baron-Cohen, 2004; Folstein & Rutter, 1977), supporting the 
modern conceptualization of ASD as a continuum, with subclinical traits extending into 
the general population (Lord & Jones, 2012; Short & Schopler, 1988; Yoder, Stone, 
Walden, & Malesa, 2009). Thus, although ASIBs offer an efficient sample for 
investigating the early emergence of ASD and broader features associated with familial 
ASD risk, it is possible that early development of ASIBs may differ from infants 
diagnosed with ASD without a family history. 
A promising, complementary model for delineating early risk factors for ASD is 
to engage in cross-group comparisons across multiple “high risk” samples. These 
comparisons may inform both converging and diverging patterns of risk that may clarify 
the complex heterogeneity of ASD. Much like in ASIBs, elevated rates of ASD are 
reported across a number of genetic syndromes, including fragile X syndrome,  a single-
gene disorder that affects 1:4000 individuals (Crawford, Acuña, & Sherman, 2001; 
Hagerman & Hagerman, 2002). Comparing infant development in ASIBs versus infants 
with FXS may deepen understanding of complex genetic, environmental and 
developmental interactions not afforded by populations in which specific genetic 
biomarkers of risk are unknown (Fung, Quintin, Haas, & Reiss, 2012; McCary & 
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Roberts, 2013; Tonnsen, Malone, Hatton, & Roberts, 2013; Tye & Bolton, 2013). 
Although few studies have examined ASD symptoms and correlates in infants and 
toddlers with FXS, extant findings suggest both converging (Roberts, Hatton, Long, 
Anello, & Colombo, 2011) and diverging (Hazlett et al., 2012; Tonnsen, Malone, et al., 
2013) patterns of ASD-related risk factors, supporting FXS as a useful framework for 
disentangling syndrome-specific and global features of ASD.  
The present series of studies focuses on the emergence of ASD-associated 
abnormalities in infants by focusing specifically on abnormal visual orienting, a 
commonly identified risk factor for ASD across both ASIBs (Elison et al., 2013; 
Elsabbagh et al., 2013; Zwaigenbaum et al., 2005) and infants with FXS (Roberts et al., 
2011). Although a number of studies have described abnormal orienting in high risk 
infants, the current literature is limited in several ways. First, extant studies have either 
reported cross-sectional group differences or gross change across wide age categories 
(e.g. within-individual change between two 2-4 month age ranges; (Elsabbagh et al., 
2013; Roberts et al., 2011; Zwaigenbaum et al., 2005), limiting understanding of subtle 
developmental changes related to the emergence and stability of attention during infancy.  
Second, extant studies have largely categorized ASD symptoms as present or absent 
(Elison et al., 2013; Elsabbagh et al., 2013; Zwaigenbaum et al., 2005), thus it is unclear 
how broader spectrum of ASD features are associated with abnormal orienting in infancy. 
Third, no studies to date have integrated multiple “high risk” comparison groups within a 
single study to inform divergent and convergent patterns of risk across. These limitations 
provide a compelling case for systematic, longitudinal surveillance of abnormal orienting 
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across high risk groups as a means to inform the timing and nature of atypical attention in 
ASD.  
The current literature is also limited by sparse understanding of the 
neurobiological mechanisms of abnormal orienting in high risk infants. Indeed, only two 
studies to date have examined neurobiological correlates of abnormal orienting in high-
risk infants (Elison et al., 2013; Roberts et al., 2011). In contrast, a number of studies in 
typically developing infants have characterized physiological processes of attention 
orienting that sustain behavioral responses. Although measures of heart-defined sustained 
attention  have been used extensively in non-clinical infant samples (e.g. Casey & 
Richards, 1988; Richards & Casey, 1991; Richards, 1997), indicators of global or 
attention-related physiology have not been examined in ASIBs, and only one study has 
explored these constructs in infants with FXS (Roberts et al., 2011). Investigating the 
intersection of ASD risk and sustained attention is warranted given the close association 
between overt and heart-defined attention in low-risk infants (e.g.  Casey & Richards, 
1988; Richards, 1987, 1997), abnormal physiological arousal identified in both ASD and 
FXS (see Klusek, Roberts, & Losh, 2015 for review) and self-regulatory and attentional 
deficits described in high risk infants (Elison et al., 2013; Elsabbagh et al., 2013; Ozonoff 
et al., 2010; Ozonoff, Macari, & Young, 2008; Roberts et al., 2011; Zwaigenbaum et al., 
2005). 
The present series of manuscripts addresses these areas of need by systematically 
examining both behavioral and heart-defined attention across two infant samples at “high 
risk” for ASD: ASIBs and infants with FXS. Study 1 examines longitudinal trajectories 
of behavioral and heart-defined attention during a passive attention task in 5-14 month 
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ASIBs compared to low risk (LR) controls. The purpose of this study is to inform 
“resting” patterns of heart activity in ASIBs, correlations between behavioral (e.g. overt 
looking) and heart-defined attention, and association between these variables and clinical 
ASD risk, providing an initial conceptualization of heart-defined and behavioral 
attention, a topic previously unexplored in the ASIB literature. In Study 2, behavioral and 
heart-defined attention were examined during a gap-overlap task, a commonly used 
spatial cueing paradigm for examining attention orienting and disengagement in ASIBs 
(Elison et al., 2013; Elsabbagh, Volein, et al., 2009; Elsabbagh et al., 2013; 
Zwaigenbaum et al., 2005). In contrast to previous studies, we used both individual 
growth curves and integrated physiology to disentangle developmental processes and 
biological substrates of abnormal task performance. Thus, the purpose of Study 2 was to 
examine both nuanced developmental changes in orienting, as well as potential biological 
mechanisms sustaining abnormal orienting behaviors. To examine the generalizability of 
abnormal behavior and heart-defined attention to non-ASIB samples, Study 3 repeated 
Study 2 tasks in a cross-sectional sample of infants with FXS, contrasted to the ASIB and 
LR participants from Study 2. This study aimed to identify both converging and 
diverging patterns of risk, informing potentially heterogeneous pathways to ASD. 
Combined, these studies provide initial evidence of abnormal behavioral and heart 
defined attention at rest (Study 1), establish the intersection of development, orienting, 
and physiology (Study 2), and examine the generalizability of abnormal patterns from 
ASIBs to infants with FXS (Study 3).  
The first step to preventing ASD-associated impairments is characterizing the 
nature, course, and mechanisms of abnormal behaviors in infancy. The present three 
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studies address this need by elucidating the behavioral and biological scope of abnormal 
attention in infants at risk for ASD. Although parsing cross-syndrome variability is a 
complex task, capturing this heterogeneity may pave the way for developmental 
surveillance that is sensitive to individual differences, as well as targeted treatments that 
address the mechanisms, rather than symptoms, of impairment. 
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CHAPTER 2 
 
INFANT HEART-DEFINED SUSTAINED ATTENTION  
IN THE BROADER AUTISM PHENOTYPE
1
 
 
                                                          
1
 Tonnsen, B. L., Richards, J. E. & Roberts, J. E. To be submitted to Child Development  
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Visual attention is one of the most robust early indicators of autism spectrum disorder 
(ASD), with atypical features identified prior to 12 months of age in infants who later 
meet diagnostic criteria (Adrien et al., 1993; Clifford & Dissanayake, 2008; Holmboe et 
al., 2010; Jones & Klin, 2013; Swettenham et al., 1998; Zwaigenbaum et al., 2005). The 
majority of studies on early attention in ASD have been conducted with infant siblings of 
children with ASD (ASIBs) who exhibit higher rates of ASD diagnoses (19%; Ozonoff et 
al., 2011) than the general population (1-2%; Centers for Disease Control, 2012, 2014). It 
is notable that abnormal attention patterns have been observed in ASIBs who do not later 
meet ASD criteria (Messinger et al., 2013; Ozonoff et al., 2014; Toth et al., 2007), 
indicating broader patterns of genetic vulnerability associated with familial diagnoses. 
The recent expansion in ASIB research has been used to inform early identification and 
treatment protocols, permitting more timely and efficient access to services for affected 
children.  However, although a number of abnormal attention processes have been 
identified as potential “red flags” for ASD, the emergence and mechanisms of these 
behaviors remain unclear.  
Integrating neurobiological signatures of attention may inform the mechanisms of 
atypical patterns and, subsequently, early detection and intervention targets. In infants, 
heart activity may be used to measure the quality of attentional engagement (e.g. Casey & 
Richards, 1988; Richards & Casey, 1991; Richards, 1997), providing valuable 
information about the underlying biological systems sustaining attentional responses. 
Indeed, although measures of heart-defined sustained attention have been used 
extensively in non-clinical infant samples, indicators of global or attention-related heart 
activity have not been examined in infants at risk for ASD. Investigating the intersection 
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of ASD risk and sustained attention is warranted given the close association between 
overt and heart-defined attention in low-risk infants (e.g. Casey & Richards, 1988; 
Richards, 1987, 1997), abnormal physiological arousal identified in a subset of children 
with ASD (Anderson & Colombo, 2009; Bal et al., 2010; Kushki et al., 2013; Ming, Julu, 
Brimacombe, Connor, & Daniels, 2005), and self-regulatory and attentional deficits 
described in high risk infants (Elison et al., 2013; Elsabbagh et al., 2013; Ozonoff et al., 
2010, 2008; Zwaigenbaum et al., 2005). Thus, to inform the emergence and mechanisms 
of abnormal attention in ASIBs, the present study contrasted longitudinal patterns of 
behavioral and heart-defined sustained attention in 5-14 month old infants at high- and 
low-risk for ASD, examining both cross-group differences and clinical correlates of risk.  
Attention in Autism Spectrum Disorder 
Autism spectrum disorder affects 1:42 males in the United States (Centers for 
Disease Control, 2014) and is associated with a range of socio-communicative 
abnormalities and restricted or repetitive behaviors (American Psychiatric Association, 
2000). To receive an ASD diagnosis, symptoms must be present in early development 
and significantly impair the individual’s daily functioning. The lifetime costs of ASD are 
estimated at $2.4 million per child, with a substantial portion of costs – up to $88,000 
annually – occurring in adulthood (Buescher, Cidav, Knapp, & Mandell, 2014). Timely 
and effective interventions may reduce lifetime costs by over $1.3 million per person by 
altering symptom trajectories (Peters-Scheffer, Didden, Korzilius, & Matson, 2012) and 
potentially restructuring early neural development (Dawson, 2008). As such, promoting 
earlier identification and treatment of ASD maximizes positive outcomes for the affected 
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child and family, as well as substantially reduces public health costs associated with the 
disorder.  
Atypical attention is one of the most commonly reported features in ASD and 
manifests through a variety of socio-communicative characteristics, including difficulty 
following and initiating others’ attention (Meindl & Cannella-Malone, 2011), failing to 
orient to one’s name (Nadig et al., 2007), and inattention or aloofness during social 
interactions (Volkmar, 2011). These behaviors, which may be loosely categorized as 
attention-related in nature, are likely driven by a complex combination of developmental, 
socio-cognitive, and neurobiological processes. Early visual attention plays a central role 
in infant socio-communicative development by facilitating leaning and communication 
(Keehn, Müller, & Townsend, 2013; Mundy & Jarrold, 2010). Effective visual orienting 
also promotes effective emotional regulation by permitting an individual to adaptively 
alter sensory input (Landry & Bryson, 2004). As such, impaired attention processes may 
begin to derail socio-cognitive development early in life, intersecting with additional 
neurobiological and environmental factors to contribute to the ASD phenotype 
(Elsabbagh & Johnson, 2007; Keehn et al., 2013). 
Attention in Infants at Risk for ASD 
Although ASD is often diagnosed clinically as “present” or “absent,” it is largely 
accepted that ASD symptoms are best considered along a continuum, with subclinical 
traits extending into the general population (Lord & Jones, 2012; Short & Schopler, 
1988; Yoder et al., 2009). Complex genetic influences are highly implicated in ASD 
expression, with sibling recurrence risk estimated at 10-19% (Constantino, Zhang, 
Frazier, Abbacchi, & Law, 2010; Ozonoff et al., 2011) and higher levels of subthreshold 
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symptoms present in family members of affected individuals (Hurley, Losh, Parlier, 
Reznick, & Piven, 2007; Micali, Chakrabarti, & Fombonne, 2004; Piven, Palmer, Jacobi, 
Childress, & Arndt, 1997). The presence of these subthreshold symptoms in individuals 
who do not meet diagnostic criteria is termed the broader autism phenotype (Baron-
Cohen, 2004; Folstein & Rutter, 1977). The existence of a broader symptom spectrum is 
supported by evidence that relatives of individuals with ASD present elevated socio-
communicative symptoms and repetitive behaviors (Piven et al., 1997), including 
aloofness, rigidity, and social language deficits (Hurley et al., 2007; Micali et al., 2004). 
The degree of symptom severity is higher in families with multiple incidences versus 
single incidences of ASD (Losh, Childress, Lam, & Piven, 2008), further indicating 
genetic vulnerability for ASD risk. Examining neurobehavioral attention patterns in first-
degree relatives of individuals with ASD, therefore, may inform the neurobiological 
processes related to ASD emergence and expression. 
Because ASD is most often diagnosed in toddlerhood or later, the majority of 
studies investigating attention in ASD have focused on older children and adults, and past 
infant research largely relied on retrospective reports and home videos solicited after the 
initial diagnosis (see Rogers, 2009, for review). More recently, longitudinal studies of 
high-risk infants have begun to inform the natural history of ASD emergence in infancy. 
Abnormal cognitive and social attentional features have been observed by ASIBs and 
have been the topic of several reviews (Jones, Gliga, Bedford, Charman, & Johnson, 
2014; Rogers, 2009). Identified features include abnormal social attention in the first year 
of life, reflected by increased gaze toward the mouth versus eyes (Merin, Young, 
Ozonoff, & Rogers, 2007), diminished attention toward people (Bhat, Galloway, & 
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Landa, 2010; Chawarska, Klin, & Volkmar, 2003; Ozonoff et al., 2010), reduced 
initiation and response to joint attention  (Rozga et al., 2011), and abnormal social 
orienting (Jones & Klin, 2013). Atypical non-social visual behaviors, such as abnormal 
visual inspection of objects (Ozonoff et al., 2008) and impaired attention disengagement 
(Elison et al., 2013; Elsabbagh, Voleina, et al., 2009; Sacrey, Bryson, & Zwaigenbaum, 
2013; Zwaigenbaum et al., 2005), have also been reported. These findings present 
compelling evidence that aberrant attention is prominent in infants later diagnosed with 
ASD and – given further characterization – could serve as a candidate marker for early 
detection and prevention efforts.    
Despite the promise of ASIB attention research for translational science, it is 
difficult to draw clear conclusions from the current literature regarding the primary 
deficit or deficits that could potentially drive the broad array of attention-related findings. 
Indeed, although most theories of ASD emergence recognize likely contributions from 
social-cognitive and self-regulatory domains, various proposals has emphasized different 
candidate constructs – such as abnormal attentional disengagement (Keehn et al., 2013), 
social orienting (Jones & Klin, 2013; Klin, Shultz, & Jones, 2014), or parallel social and 
non-social processes (Bedford et al., 2014) – as primary influences in developmental 
cascades that produce ASD symptomatology. An alternate and potentially 
complementary theory is that attentional deficits emerge secondary to abnormal 
physiological arousal and self-regulation (Porges, 2003, 2004). This framework has been 
highlighted by several ASD research groups (Bal et al., 2010; Klusek et al., 2015; 
Quintana, Guastella, Outhred, Hickie, & Kemp, 2012) but has not been applied to studies 
of ASD in infants. The following sections will examine the applicability of this 
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framework for characterizing attention deficits in ASIBs, first by describing the 
theoretical intersection of autonomic functioning in ASD symptomatology, and second 
by examining this intersection in the context of infant attention.  
Autonomic Functioning in ASD 
Porges’ polyvagal theory posits the human autonomic system has evolved to 
maintain both behavioral and psychosocial characteristics such as communication 
abilities, emotional expression, and self-regulation (Porges, 1995). Understanding the 
association between polyvagal functioning and ASD first requires basic understanding of 
quantification and processes of autonomic nervous system function. Autonomic 
functioning is often measured through quantification of electrocardiogram (ECG) signal. 
The ECG measures activity from several areas of the heart, which generate waves 
conventionally labeled P, Q, R, S, and T. Heart activity is quantified as the temporal 
interval between R waves, commonly described as interbeat interval (IBI) or R-R 
interval. Heart rate (HR) is the inverse of IBI and may be quantified as beats-per-minute 
(BPM). Heart rate reflects both sympathetic and parasympathetic processes that are 
responsible for speeding or slowing HR, respectively. Parasympathetic heart activity is 
reflected in respiratory sinus arrhythmia (RSA), an index of cardiovascular activity 
associated with respiration.  Thus, IBI and RSA are commonly used indicators of 
combined sympathetic and parasympathetic (IBI) versus parasympathetic (RSA) 
functioning.  
Parasympathetic functioning is regulated by the vagus (cranial nerve X), which 
influences autonomic functioning through the heart’s sinoatrial node. High vagal tone 
operates on this node as a “brake,” inhibiting or slowing HR. When vagal tone relaxes 
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and lowers, this break is lifted, reducing inhibition and permitting acceleration of HR. 
Modulating the vagal brake is important to both mobilizing physiological resources 
during states of acute stress and promoting restoration in the absence of threat. Notably, 
both cardiac and facial muscles are regulated by fibers that originate from the same 
nucleus within the vagus. Thus, vagal health affects both effective modulation of heart 
activity, as well as more complex behaviors such as facial expression and vocalizations. 
Because the vagus facilitates communication between the brain and a wide number of 
visceral processes implicated in ASD (e.g. digestion, metabolic functioning, 
cardiovascular activity, temperature regulation), polyvagal theory has received increased 
attention as an explanatory framework for the neurobiology of ASD symptoms (Bal et al., 
2010; Klusek et al., 2015; Quintana et al., 2012). 
Studies of abnormal autonomic functioning in ASD generally support associations 
between vagal activity and the disorder, although findings vary across samples, ages, and 
tasks (see Cheshire, 2012; Klusek et al., 2015, for review). In general, individuals with 
ASD are reported to exhibit higher overall HR (Bal et al., 2010; Kushki et al., 2013; 
Ming et al., 2005) and larger tonic pupil size (Anderson & Colombo, 2009). Studies of 
RSA are mixed, with a number reporting lower overall RSA in ASD (Bal et al., 2010; 
Ming et al., 2005; Vaughan Van Hecke et al., 2009) but others reporting no group 
differences (e.g. Klusek, Martin, & Losh, 2013; Watson & Roberts, 2012). Autism is also 
associated with difficulties modulating arousal when task demands change (Althaus, 
Mulder, Mulder, Aarnoudse, & Minderaa, 1999; Smeekens, Didden, & Verhoeven, 2015; 
Vaughan Van Hecke et al., 2009). Within ASD samples, lower ASD symptomatology is 
correlated with lower HR and higher RSA (Bal et al., 2010; Klusek et al., 2013; Vaughan 
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Van Hecke et al., 2009), suggesting a gradient of within-syndrome variability. Together, 
these studies implicate abnormal autonomic functioning in ASD, although future work is 
needed to clarify specific implications of abnormal autonomic functioning and 
developmental pathways of risk. 
Heart-Defined Sustained Attention  
In addition to providing a broad biomarker of self-regulation, autonomic 
functioning is closely associated with behavioral attention. Indeed, patterns of heart 
activity have been used to index behavioral attention responses for over 50 years 
(Graham & Clifton, 1966; Lacey, 1959). When the brain’s arousal system is activated, 
cardioinhibitory centers initiate parasympathetic processes to slow HR. In infants, these 
decelerations may be use to quantify qualities of stimulus engagement that cannot be 
measured using overt looking patterns alone (Casey & Richards, 1988; Richards & 
Casey, 1991; Richards, 1997). Richards and colleagues have demonstrated that these 
patterns of HR decelerations index three primary phases attention in infants: orienting, 
sustained attention, and attention termination (Casey & Richards, 1991; Richards & 
Casey, 1991; Richards, 2000). Orienting in infants is reflected by a sudden deceleration 
of 8 to 10 HR beats per minute (BPM; see Richards, 1995, for review). Sustained 
attention (SA) is indexed by maintenance of this decelerated HR, reflecting the exertion 
of additional cognitive resources to process the stimulus. Attention termination occurs 
when HR begins to return to prestimulus levels, reflecting decreased stimulus 
engagement despite continued looking. Quantifying duration and magnitude of SA 
provides useful information about the quality of stimulus processing that may not be 
detectible from overt behavior alone. Sustained attention may also inform the 
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mechanisms of behavioral responses. For example, infants in periods of SA are less 
distractible across a variety of tasks, including computerized orienting paradigms (Casey 
& Richards, 1988; Richards, 1997) and toy play activities (Lansink & Richards, 1997; 
Roberts et al., 2011). Thus, SA is a well-established biomarker of attention in infants.  
A small number of studies have examined HR deceleration as an index of global 
attention in older individuals with ASD. Corona and colleagues (1998) reported that 
children with ASD (ages 3-5 years) demonstrated less change in HR when observing an 
examiner in distress, using comparisons of average HR across epochs (Corona, 
Dissanayake, Arbelle, Wellington, & Sigman, 1998). However other studies have 
reported no group differences in HR decelerations between ASD and non-ASD 
participants when viewing pictures with varied social and emotional valence (Louwerse 
et al., 2014; Mathersul, McDonald, & Rushby, 2013). No studies to date have integrated 
measures of heart-defined SA to index attentional engagement in infants at elevated risk 
for ASD. 
The Present Study 
Identifying potential biomarkers of ASD risk may inform earlier and more 
effective detection and intervention, as well as lend insight into the developmental 
processes associated with ASD emergence. Although abnormal attention and physiology 
are well-documented in ASD, the development and intersection of these processes in 
infancy are poorly understood. Only a handful studies have examined ASIBs’ attentional 
response using psychophysiological techniques (e.g. Elsabbagh et al., 2012; Key & 
Stone, 2012; McCleery, Akshoomoff, Dobkins, & Carver, 2009), and no studies to date 
have examined ASIB attention by integrating measures of heart activity, a reliable 
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biomarker of attention in typically developing infants (e.g. Casey & Richards, 1988; 
Richards & Casey, 1991; Richards, 1997).   
To examine the biobehavioral development of abnormal attention in high-risk 
infants, the present study longitudinally assessed high-risk ASIBs and low-risk controls 
ranging from 5-14 months of age. This age range was chosen in light of previous studies 
suggesting abnormal attention in ASIBs emerges between 6 and 12 months of age 
(Elsabbagh et al., 2013; Zwaigenbaum et al., 2005). The primary goals were to examine 
(1) correspondence between behavioral and heart-defined attention, (2) group differences 
in attention patterns across age, and (3) associations between attention indicators and 
clinical ASD risk among ASIBs. This work aims to identify whether heart-defined 
attention may serve as a biomarker of ASD risk, potentially informing earlier, targeted, 
and optimized intervention efforts.  
Methods 
Participants 
Participants were drawn from a study of early development in high risk infants. 
Infants were required to be born full term (37 weeks or later, >2000 grams) and live with 
their biological mother. Infant siblings were required to be full biological siblings of a 
child with a documented ASD diagnosis, verified using medical records. Parents reported 
no documented developmental delays or diagnosed genetic or medical conditions at study 
entry. Infants were enrolled between 4.5 and 10.5 months of age and were assessed on up 
to 3 occasions. These assessments occurred across three age windows, centered around 6, 
9 and 12 months: 5-8 months, 8-11 months, and 11-14 months. Nine additional “low 
risk” (LR) participants were assessed but excluded from the present study due to 
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developmental or medical concerns (n = 4; e.g. epilepsy, high ASD screening scores at 12 
months), a sibling being considered for ASD during the course of the study (n = 1), and 
chronological age-matching purposes (n = 4).  
The final sample included 43 infants (21 ASIBs, 22 LR controls) assessed 
between 5 and 14 months of age for a total of 77 assessments. Groups exhibited similar 
numbers of participants with one assessment (ASIB n=8, LR n=10), two assessments 
(ASIB n=8, LR n=8) and three assessments (ASIB n=5, LR n=4). Each group included 4 
female participants. In addition to the 77 assessments included in analyses, 22 additional 
assessments were conducted but excluded due to greater than 5% error in heart activity 
data (n = 15; 6 ASIB), technical difficulties (n = 6; 4 ASIB), and infant noncompliance (n 
= 1; 1 ASIB). Non-compliance was defined as refusing to sit in front of the screen; 
participants who complied with sitting but did not attend to the screen were included in a 
subset of analyses to capture variability in overt attention. Proportion of missing data 
(22.2%) was slightly higher than previous studies in similar samples (Elsabbagh et al., 
2009; 16%), likely reflecting physiological data collection not used in prior studies. 
Number of assessments with missing behavioral or physiological data were equivalent 
across groups (n = 11 each).  
Procedure and Measures 
Parents provided consent prior to the onset of the study and were compensated for 
participation. To minimize family travel, assessments alternated between laboratory and 
home environments, with assessments in the 6 month assessment window occurring in 
the laboratory, 9 month in home, and 12 month in laboratory. As part of a larger battery, 
each assessment included a visual attention task and additional developmental and 
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clinical evaluations. The present study includes attention and physiological data from all 
assessments, as well as developmental and clinical testing from the 12 month assessment 
window only due to increased stability of these measures at older ages. Materials, 
equipment, and experimental set-up were identical across settings. Order of assessment 
tasks was standardized across assessments, with the visual attention task attempted prior 
to other testing to maximize infant engagement. If the infant was fussy or noncompliant, 
the attention task was reattempted following other components.  All testing was 
conducted with the child’s mother present.  
Attention Task. During each assessment, participants’ looking behavior and 
heart activity were measured while they viewed an engaging 135-second children’s video 
clip (Baby Einstein series). Participants were seated in a darkened room, 10” away from 
an 11 x 24” LCD monitor. Two video cameras simultaneously recorded stimuli and 
participants’ faces. To minimize distractions and standardize environments, the monitor 
and infant were surrounded on three sides by a portable, nonreflective black felt shield. 
Electrocardiogram signal (ECG) was collected using Alive Heart Monitors (Alive 
Corporation, Gold Coast, Australia), a telemetry based system that directly attached to 
the infant’s chest via two electrodes. Signal was transmitted live to a laptop via Bluetooth 
technology.  If the child did not attend to the video voluntarily, the examiner provided up 
to 3 prompts to re-engage the child. After 3 prompts, the child was permitted to look 
toward or away from the screen. 
Clinical Autism Risk. The Autism Observation Scale for Infants (AOSI; Bryson 
et al., 2008) is a semi-structured, interactive assessment that measures risk factors for 
ASD in infants ages 6-18 months. The AOSI includes various play-based behavioral 
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presses designed to elicit 18 behaviors empirically related to ASD risk in ASIBs. These 
items measure a variety of constructs including visual attention (visual tracking, 
disengagement of attention, orienting to name), social behaviors (response to facial 
emotion, anticipating social games, imitating, babbling, eye contact, social smile, shared 
affect), sensory-motor symptoms (coordination of gaze and action, motor control, motor 
and sensory behaviors), and temperament and reactivity (behavioral reactivity, 
cuddliness, soothability, transitions). Administration takes approximately 20 minutes and 
is videotaped for offline coding.  Item scores are summed to yield a total score (0-50), 
and the number of elevated items may also be used to assess whether infants exceed a 
threshold of clinical risk (“number of markers” >7). The AOSI has demonstrated good to 
excellent interrater reliability on individual items (.53-1.0) and acceptable total score test-
retest reliability (.61) at 12 months (Bryson et al., 2008). Previous studies have 
successfully employed  the AOSI  as indicators of clinical ASD risk in similarly aged 
ASIB samples (Brian et al., 2008; Rogers et al., 2014b; Zwaigenbaum et al., 2005).The 
AOSI was administered by staff trained to research reliability through a rigorous series of 
supervised administrations and reliability coding. All AOSI data were collected during 
the 12 month assessment window. Assessments were scored by a primary examiner, with 
20% of assessments also scored by a second rater for reliability. Interrater reliability at 
the item level was 89%. Table 1.1 includes descriptive information about AOSI total 
scores and number of markers. Three of 19 ASIBs with AOSI data exceeded the clinical 
threshold of 7 elevated AOSI items. 
The present study used the AOSI Total Score at the final assessment (e.g. between 
11-14 months) as a behavioral indicator of broader autism phenotype symptomatology. 
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Previous studies suggest the AOSI is sensitive to subthreshold symptoms of the ASD 
endophenotype in ASIBs, as ASIBs without later ASD diagnoses have exhibited AOSI 
total scores that generally fall between LR and ASD groups (Gammer et al., 2015a). 
Although we did not use the AOSI diagnostically, total score on the AOSI at 12-14 
months has also been established as a strong predictor of later ASD diagnoses on gold-
standard instruments (Gammer et al., 2015b; Zwaigenbaum et al., 2005), suggesting the 
AOSI is a relatively sensitive clinical tool for emerging ASD features. Thus, we 
examined AOSI total score as a continuous metric of risk, rather than to inform 
diagnostic classification. However, future work is underway to also examine the 
association between early attentional features and gold-standard ASD diagnoses later in 
development.    
Developmental Ability. The Mullen Scales of Early Learning (MSEL, Mullen, 
1995) is a standardized measure of cognitive development for children under 68m. The 
measure includes five developmental domains: gross and fine motor, receptive and 
expressive language, and visual reception. Scales have demonstrated adequate internal 
consistency (.75-.83), test-retest reliabilities (.76-.96), and interrater reliabilities (.91-.96). 
Participants’ MSEL Early Learning Composite Standard Score from the 12-month 
assessment window was used as a covariate in analyses, as previous research indicates a 
relationship between attention and mental age in ASD (Keehn, Lincoln, Müller, & 
Townsend, 2010; Leekam, Hunnisett, & Moore, 1998).  All administrators underwent 
rigorous training, which included reading training materials, observing several 
administrations, completing practice administrations on low-risk children, co-
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administering the MSEL on high-risk children alongside trained staff, and independently 
administering the MSEL under the supervision of trained staff.  
Quantification of Behavioral and Physiological Variables 
Behavioral data were integrated into Observer XT 10.1 software (Noldus 
Information Technology, 2010) for offline coding. Proportion of time looking toward the 
screen (“behavioral looking”) was calculated for each participant. Interrater agreement 
for behavioral looking codes across 20% of files was 83%.  
Physiological artifact editing was completed by a coder trained to research-
reliability through a standardized training sequence supervised by the Brain-Body Center 
staff. Files requiring greater than 5% editing were excluded from analyses (n=15; 6 
ASIB, 9 LR), consistent with previous studies (e.g. Corona et al., 1998). Figure 2.1 
provides further justification for using this 5% threshold. This figure depicts the 
distribution of editing required across participants with data that could be edited (an 
additional 6 files are not depicted because the proportion edited could not be generated, 
due to excessive artifacts). As this figure depicts, all data with greater than 5% error fell 
outside of 1.5 interquartile range, suggesting 5% is a reasonable threshold for considering 
“outliers” in data quality.    
Physiological data were quantified using both summary and heart-defined 
attention variables. First, data were converted to interbeat interval (IBI), edited for 
artifacts, and analyzed using the CardioEdit and CardioBatch programs (Brain-Body 
Center, 2007).  Three primary summary variables were generated using CardioBatch: 
overall IBI, standard deviation (SD) of IBI, and respiratory sinus arrhythmia (RSA). 
Next, duration and magnitude of HR deceleration during SA were analyzed using mean-
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change algorithms in SAS 9.3 (Casey & Richards, 1991; Richards & Casey, 1991). 
Within the algorithm, behavioral codes were used to isolate portions of the task in which 
participants looked toward the screen. In each period of looking, numerical algorithms 
calculated heart-defined attention phases by comparing IBI to baseline, defined as the 
median IBI of 5 beats preceding gaze toward the screen. Baseline values were reset each 
time the participant looked away from the screen for more than 1.5 s. Attention orienting 
was defined as IBIs directly following the initiation of behavioral attention, prior to the 
onset deceleration. The onset of sustained attention (SA) was indexed by 5 successive 
beats with longer IBIs than baseline. Attention termination initiated after 5 successive 
beats with IBIs shorter than baseline. Figure 2.2 displays individual heart-defined 
attention phases across these three phases relative to baseline, collapsed across 
assessments, individuals and groups. Each individual figure line represents a single phase 
of attention. As expected based on previous use of SA algorithms, infants exhibited 
variable durations, depths and variability of SA across phases.  The present study focused 
exclusively on SA, which was quantified using three primary dependent variables: 
proportion of time in SA, average depth of SA, and standard deviation of IBI during SA.  
Due to the short duration of the task and necessity of behavioral attention to 
calculate SA variables, SA variables were not computed for participants who spent less 
than 30% of the task (~40 seconds) looking toward the screen (n= 9; 6 ASIB, 3 LR). This 
threshold was selected due to 1) the short duration of the visual attention task, 2) 
necessity of behavioral looking to code SA variables, and 3) presence of bimodal SA 
values in participants with low proportion of time in behavioral attention, suggesting 
brief behavioral attentiveness does not produce SA data representative of longer data 
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samples. However, given our goal to explore behavioral attentiveness as a primary 
dependent variable, these participants were retained in behavioral looking analyses to 
prevent biasing behavioral data 
Analyses 
Analyses were conducting using SAS 9.3 (Apex, NC) with α set to less than .05. 
Data were evaluated for analytic assumptions and outliers prior to analyses. Groups did 
not differ in number of assessments per participant, F (1, 41) = 0.30, p = .59, or mean 
chronological age across assessments, F (1, 75) = 0.32, p = .57. Normal probability plots 
of residuals at each analysis level indicated non-normal distribution of the following 
variables, which were log-transformed prior to analyses: average IBI, IBI SD, RSA, 
proportion time looking toward screen, proportion time in SA, IBI SD during SA, 
average IBI deceleration during SA, and total AOSI score. Descriptive statistics for raw 
data are presented in Table 2.1. 
We first examined associations between behavioral looking and physiological 
variables to test our hypothesis that behavioral attention would positively correlate with 
lower IBI, higher RSA, and greater SA (higher proportion of time in SA, greater IBI SD 
during SA, larger IBI deceleration during SA).  These analyses were conducted using 
Spearman partial correlations, controlling mental and chronological age.  
Next, a series of multilevel models were constructed to test the hypothesis that the 
ASIB group would (1) be more behaviorally attentive than LR controls and (2) display 
higher IBI and lower RSA, and (3) would display greater SA, indexed by greater 
proportion of time in SA, greater IBI variability during SA, and deeper SA decelerations. 
To test these hypotheses, a series of multilevel models were fit to test the effect of group 
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membership (level 2 predictor) on initial level and change of behavioral attention 
(proportion time looking toward screen), heart activity (IBI, RSA, IBI SD), and heart-
defined sustained attention (proportion time in SA, SD of IBI during SA, average IBI 
deceleration). To test our hypothesis that clinical ASD risk would be predicted by 
abnormal behavioral and heart-defined attention among ASIBs, we repeated these models 
in the ASIB group only, using AOSI total score as a continuous level 2 predictor. For 
each model, continuous age interactions were probed using post hoc nonparametric 
Wilcoxon signed ranked tests that tested group differences in dependent variables across 
three separate age ranges: 5-8 months, 8-11 months, and 11-14 months. The proportion of 
variance explained by conditional models was estimated using pseudo R
2
, calculated as 
the proportion of residual variance in the null model reduced by combined explanatory 
variables (Singer & Willett, 2003).  
Multilevel model fit was determined for each dependent variable using a series of 
model comparisons, which are summarized in Table 2.2. First, intraclass correlation 
coefficients (ICC) were constructed to determine the proportion of variance accounted for 
by individuals. Next, AIC and BIC were contrasted across several model types to 
determine which random effects best characterize data variance and covariance. As 
detailed in the table, ICCs indicated substantial variance in dependent variables occurring 
between individuals for three dependent variables: proportion time in behavioral 
attention, overall IBI, and overall RSA. The ICCs for the remaining variables were 0, 
indicating that nearly all variance in the dependent variables was accounted for by 
observation-level data rather than participant-level data. Figure 2.2 depicts high 
variability of data within and between individuals for IBI SD during SA (ICC=0). Given 
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the high within-individual variability, data were analyzed using both multilevel and 
general linear model methods, which produced consistent results. As such, multilevel 
results are reported for continuity. Across variables, AIC and BIC statistics indicated 
observations are best modeled as nested within individuals (Model 2). Notably, modeling 
age as a random effect (Model 3) either worsened or negligibly changed model fit, 
indicating the association between age and dependent variables was relatively stable 
across individuals. Thus across analyses, intercepts were modeled as random effects 
nested within individuals, whereas age was included as a fixed effect only.   
For each dependent variable, unconditional means and growth next models 
estimated level and change in attention over time. 
Equation 1. Yij = ß0j + ß1j (TIMEij) + eij 
Yij indicates the dependent variable (e.g. proportion looking, depth of SA) of observation 
i within individual j. ß0j and ß1j represent the true change trajectory intercept and slope, 
respectively, of individual  j. eij represents random error for prediction of the 
unconditional model.  
To test the hypothesis that level and change in attention vary across groups, group 
and cognitive ability were added to the model as level 2 time-invariant explanatory 
variables. 
   Equation 2. ß0j = g00 + g01 Zj + u0j  Equation 3. ß1j = g10 + g11 Zj  
Equation 2 predicts overall level of attention (intercept coefficient ß0j) from group 
membership (Zj). Equation 3 predicts the relationship between attention and age, 
expressed as the slope coefficient ß1j, from group membership (Zj). g00 and u0j represent 
the fixed and random effects of time-invariant Level 2 predictors (group, group x age) 
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and covariates (cognitive ability) on the intercept of attention (ß0j). g10 represents the 
fixed effect of Level 2 predictors on the slope (ß1j). Significant group effects indicate 
mean differences at the centered age of the sample (9 months), and significant age x 
group interaction indicates group differences in change over time. To examine effects of 
12 month AOSI scores on behavioral performance in ASIBs, a second set of models 
included AOSI scores as time-invariant predictors of level and change in attention, 
controlling for cognitive ability. The proportion of variance explained by conditional 
models was estimated using pseudo R
2
 (Singer & Willett, 2003). 
Results 
Biobehavioral Variable Correlations 
Consistent with hypotheses that behavioral attention would correspond to greater 
heart-defined SA, proportion of time in behavioral and heart-defined attention positively 
correlated (ρ = -.69, p < .001). These effects were maintained in both ASIB and LR 
groups when examined individually. Contrary to hypotheses, proportion of time in 
behavioral attention did not correlate with global heart activity (IBI, RSA, IBI variability) 
or qualities of heart-defined SA (SA IBI variability, SA IBI change; p’s > .05). Thus, the 
association between behavioral attention and physiology was specific to the proportion of 
time in SA.  
Group Differences in Attention 
Unconditional models described significant variability in mean levels of variables 
and characterized general trends in variables across time. Significant variability was 
observed in mean levels of all dependent variables (p < .001), warranting examination of 
fixed and random effects in subsequent conditional models. Across the sample, 
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proportion of time in SA decreased with age (β = -0.02, p = .03), whereas the following 
variables increased: IBI (β = 0.01, p = .008), IBI SD (β = 0.05, p = .03), RSA (β = 0.03, p 
= .05) and IBI SD during SA (β = 0.06, p = .05). The remaining unconditional age effects 
were not significant.  
Conditional models indicated group differences in proportion of time spent in 
both behavioral and heart-defined SA. Fixed effects for these models are listed in Table 
1.3.To summarize, ASIB and LR groups exhibited different age-related patterns of 
proportion time in both behavioral and heart-defined attention. Figure 1.4 depicts these 
associations, demonstrating individual trajectories of behavioral and heart-defined SA 
across age (gray lines), as well as average trajectories for each group across all data 
points (thick black lines). The LR group exhibited age-related decreases in attentiveness 
across ages, whereas the ASIB group exhibited subtle increases over time. Post-hoc 
analyses supported this trend, with greater SA in ASIBs (Z = 1.76, p = .04) and 
behavioral inattention in LR controls (Z = -2.00, p = .02) within the oldest age window 
and was marginally higher SA in the LR group (Z = -2.47, p = .07; p=.14) within the 
earliest age window. Additional post-hoc comparisons were not significant, and groups 
did not differ in other global or heart-defined attention parameters. The conditional 
models explained 18% and 13% of the variability in the behavioral and heart-defined 
sustained attention unconditional means models, respectively. Thus, groups were 
primarily distinguished by distinct age-related patterns of attention, reflected at 
behavioral and physiological levels, with age-related decreases in attention in the LR but 
not ASIB groups.  
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Predictors of Clinical ASD Risk among ASIBs 
Within-group conditional models for the ASIB group indicated significant 
associations between clinical ASD risk and a subset of physiological variables. Fixed 
effects for these models are presented in Table 2.4. Among ASIBs with available AOSI 
data (n = 19; behavioral assessment n = 39; physiological assessments n = 37), higher 
clinical ASD risk scores were associated with abnormal age-related changes in global 
(overall IBI, overall IBI variability) and SA (IBI change during SA, IBI variability during 
SA) parameters. For each of these variables, participants with lower clinical risk 
increased over time, whereas participants with higher clinical risk showed less robust 
changes across age (lower IBI and IBI variability; less IBI change and IBI variability 
during SA). In other words, ASIBs with higher clinical risk exhibited less typical patterns 
of change in each physiological variable over time, increasingly deviating from 
participants with lower clinical risk. An example of this pattern is depicted in Figure 2.5, 
with the low risk control data displayed for reference. As this figure depicts, both low 
clinical risk and LR groups increased in IBI SD, whereas participants with higher clinical 
risk exhibited more stable levels of IBI SD across age. The predictors in these models 
accounted for between 19-44% of the variance in unconditional growth models, as 
detailed in Table 2.4.  
Discussion 
Physiological self-regulation provides a basis for attention processes by adjusting 
arousal to most efficiently meet environmental demands (Porges, 1996; Posner & 
Rothbart, 2000). Within ASD, self-regulatory deficits are well-established and have been 
posited to relate to emerging ASD features early in development (Klusek et al., 2015). 
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The present study is the first to examine – and identify -- abnormal patterns of both 
behavioral and heart-defined attention in ASIBs within the first year of life, suggesting 
abnormal arousal may contribute to the ASD endophenotype in infants. Furthermore, we 
identified a subset of variables that predicted clinical markers of ASD risk at 12 months, 
warranting further investigation of whether infant arousal – particularly as related to 
visual attention – may operate as biomarkers of clinical risk in this population.  
Although identifying biomarkers of ASD offers potential to revolutionize early 
detection and prevention efforts, it is notable that the vast majority of biomarker research 
in ASD, including the present study, suggest heterogeneous patterns of risk. We 
identified a number of attention-related predictors of behavioral ASD features among 
ASIBs, suggesting physiological patterns may relate to emerging ASD symptomatology. 
However, similar to previous studies (Messinger et al., 2013; Ozonoff et al., 2014; Toth 
et al., 2007), we also identified abnormal neurobiological features that distinguished 
ASIBs from controls but did not predict clinical ASD symptoms. A likely explanation for 
these patterns is that components of attention represent intermediate endophenotypes of 
ASD rather than specific, one-to-one clinical biomarkers of risk. An endophenotype is a 
measurable, heritable trait that associated with a clinical profile (Gottesman & Gould, 
2003). Importantly, endophenotypes are present in individuals affected with the clinical 
profile (e.g. ASD) as well as their relatives, signifying “‘downstream’ traits or facets of 
clinical phenotypes, as well as the ‘upstream’ consequences of genes” (Gottesman & 
Gould, 2003, p. 637). Heart activity has been endorsed as a potential endophenotype of 
ASD due to the high heritability of physiological profiles and abnormal autonomic 
functioning observed in a subset of individuals with ASD (Klusek et al., 2015). Similarly, 
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a number of researchers have conceptualized atypical profiles in ASIBs and first-degree 
relatives of individuals with ASD as endophenotypes given clear genetic vulnerabilities 
and associations with ASD symptoms (Elsabbagh & Johnson, 2010; Klusek et al., 2015; 
Losh et al., 2008; Walsh, Elsabbagh, Bolton, & Singh, 2011).  Our findings contribute to 
this framework by suggesting that abnormal autonomic and attentional functioning 
emerges in the first year of life among a subset of infants at genetic risk for ASD. 
We also identified both behavioral and physiological patterns that distinguished 
infants with and without family history of ASD. Notably, gross indicators of behavioral 
and physiological attention – specifically the proportion of time in both behavioral and 
sustained attention – distinguished ASIB and LR groups but did not predict clinical ASD 
risk among ASIBs. Specifically, ASIBs demonstrated more subtle decreases in both 
behavioral attention and SA over time, relative to low risk controls. This pattern of 
sustained engagement – rather than typical decreases in engagement with age – parallels 
clinical observations of attention-related perseveration or “sticky attention” in older 
children with ASD (Sasson, Turner Brown, Holtzclaw, Lam, & Bodfish, 2008). However, 
these relatively diffuse temporal variables did not predict within-group variability in 
clinical ASD risk, suggesting insufficient sensitivity to detect subtle, clinically-relevant 
changes over time. Thus although it is striking that overt attentional patterns 
distinguished groups at such a young age, these variables did not predict within-group 
variability among ASIBs.  
In contrast to behavioral markers that distinguished groups but did not predict 
clinical risk, global indicators of physiology exhibited an opposing pattern; similar 
patterns were exhibited at the group level, with subtle but significant deviations observed 
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in ASIBs with higher clinical ASD risk. Group comparisons indicated similar mean 
levels and age related patterns of global IBI, RSA and IBI variability, with both groups 
exhibiting age-related increases in IBI typical to infant development. However, ASIBs 
with higher clinical ASD risk markers in the 12 month assessment window exhibited 
slower rates of change in IBI and IBI SD across age, suggesting gradual deviations from 
typical trajectories. These deviations were not robust enough to produce differences 
between LR and ASIB groups as a whole, potentially reflecting modest sample size or 
emerging differences in a subset of the ASIB sample. These patterns suggest that 
autonomic dysfunction observed in children and adults with ASD (see Cheshire, 2012; 
Klusek et al., 2015, for review) may be detectable during the first year of life. However, 
higher clinical risk was associated with relative hypoarousal, a pattern that contradicts 
previous findings that ASD is associated with hyperarousal in older individuals (Bal et 
al., 2010; Kushki et al., 2013; Ming et al., 2005). Given arousal has been previously 
unstudied in ASIBs, it is possible that developmental profiles differ from infancy and 
later development. Indeed, in fragile X syndrome, ASD features are associated with 
hypoarousal in the first year of life but hyperarousal in later toddlerhood (Roberts, 
Tonnsen, Robinson, & Shinkareva, 2012), thus it is possible that ASD is associated with 
shifts in arousal across early development. Further longitudinal work is needed to test this 
theory in ASIBs, as well as to examine the association between early abnormalities and 
later ASD diagnoses.   
Whereas behavioral attention and global physiology produced group differences 
(behavioral attention) or predicted clinical ASD risk among ASIBs (global physiology), 
qualities of heart-defined SA both differentiated groups and predicted clinical ASD risk 
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in ASIBs, supporting SA as a potentially robust indicator of abnormal development in 
this sample.  Similar to previous samples (Casey & Richards, 1988; Richards & Casey, 
1991; Richards, 1997), behavioral attention correlated with measures of SA, supporting 
the measure as a biomarker of attention in ASIBs. Notably, specific qualities of SA – 
rather than proportion of time in SA – predicted clinical ASD risk among ASIBs, with 
higher clinical ASD risk among ASIBs who exhibited slower changes in SA-related IBI 
variability and IBI change across ages, resulting in lower levels of IBI variability and 
change at older ages. These emerging group differences may evolve into blunted arousal 
modulation observed in children and adults with ASD (Althaus et al., 1999), although this 
theory must be tested empirically. Interestingly, similar patterns of lower IBI variability 
and less IBI change during SA have been reported  in infants with fragile X syndrome, a 
single-gene disorder highly associated with ASD (Roberts et al., 2011). Together, these 
data suggest that heart-defined SA may inform the heterogeneity of ASD risk in infancy, 
although future work is needed to determine the course and implications of these 
associations. 
Future Areas of Study  
Together, our data suggest ASD-related physiological dysregulation may emerge 
in infancy, laying the foundation for several future areas of study including (1) the 
integration of physiology and translational science, (2) longitudinal profiles and 
consequences of abnormal arousal in ASIBs, and (3) generalizability of these features to 
other high-risk groups.  
First, our data provide initial evidence that physiological profiles may inform the 
etiology and emergence of ASD-related features, warranting further study of the utility 
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and scope of integrating physiology in translational science. Next steps will include 
establishing the specific onset of self-regulatory deficits, given our data suggest emergent 
group differences between ASIBs and LR controls by 6 months of age. Further work is 
also needed to clarify whether global atypicalities and attention-specific impairments 
present as additive or multiplicative components of risk. For example, questions may 
include whether abnormal SA drives global physiological differences, or whether 
abnormal SA is a downstream effect of broader self-regulatory deficits. Similarly, the 
etiology of these self-regulatory deficits – and potential endophenotypes of ASD – must 
be explored through the integration of clinical science, neuroscience and genetics.  
This work may lay foundation for interventions to improve ASD-related 
outcomes, potentially by targeting infant self-regulation. Although a heart-defined SA 
predicted clinical ASD risk within our ASIB sample, a number of questions also remain 
regarding the potential utility and applicability of this biomarker in clinical research. It 
will be important to determine the incremental validity of employing measures of heart-
defined SA beyond simply measuring global indicators of heart activity, as these 
measures also predicted clinical ASD risk in the present sample. For example, further 
work may examine whether SA is more sensitive to clinical risk or more closely related 
to attention-related impairments observed in ASD, as well as study potential directional 
effects between attention-related physiology and global arousal modulation.  These 
studies may inform whether SA provides an incrementally sensitive marker of 
developmental change in ASIBs, a first step to potentially incorporating measures of SA 
into early detection and intervention monitoring protocols.  
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An important next phase of this work will be to establish long term profiles and 
developmental cascades associated with abnormal physiology. Although exploring 
group-level differences in ASIBs – regardless of later ASD status – informs 
endophenotypes of risk, it will also be important to establish the association between 
abnormal behavioral and heart-defined SA to later ASD diagnoses and other 
developmental concerns (e.g. language impairments, mental health concerns) reported in 
a subset of first-degree relatives of individuals with ASD. As noted by Rogers (2009), 
unpacking group differences by examining within-group variability and outcomes is 
critical given (1) a number of studies have reported developmental abnormalities in 
ASIBs that did not predict specific developmental concerns, and (2) developmental 
abnormalities do not necessarily follow a linear course, thus developmental differences in 
infancy may not map onto later developmental atypicalities. Although the present study 
provides a first step to these investigations by characterizing associations between 
attention and clinical ASD risk in infancy, longitudinal follow-up of these participants 
will be critical to informing long-term processes associated with these early impairments. 
Indeed, this work is currently underway in the present sample and will be the topic of 
future publication. 
 The associations we observed between physiological variables and clinical ASD 
risk also warrant further investigation into the generalizability of these findings to other 
infant samples at elevated risk for ASD. For example, infants with fragile X syndrome 
exhibit elevated rates of ASD symptoms (Bailey, Skinner, Davis, Whitmarsh, & Powell, 
2008; Kaufmann et al., 2004), and abnormal patterns of heart-defined SA have been 
associated with ASD symptoms in a small sample of affected infants (Roberts et al., 
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2011). Indeed, Roberts et al reported lower IBI variability, less IBI change during SA, 
and longer behavioral looks in infants with fragile X compared to LR controls, patterns 
that parallel physiological predictors of clinical ASD risk in our ASIB sample. Given 
ASIBs have been shown to exhibit abnormal behavioral patterns not associated with later 
ASD diagnoses (Messinger et al., 2013; Ozonoff et al., 2014; Toth et al., 2007), cross-
syndrome comparisons are important to informing the specificity and generalizability of 
potential ASD precursors detected in ASIB samples. 
Limitations 
 These future directions highlight a number of limitations of the current study, 
including the relatively small sample, lack of long-term ASD and developmental outcome 
measures, and lack of non-ASIB high-risk comparison groups. Due to infant 
noncompliance, our analyses also do not include several assessments in which 
participants either did comply with the task (n=1 ASIB) or provided insufficient 
behavioral looking to examine physiological data (n= 9; 6 ASIB, 3 LR). Although 
behavioral looking paradigms that included the later 9 participants produced similar 
patterns to physiological paradigms that excluded these participants, future studies may 
examine attention during longer paradigms longer paradigms to improve participants’ 
engagement opportunities an increase sample representativeness. Although the present 
study employed a passive looking paradigm to examine endogenous attentional 
regulation, gaze-contingent paradigms may also be used by future studies to elicit greater 
behavioral attention by providing real-time feedback regarding participant compliance. 
Examining heart-defined SA across multiple contexts and task designs is important to 
informing the applicability of this method to translational science.  
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Conclusion 
The present study provides initial evidence that infants at elevated genetic risk for 
ASD, as a group, exhibit abnormal patterns of both behavioral and heart-defined 
attention, with a subset of physiological markers predicting clinical ASD risk. In addition 
to informing the early course of ASD emergence by identifying abnormal physiological 
dysregulation in ASIBs within the first year of life, this work provides a foundation for 
further study of heart-defined SA as a potential endophenotype of ASD, as well as a 
potential tool for sensitively monitoring developmental change over time. Given further 
characterization and study, these biomarkers could both inform etiological processes, 
targeted detection, and optimized interventions for infants at elevated risk for ASD.  
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Table 2.1: Descriptions of Primary Variables at both Individual and Assessment Levels 
 
  
High Risk Infant Sibling (n=21) 
 
Low Risk Control (n=22) 
  
 
n 
 
SD min max 
 
n 
 
SD min max 
Individual-Level Variables 
n assessments 
 
21 1.86 0.79 1 3  22 1.73 0.77 1 3 
MSEL SS  
 
21 97.62 16.26 60 137  22 102.82 10.69 80 117 
AOSI Total Score  
 
19 6.47 4.72 1 19       
AOSI N Markers 
 
19 4.32 2.38 1 10       
Assessment-Level Variables 
Age in months 
 
39 9.89 2.42 5.98 13.41  38 10.18 2.17 5.69 13.74 
% Inattentive  39 0.40 0.24 0.08 0.95  38 0.44 0.22 0.03 0.81 
Heart Activity 
 
           
     Overall IBI 
 
39 473.90 45.01 382.58 583.41  38 473.19 48.49 396.11 580.71 
     Overall RSA 
 
39 4.00 1.11 1.93 6.78  38 4.46 1.14 2.59 6.79 
     Overall IBI SD 
 
39 29.32 15.41 5.63 81.69  38 31.89 12.91 11.48 65.35 
Sustained Attention 
 
           
     Proportion SA 
 
37 0.30 0.21 0.00 0.92  36 0.30 0.21 0.00 0.95 
     SA IBI SD 
 
35 27.10 16.90 5.45 89.09  35 29.51 14.38 4.47 63.39 
     SA Mean IBI Δ 
 
35 33.53 22.99 3.96 110.47  35 36.55 22.41 7.97 130.15 
 
Note. Individual-level variables are measured on one occasion per individual (final assessment, during “12 month” assessment 
window) and assessment-level variables are collapsed across all assessments and individuals in each group. MSEL=Mullen Scales of 
Early Learning (Mullen, 1995), AOSI=Autism Observation Scale for Infants (Bryson et al., 2008), IBI=interbeat interval, 
RSA=respiratory sinus arrhythmia, SD=standard deviation, SA=sustained attention  
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Table 2.2: Model Fit Parameters and R
2
, Cross-Group Comparisons 
 
Dependent Variable  Model 1 
No Random 
Effects 
Model 2 (Null 
Model) 
Fixed: Intercept, Age 
Random: Intercept 
Model 3 
Fixed: Intercept, Age 
Random: Intercept, Age 
 ICC 
Level 1 
R
2
 
Full Model  
vs. Null 
Model 
Inattentive 
 
AIC 
BIC 
-53.9 
-51.5 
-49.8 
-46.3 
-47.4 
-40.3 
 .37 .18 
Heart Activity        
     Overall IBI AIC 
BIC 
-118.6 
-116.4 
-118.1 
-114.7 
-116.1 
-109.4 
 .26 -.03 
     Overall RSA AIC 
BIC 
26.8 
29.0 
31.3 
34.7 
29.3 
36.1 
 .06 .05 
     Overall IBI SD AIC 
BIC 
92.3 
94.5 
93.1 
94.7 
90.8 
97.6 
 0 .003 
Sustained Attention        
     Proportion SA AIC 
BIC 
-60.2 
-58.0 
-57.3 
-55.6 
-53.6 
-48.5 
 0 .13 
     SA IBI SD AIC 
BIC 
118.6 
120.8 
119.8 
121.5 
118.6 
125.3 
 0 -.03 
     SA Mean IBI Δ AIC 
BIC 
132.6 
134.8 
136.4 
138.1 
141.4 
148.2 
 0 -.03 
 
Note. Full Model included main effects of age, diagnostic group, the interaction between age and diagnostic group, mental age 
(covariate). R
2
 = (Residual Variance Null Model – Residual Variance Full Model)/Residual Variance Null Model. Level-1 ICC = 
Intercept Variance / (Intercept Variance + Residual Variance) when intercept is modeled as a random effect.  IBI=interbeat interval, 
RSA=respiratory sinus arrhythmia, SD=standard deviation, SA=sustained attention 
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Table 2.3: Fixed Effects of Group Membership on Heart Activity  
 
Model Component Estimate SE df t-value p 
% Time Inattentive      
Intercept 0.33 0.03 49 9.65 <.0001 
Age 0.02 0.01 49.2 2.31 0.03 
Group 0.03 0.05 46.1 0.60 0.55 
Group*Age -0.04 0.01 47.9 -3.12 0.003 
Intellectual Ability 0.00 0.00 37 0.72 0.47 
Overall IBI      
Intercept 6.13 0.02 47.7 311.67 <.0001 
Age 0.02 0.01 47.1 2.55 0.01 
Group 0.02 0.03 47.9 0.64 0.53 
Group*Age -0.01 0.01 48.1 -0.99 0.33 
Intellectual Ability 0.00 0.00 40.9 -0.61 0.55 
Overall RSA      
Intercept 1.45 0.06 34.8 24.34 <.0001 
Age 0.02 0.02 39.1 0.79 0.43 
Group -0.15 0.09 35.3 -1.68 0.10 
Group*Age 0.02 0.03 40.8 0.68 0.50 
Intellectual Ability 0.00 0.00 27.7 -1.66 0.11 
Overall IBI SD      
Intercept 3.37 0.09 37.5 36.02 <.0001 
Age 0.03 0.04 49.9 0.79 0.43 
Group -0.18 0.14 38 -1.32 0.19 
Group*Age 0.04 0.05 51.6 0.78 0.44 
Intellectual Ability 0.00 0.00 32.8 -0.86 0.40 
Proportion SA      
Intercept 0.29 0.03 63 10.86 <.0001 
Age -0.04 0.01 63 -3.36 0.00 
Group 0.01 0.04 63 0.23 0.82 
Group*Age 0.04 0.01 63 2.49 0.02 
Intellectual Ability 0.00 0.00 63 1.82 0.07 
Average IBI SD during SA     
Intercept 3.18 0.11 62 27.74 <.0001 
Age 0.07 0.05 62 1.54 0.13 
Group -0.09 0.17 62 -0.52 0.60 
Group*Age -0.02 0.06 62 -0.37 0.71 
Intellectual Ability 0.00 0.01 62 -0.71 0.48 
Average IBI Change during SA     
Intercept 3.43 0.13 62 26.40 <.0001 
Age 0.03 0.05 62 0.64 0.52 
Group -0.19 0.19 62 -0.98 0.33 
Group*Age 0.00 0.07 62 0.04 0.97 
Intellectual Ability 0.00 0.01 62 0.01 0.99 
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Table 2.4: Fixed Effects of Autism Risk on Heart Activity and Heart Defined Attention 
 
Model Component Estimate SE df t-value p 
% Time Inattentive (R2=.01)     
Intercept 0.42 0.11 15.20 3.84 0.002 
Age -0.03 0.03 19.40 -1.13 0.27 
Autism Risk -0.03 0.06 14.70 -0.59 0.56 
Autism Risk*Age 0.01 0.01 20.90 0.41 0.69 
Intellectual Ability 0.00 0.00 15.00 1.32 0.21 
Overall IBI (R2=.22)      
Intercept 6.16 0.06 16.30 107.36 <.0001 
Age 0.05 0.02 22.30 3.10 0.01 
Autism Risk -0.01 0.03 15.50 -0.25 0.81 
Autism Risk*Age -0.02 0.01 24.00 -2.59 0.02 
Intellectual Ability 0.00 0.00 16.20 -0.12 0.90 
Overall RSA (R2=.13)      
Intercept 1.06 0.16 14.40 6.86 <.0001 
Age 0.15 0.06 24.60 2.41 0.02 
Autism Risk 0.11 0.08 13.40 1.42 0.18 
Autism Risk*Age -0.05 0.03 26.30 -1.69 0.10 
Intellectual Ability 0.00 0.00 15.50 -0.93 0.37 
Overall IBI SD (R2=.33)      
Intercept 2.74 0.26 13.90 10.64 <.0001 
Age 0.41 0.09 22.70 4.46 0.0002 
Autism Risk 0.21 0.13 13.00 1.57 0.14 
Autism Risk*Age -0.17 0.05 24.60 -3.67 0.001 
Intellectual Ability 0.00 0.00 14.40 -0.58 0.57 
Proportion SA (R2=-.02)      
Intercept 0.26 0.09 32.00 2.96 0.01 
Age 0.01 0.04 32.00 0.37 0.72 
Autism Risk -0.02 0.04 32.00 -0.34 0.73 
Autism Risk*Age 0.00 0.02 32.00 -0.14 0.89 
Intellectual Ability 0.00 0.00 32.00 -0.73 0.47 
Average IBI Variability during SA(R2=.44) 
Intercept 2.58 0.33 14.20 7.89 <.0001 
Age 0.44 0.10 19.70 4.36 0.0003 
Autism Risk 0.20 0.17 14.00 1.14 0.27 
Autism Risk*Age -0.19 0.05 21.60 -3.62 0.002 
Intellectual Ability -0.01 0.01 18.50 -1.15 0.26 
Average IBI Change during SA (R2=.19) 
Intercept 3.05 0.39 12.90 7.79 <.0001 
Age 0.40 0.14 21.20 2.73 0.01 
Autism Risk 0.05 0.20 12.50 0.23 0.82 
Autism Risk*Age -0.18 0.07 23.20 -2.40 0.02 
Intellectual Ability 0.00 0.01 18.00 -0.17 0.87 
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Figure 2.1: Boxplot of Physiological Data Editing, Justifying 5% Cutoff 
 
Note. The upper whisker of the boxplot (0.049) marks 1.5 times the interquartile range 
(0.018) above the mean (0.022). A total of 15 files were excluded from analyses due to 
artifact rates exceeding 5% of IBIs. Figure 1.1 includes participants excluded from 
analyses due to edit rates exceeding 5% (editing rate <.055, n = 9) but does not depict 
additional participants whose files could not be edited due to excessive artifacts estimated 
to be 40% or greater (n = 6). These data justify using a 5% cutoff for physiological data 
inclusion, consistent with prior studies (Corona et al., 1998).  
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Figure 2.2:  IBI Difference from Baseline across Participants and Phases by Phase Type  
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Figure 2.3: High Within- and Between-Person Variability in IBI during Sustained 
Attention 
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Infant Sibling (ASIB) Low Risk Control 
Figure 2.4: Group Difference in Behavioral and Heart-Defined Attention across Age 
Note: Gray = average trajectories within individuals; black = overall regression lines by 
group
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Figure 2.5: IBI Variability during SA across Age, Separated by Clinical Autism Risk    
 
 Note. Autism Observation Scale for Infants (AOSI) dichotomized using the median 
(Total Score > 5 = “High AOSI”) for display purposes only. Average IBI SD in the LR 
group is displayed for reference. Gray = average trajectories within individuals; black = 
overall regression lines by group 
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CHAPTER 3 
 
BIOBEHAVIORAL SIGNATURES OF VISUAL ATTENTION  
IN THE BROADER AUTISM PHENOTYPE
2
 
 
                                                          
2
 Tonnsen, B. L., Richards, J. E. & Roberts, J. E. To be submitted to Journal of the 
American Academy of Child and Adolescent Psychiatry  
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The ability to flexibly orient attentional processes in response to environmental stimuli is 
critical for optimal learning and development. Children with autism spectrum disorder 
(ASD) often exhibit abnormal patterns of attention disengagement, the component of 
orienting that involves separating attention from an ongoing stimulus, a deficit that has 
been posited to contribute to later symptom expression (Elsabbagh & Johnson, 2007; 
Keehn et al., 2013; Zwaigenbaum et al., 2005). A number of studies suggest this 
abnormal process emerges early in development, prior to the age of ASD diagnosis, and 
thus may serve as a robust indicator of later ASD risk. For example, “high risk” infants 
with a family history of ASD display abnormal orienting toward social and nonsocial 
stimuli (Dawson, Meltzoff, Osterling, Rinaldi, & Brown, 1998; Landry & Bryson, 2004; 
Swettenham et al., 1998) and slower saccade latencies on computerized orienting tasks 
(Elison et al., 2013; Elsabbagh et al., 2009, 2013; Zwaigenbaum et al., 2005), compared 
to “low risk” controls. Although these patterns of abnormal attention disengagement have 
been identified across multiple high-risk samples and measures, the developmental 
course and biological underpinnings of these deficits are unclear, limiting knowledge 
about potential developmental cascades that could be minimized through early detection 
and prevention efforts. The present study examined behavioral and physiological patterns 
of attention orienting in a longitudinal sample of infants at elevated risk for ASD due to 
having an older sibling with an ASD diagnosis (“infant siblings”). This work aims to 
establish the longitudinal course of abnormal attention orienting in infant siblings, 
potential physiological mechanisms subserving this process, and clinical implications of 
risk.  
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Autism Precursors in Infants  
Characterizing the natural history of autism precursors in infancy permits 
implementation of targeted interventions that may alter aberrant behavioral and neural 
development (Dawson, 2008). Indeed, early ASD treatment has been linked to substantial 
improvements in language development, adaptive behaviors, social skills, and intellectual 
functioning (Dawson et al., 2010; Eldevik et al., 2009). In addition to benefitting the 
affected child, early detection also contributes to family well-being by permitting early 
access to community resources and genetic counseling. These resources are particularly 
important in light of high stress and depression reported in parents of children with 
disabilities (Dabrowska & Pisula, 2010; Estes et al., 2009). Early intervention also 
reduces the public health costs associated with ASD by up to 65% (Järbrink & Knapp, 
2001), which is particularly important given ASD is the third most expensive diagnosis in 
special education (Ganz, 2007) and requires lifetime treatment costs estimated as $2.4 
million per child (Buescher et al., 2014). Despite the individual and community-level 
benefits of early intervention, the average age of ASD diagnosis remains at 4.4 years 
(Centers for Disease Control, 2014), resulting in treatment delays. Thus, understanding 
early predictors of ASD is a concern of public health importance.  
Prospectively studying infant samples at elevated risk for ASD facilitates these 
translational efforts by permitting active surveillance of aberrant symptom profiles as 
they emerge. Infant siblings of children with autism (ASIBs) exhibit 10-20 times higher 
rates of autism diagnoses (19%; (Ozonoff et al., 2011) than the general population (1-2%; 
(Centers for Disease Control, 2014) and comprise the most commonly studied “high-risk” 
ASD sample. Research on ASIB development can be categorized by two approaches. The 
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first seeks to evaluate the unique characteristics of ASIBs that distinguish them from 
infants without a family history of ASD. This approach parallels an extensive body of 
adult-focused literature documenting subthreshold ASD symptoms that extend to the 
general population as part of the broader autism phenotype (Bolton et al., 1994; Dawson 
et al., 2002; Ozonoff et al., 2014; Pickles et al., 2000). Identifying these broader 
phenotypic features associated with genetic ASD heritability – sometimes referred to as 
the ASD endophenotype (Elsabbagh & Johnson, 2007; Walsh et al., 2011) – may inform 
the genetic architecture of ASD and risk factors for symptom expression. A second, 
complementary approach to ASIB research investigates specific associations between 
early abnormalities and later ASD diagnoses. This approach recognizes the utility of 
differentiating between ASIBs who demonstrate subtle atypicalities from those who 
ultimately receive an ASD diagnosis. Examining multiple outcomes is particularly 
warranted given ASIBs without ASD are also at risk for other developmental delays or 
disorders (Messinger et al., 2013; Ozonoff et al., 2014; Toth et al., 2007), and a subset 
display abnormal developmental trajectories not associated with ASD by 12 months of 
age (Ozonoff et al., 2014). These two approaches – examining the ASD endophenotype, 
as well as specific predictors of ASD diagnoses – provide complementary information 
about genetic vulnerability for ASD and potential “red flags” for individual development.  
Attention and the ASD Endophenotype  
Abnormal attention has been described as a central feature of the ASD 
endophenotype due to consistent, clinically-relevant abnormalities in observed in ASD 
(see Keehn et al., 2013, for review) and early-emerging differences in ASIBs as early as 
two months of age (Jones & Klin, 2013). As originally proposed by Posner and 
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colleagues (Posner & Petersen, 1990; Posner, 1980), attention is commonly conceived as 
interconnected networks of orienting, alerting, and executive control; which interact to 
produce stimulus response (Posner & Fan, 2008). According to Posner’s model, the 
orienting network facilitates movement of attention toward sensory events; the alerting 
network is responsible for maintaining vigilance and sustaining attention; and the 
executive control network regulates and resolves conflict between anticipated and 
observed thoughts, feelings, and occurrences (Macleod et al., 2010; Posner & Rothbart, 
2007).  Two components of these attentional networks – orienting and arousal – are of 
particular relevance for understanding attention in infants at risk for autism. Here, we 
review the neurobiology and development of orienting and arousal, measurement of each 
construct, and current knowledge of their functioning within ASD.  
Orienting 
Attention orienting involves aligning attention with sensory or memory input by 
disengaging, shifting, and reengaging attention (Posner & Cohen, 1984; Posner, 1980) 
and is generally associated with neural activity in the ventral frontal-parietal brain regions 
(Corbetta & Shulman, 2002). Sokolov (1963) first described orienting as a novelty-
sensitive reflex that enhances stimulus processing. Orienting may occur overtly, with 
accompanying head and eye movements, or covertly, without behavioral indicators 
(Posner, 1980). Similarly, orienting may be exogenously driven by individual intention or 
exogenously drive by stimulus input.  
The ability to flexibly orient attention emerges and strengthens across the first 
year of life. Although the emergence of orienting in infants was originally attributed to 
shifts from subcortical to cortical processing (Bronson, 1974), more recent models 
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describe interactions among multiple developing pathways. Around 1 month of age, 
infants are able to produce saccades but display difficulty disengaging from stimuli, 
resulting in obligatory looking (see Johnson, 1989, for review). According to Johnson 
(1989), obligatory looking emerges due to the onset of an inhibitory pathway that 
prevents orienting. The maturation of additional cortical layers from age 2 months 
onward overrides this inhibitory pathway, permitting increased visual flexibility. Thus, 
the ability to disengage attention from visual stimuli, which enables attention orienting to 
occur, improves from 2 to 6 months of age (Frick, Colombo, & Saxon, 1999) and 
continues to develop until pre-adolescence or later (Wainwright & Bryson, 2002).   
Measuring orienting. The gap-overlap task is a commonly used paradigm to 
measure flexibility of attention orienting, particularly the process of attention 
disengagement (e.g. (Hood & Atkinson, 1993). An extension of spatial cueing tasks 
developed by Posner and colleagues (e.g. Posner & Petersen, 1990; Posner, 1980), gap-
overlap paradigms require a participant to shift attention from a central stimulus to a 
subsequently presented peripheral stimulus. Reaction times (RT) are compared across 
experimental manipulations, which may include three trial types: baseline, gap, and 
overlap. During baseline trials, the central stimulus is extinguished simultaneously with 
peripheral stimulus onset. During gap trials, a temporal gap separates the offset of the 
central stimulus and onset of peripheral stimulus, providing an exogenous cue for 
orienting to occur. During overlap trials, the peripheral stimulus appears during 
presentation of the central stimulus, requiring the participant to disengage attention from 
the central stimulus prior to shifting attention to the peripheral stimulus. Reaction times 
across conditions are then compared to assess disengagement, the relative increase in RT 
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in overlap versus baseline trials, and facilitation, the relative reduction in RT in gap 
versus baseline trials. This paradigm has been used to examine attention orienting in 
clinical and non-clinical samples from infancy to adulthood (e.g. Hood & Atkinson, 
1993; Kikuchi et al., 2011; Van Der Geest, Kemner, Camfferman, Verbaten, & Van 
Engeland, 2001; Zwaigenbaum et al., 2005). 
Orienting in ASD and ASIBs. Abnormal orienting has been extensively 
documented in ASD. In fact, individuals with ASD are often described as displaying 
sticky attention (Kawakubo et al., 2007; Keehn et al., 2013) due to persistent orienting 
deficits observed toward social and nonsocial stimuli (Dawson et al., 1998; Landry & 
Bryson, 2004; Swettenham et al., 1998). The term sticky attention is distinguished from 
the terms sticky fixation or obligatory looking, which are terms used to describe young 
infants who are unable to disengage visual attention due to immature cortical 
development (Johnson, 1989). Characteristics of sticky attention in ASD appear to 
emerge during infancy, prior to the full presentation of symptoms required for ASD 
diagnosis. Behavioral studies have reported that ASIBs who later meet ASD criteria 
attend less toward an examiner in distress (Hutman et al., 2010) and display atypical joint 
attention and requesting behaviors (Rozga et al., 2011). Similarly, cognitive paradigms 
indicate that between 6-12 months of age, a subset of ASIBs begin to exhibit abnormal 
attention orienting, particularly in their ability to disengage attention from to attend to 
competing stimuli (Elison et al., 2013; Elsabbagh et al., 2013; Elsabbagh, Volein, et al., 
2009; Zwaigenbaum et al., 2005). Although the neurodevelopmental cause of sticky 
attention in ASD is unclear, slower attention disengagement has been posited to restrict 
early learning and social opportunities essential to typical development, potentially 
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intensifying ASD symptom trajectories (Elsabbagh & Johnson, 2007; Keehn et al., 2013; 
Zwaigenbaum et al., 2005).  
To date, four primary studies have employed spatial cuing “gap-overlap” tasks to 
investigate attention disengagement in ASIB samples. Key findings are summarized in 
Table 3.1. Results from these studies generally suggest that slower orienting – 
particularly during attention disengagement – emerges within the first year of life in a 
subset of ASIBs, although specific findings vary across samples and methodologies. In 
one of the first prospective ASIB studies, Zwaigenbaum and colleagues (2005) reported 
that change in smoothness of visual tracking and speed of disengagement between 6 and 
12m, but not group differences at 6m, distinguished ASIBs from low risk (LR) controls, 
and slower disengagement at 12m correlated with 24m algorithm scores on the Autism 
Diagnostic Observation Schedule (ADOS). Notably, based on descriptive statistics 
provided by the authors, group differences in disengagement at 6m produced a 
moderately sized effect (d=.47;Cohen, 1988), suggesting emerging differences that may 
have been detectable in a larger sample. Longer latencies on Overlap trials have been 
similarly reported 8-12m ASIBs (Elsabbagh, Volein, et al., 2009), as well as in 6-8m 
ASIBs who later meet ASD criteria (Elison et al., 2013). These data suggest that slower 
disengagement is a relatively consistent construct in ASIBs and may indicate risk for 
later ASD symptomatology.  
Zwaigenbaum’s initial (2005) study highlights the utility of longitudinal designs 
to detect developmental processes – such as within-individual change – that cannot be 
detected through static, cross-sectional designs. In a longitudinal sample of infants at 
approximately 7 (range 6-10) and 14 (range 12-15) months, Elsabbagh and colleagues 
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(2013) similarly reported that slower speed of disengagement in older infants, but not 
younger infants, related to later ASD outcomes in ASIBs. Again, ASIBs who later 
exhibited ASD failed to show typical improvements in overlap latencies over time, with 
40% of ASIBs later diagnosed with ASD displaying slower overlap latencies at 14m. 
However, the authors also reported that ASIBs defined as “atypical” – either because they 
did not meet full ASD criteria or displayed developmental impairments – similarly did 
not improve over time, and slower latencies were observed across trial types in children 
with lower intellectual abilities. This finding suggests that blunted improvement in the 
orienting network may relate to the broader ASD endophenotype rather than ASD-
specific risk factors, although further work is needed to replicate and explain these 
findings.   
Arousal 
Given accumulating evidence of abnormal orienting in the first year of life among 
ASIBs, an important next step is to examine potential mechanisms of these impairments. 
It is possible that abnormal orienting in ASD may reflect simultaneous abnormalities in 
the alerting network, particularly in the domain of physical arousal, which has been 
described extensively in ASD (see Keehn et al., 2013, for review) and ASIBs (Study 1). 
Alertness– often defined as a state of readiness to process information – was originally 
investigated in 1949 when Moruzzi and Magoun directly stimulated the reticular 
formation of cats to produce sleep and wakefulness (Moruzzi & Magoun, 1949). Since 
this classic experiment, our conceptualization of alerting has evolved to include both 
tonic and phasic components (Porges, 1976, 1980). Tonic alertness refers to general 
levels of arousal and wakefulness, whereas phasic alertness describes the reactive, 
 56 
 
transient process of increasing arousal in response to an external stimulus (Sturm & 
Willmes, 2001). These processes are closely linked to the reticular activating system, 
thalamus, and neurochemical pathways that connect the brainstem and neocortical areas 
(see Colombo, 2001; Reynolds & Richards, 2007; Richards, 2008, for review).  
Measuring alerting. Voluntary control of tonic alertness, termed sustained 
attention, is reflected by bodily, physiological, and brain changes indicative of increased 
processing (Jennings, 1986; Porges, 1976; Richards, Reynolds, & Courage, 2010).  As 
attention increases, parasympathetic terminals release acetylcholine at the heart’s 
sinoatrial node, slowing depolarization of synapses and resulting in HR deceleration. As 
attention decreases, sympathetic terminals release norepinepherine to speed 
depolarization, resulting in increased HR. Decades of research have examined these 
decelerative patterns of HR as biomarkers of sustained attention (Graham & Clifton, 
1966; Lacey, 1959). In infants, these attention-related HR fluctuations have been 
quantified as three phases: orienting, sustained attention, and attention termination (Casey 
& Richards, 1991; Richards & Casey, 1991; Richards, 2000). Attention orienting is 
marked by deceleration of HR by 8-10 beats per minute (BPM), sustained attention is the 
maintenance of this decelerated HR as stimulus details are processed, and attention 
termination is the return of heart-rate to prestimulus levels. Importantly, this progression 
through attention phases occurs during continued behavioral looking, thus heart-defined 
measures capture qualities of attention not detectable using overt looking alone. 
Infants’ behavioral performance on orienting tasks has been closely associated 
with heart-defined sustained attention. Richards (1987) presented 14 to 26 week infants 
with central stimuli that were interrupted by peripheral stimuli on a subset of trials. 
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Infants who were in periods of heart-defined sustained attention were less distractible 
than infants in periods of attention termination. In subsequent studies, same-aged infants 
were less likely to orient to a briefly-presented peripheral stimulus during heart-defined 
orienting and sustained attention compared to pre-attention and attention termination 
(Casey & Richards, 1988; Richards, 1997). These findings have been replicated across a 
variety of stimuli types, including children’s videos (Richards & Casey, 1991) and toy 
play (Lansink & Richards, 1997; Roberts, Hatton, Long, Anello, & Colombo, 2011). 
Although the majority of sustained attention studies have examined non-clinical samples, 
sustained attention has also been used to index attention in infants with fragile X 
syndrome, a single-gene disorder highly associated with intellectual disability and ASD 
(Roberts et al., 2011). Thus, sustained attention is a valid and reliable biomarker of 
attention engagement in infants and is closely associated with behavioral performance on 
orienting tasks. 
Arousal in ASD and ASIBs. Abnormal autonomic functioning has been posited 
to contribute to the emergence and expression of numerous psychological conditions 
(Beauchaine, 2001; Clark & Watson, 1991; Porges, 1976) and is well-documented in 
children and adults with ASD (see Cheshire, 2012; Keehn et al., 2013; Klusek et al., 
2015, for review). Although findings vary across studies, ASD is generally associated 
with faster HR (Bal et al., 2010; Kushki et al., 2013; Ming et al., 2005) and difficulty 
modulating arousal during changing task demands (Althaus et al., 1999; Smeekens et al., 
2015; Vaughan Van Hecke et al., 2009). In general,  respiratory sinus arrhythmia (RSA), 
HR variability associated with respiration, is lower at rest in ASD (Bal et al., 2010; Ming 
et al., 2005) but may increase abnormally during cognitive stress (Porges, 2013), 
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suggesting inability to modulate vagal functioning. It has also been proposed that ASD 
includes both hyper- and hyporesponsive subtypes, which may be associated with 
increased self-soothing and self-stimulatory behaviors, respectively (Hirstein, Iversen, & 
Ramachandran, 2001). In older participants with ASD, shallower HR decelerations have 
been reported in response to an emotional event (Corona et al., 1998), although other 
studies have reported similar HR patterns across groups (Louwerse et al., 2014; 
Mathersul et al., 2013).  Faster HR and lower respiratory sinus arrhythmia also 
correspond to greater ASD symptomatology within ASD samples (Bal et al., 2010; 
Klusek et al., 2013; Vaughan Van Hecke et al., 2009), supporting autonomic functioning 
as a potential index of symptom severity. Interestingly, developmental shifts from 
hypoarousal to hyperarousal have been linked to later ASD symptoms in infants and 
toddlers with fragile X syndrome (Roberts et al., 2012), suggesting abnormal heart 
activity may relate to ASD precursors in infancy. Given these well-documented 
abnormalities, it is possible that abnormal autonomic functioning may index – and 
possibly contribute to -- abnormal orienting observed in ASD. 
Although a number of studies have documented abnormal autonomic functioning 
in ASD, this topic has been largely unstudied in “high risk” infants. We previously 
examined patterns of global autonomic functioning and heart-defined SA in a 
longitudinal sample of 5-14m ASIBs and LR controls (Study 1). During passive viewing 
of a brief children’s video, ASIBs demonstrated atypical maintenance of greater 
behavioral and heart-defined SA across age, despite age-related reductions in these 
markers (e.g. increased inattention) in LR controls. The quality of SA during the task 
predicted clinical ASD risk at the latest time point. Specifically, ASIBs with higher 
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clinical risk markers exhibited slower developmental changes in both global (overall IBI, 
overall IBI variability) and sustained-attention related (IBI change during SA, IBI 
variable during SA) physiological markers, relative to ASIBs with lower clinical risk 
scores. Thus, higher ASD clinical risk was predicted by increasingly abnormal 
physiological trajectories across age. To our knowledge, Study 1 is the first paper to 
document abnormal autonomic functioning in ASIBs and suggests that abnormally 
elevated behavioral and heart-defined attention, as well as increasingly deviant 
physiological profiles across time, may characterize the ASD endophenotype in infants. 
However, additional work is needed to examine these constructs in different experimental 
contexts. For example, it is likely that physiological profiles will differ substantially in 
response to passive viewing paradigm versus gaze-contingent tasks, such as gap-overlap 
paradigms that require participant looking. Studying sustained attention in different 
contexts may also inform whether atypical patterns we previously documented in ASIBs 
relate to abnormal attention orienting. With further study, examining the intersection of 
physiological functioning and attention orienting may inform whether abnormal 
autonomic functioning serves as a biological indicator, and potential contributing factor, 
to aberrant behavioral profiles in ASIBs.  
Unpacking ASIB Orienting: An Integrated Perspective 
 From the previous literature, it is clear that abnormal attention orienting, 
particularly attention disengagement, is present early in development in a subset of 
infants at risk for ASD. It is also possible that autonomic functioning may index these 
early abnormalities, potentially providing a sensitive biomarker of risk and 
developmental change. A critical next step will be to unpack the developmental course 
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and mechanisms of aberrant attention disengagement during the first year of life, both 
through longitudinal surveillance and diversified methodologies. This work will inform 
the applicability of aberrant disengagement to characterizing the ASD endophenotype 
and identifying early ASD risk.  
It is increasingly recognized that longitudinal surveillance is critical to delineating 
abnormal trajectories in neurodevelopmental disorders (Cornish, Scerif, & Karmiloff-
Smith, 2007; Karmiloff-Smith, 2009; Tonnsen, Grefer, Hatton, & Roberts, 2014; 
Tonnsen, Malone, et al., 2013).Indeed, the two prior longitudinal studies of attention 
disengagement in ASIBs (Elsabbagh et al., 2013; Zwaigenbaum et al., 2005) have 
revealed within-individual patterns of change that were not detectable in cross-sectional, 
static designs. However, to date, the majority of ASIB attention studies, including the two 
longitudinal studies of gap-overlap performance in ASIBs, have examined associations 
between clinical outcomes and 1-2 behavioral time points across the first 24 months of 
life (see Jones et al., 2014, for detailed review of studies). These studies have used 
categorical models to examine age effects (e.g. repeated measure analysis of variance), 
often collapsing participants in age “bins” to examine developmental change. For 
example, all previous ASIB gap-overlap studies have employed categorical age groups, 
some collapsing participants across age ranges as large as 4 months (Elsabbagh et al., 
2013; Elsabbagh, Volein, et al., 2009). Given the rapid maturation of attention orienting 
during the first year of life, this categorical approach gives a valuable estimate of gross 
developmental change but may ultimately limit our conceptualization of nuanced age-
related changes relevant to ASD emergence. In recognition of this limitation, a number of 
ASIB studies have begun employing more developmentally sensitive surveillance 
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strategies using multiple time points within the first year of life (Jones & Klin, 2013; 
Ozonoff et al., 2010, 2014; Sacrey et al., 2013), although this approach has yet to be 
applied to examine attention orienting in ASIBs.   
Further studies are also needed to clarify the neurobiological processes sustaining 
abnormal attention orienting in ASIBs. Measuring these biological processes, in addition 
to their behavioral artifacts, would likely permit more sensitive measurement of 
individual differences, increasing our capacity to identify etiological processes, inform 
treatment targets, and measure developmental change (Walsh et al., 2011). However to 
date, only one study of attention disengagement in ASIBs has employed neurobiological 
methods to inform behavioral differences. Elison and colleagues (2013) reported that 
group differences in disengagement were differentially related to white matter radial 
diffusivity, measured by diffusor tensor imaging. In LR controls, slower disengagement 
related to white matter immaturity in the splenium, a region of the corpus callosum that 
undergoes substantial postnatal development and has been associated with attention 
disengagement. This association was not found in the ASIB group, suggesting a potential 
neurobiological atypicality underlying orienting deficits in ASIBs. This study begins to 
inform the neurobiology of abnormal orienting in ASIBs, although a number of questions 
remain, including the developmental course of abnormal development, additional 
neurobiological processes implicated in atypical orienting, and whether additional 
vulnerabilities – such as self-regulatory deficits reported in ASD – may relate to 
disengagement abnormalities. For example, although arousal is associated with attention 
disengagement in typically developing infants (Casey & Richards, 1988; Richards, 1997) 
and has been implicated in aberrant attention in children with ASD (Corona et al., 1998), 
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the association between behavioral orienting and physiological arousal has not been 
studied in ASIBs. 
The Current Study 
 Examining early patterns of abnormalities in ASIBs may inform both the ASD 
endophenotype and specific predictors of clinical risk. Although a handful of studies have 
reported abnormal attention disengagement – or “sticky attention” – in ASIBs, the 
specific developmental course and neurobiological underpinnings of this aberrant process 
are unclear. Examining these points of ambiguity is an important next step to informing 
translational efforts that may facilitate earlier identification and treatments, potentially 
preventing  maladaptive outcomes associated with ASD (Dawson, 2008). 
 To characterize the course and mechanisms of aberrant attention disengagement, 
the present study longitudinally examined visual and heart-defined sustained attention 
(SA) in 5-14m ASIBs and low-risk (LR) controls. Using a gap-overlap task with 
concurrently measured heart activity, we aimed to inform both the nature of behavioral 
abnormalities, as well as the physiological patterns sub serving these behaviors. We 
specifically examined (1) developmental differences in behavioral and heart-defined 
attention across groups, (2) associations between behavioral and heart-defined attention, 
and (3) the association between these variables and clinical autism risk among ASIBs. 
We hypothesized that relative to LR controls, ASIBs would exhibit increasingly longer 
latencies to disengage attention across age. Longer latencies would be indexed 
physiologically by longer proportion of time in SA, as well as increased depths and 
stability of SA decelerations. Abnormal behavioral and physiological trajectories would 
predict higher clinical risk symptoms around 12 months of age.  
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Methods 
Participants  
 Participants included 46 infants (23 ASIB, 23 LR) assessed on 1-3 occasions each 
for a total of 99 assessments (ASIB one assessment n=7, two n=5, three n=11; LR one 
n=6, two n=8, three n=9). Participants for the present study largely overlapped with 
Study 1, with slight variability due to missing data and the later initiation of data 
collection for Study 1’s passive viewing task. Infant sibling and LR groups contained 
similar numbers of females (3 ASIBs; 5 LR; Table 3.1). Recruitment procedures and 
exclusionary criteria were identical to Study 1, and participants overlapped across 
studies. Additional assessments were conducted but excluded due technology problems 
(n = 13; 4 ASIB) and noncompliance (n = 2 ASIBs). Physiological data were excluded 
for additional 18 behavioral assessments (11 ASIB) due to high artifacts, were not 
collected from 5 participants (2 ASIB) during the initial battery implementation, and 
were not collected for 1 LR participant due to parental preference. Seven additional LR 
participants were assessed but excluded from the present study due to matching (n = 2) 
and other developmental or medical concerns (n = 5; 1 epilepsy, 3 suspected ASD, 1 
suspected ASD in sibling during study course).  Proportion of missing behavioral (13%) 
and physiological data (18%) was similar to previous studies in similar samples 
(Elsabbagh et al., 2009; 16%).  
Procedures and Measures 
 Procedures paralleled Study 1. To review, the present study includes attention 
data from all assessments, as well as developmental and clinical testing from the 12 
month assessment window. Materials, equipment, and experimental set-up were identical 
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across settings. The following measures from Study 1 were collected for Study 2 using 
identical procedures and are therefore not reviewed in detail: ECG and heart-defined 
sustained attention, AOSI Total Score (ASD symptoms in 12 month window), and 
Mullen Scales of Early Learning Standard Score (developmental abilities in 12 month 
window). Within the present sample, 3 of the 21 ASIBs with AOSI data exceeded the 
clinical risk threshold of 7 items. 
Attention orienting. Behavioral attention was measured using a gap-overlap task. 
Participants were seated in a darkened room, 10” away from an 11 x 24” LCD monitor. 
Two video cameras simultaneously recorded stimuli and participants’ faces. To minimize 
distractions and standardize environments, the monitor and infant were surrounded on 
three sides by a portable, nonreflective black felt shield. During the video, 
electrocardiogram signal (ECG) was collected using Alive Heart Monitors (Alive 
Corporation, Gold Coast, Australia) and was transmitted live to a laptop via Bluetooth 
technology.   
The gap-overlap task used in the present study was provided courtesy of the 
Centre for Brain & Cognitive Development, Birbeck College, University of London. The 
task includes three phases: baseline, gap, and overlap. During each trial, an engaging 
animated sun or clown hat spun in the center of the screen at a 12
o
 by 12
o
 visual angle, 
attracting the infant’s attention. The peripheral target, an animated animal accompanied 
by a consistent sound effect (e.g. cow presented with “moo” sound), then randomly 
presented either to the left or right of the central stimulus at the eccentricity of 13
o
. The 
target was manually triggered by the examiner, ensuring the participant was attending at 
the start of the trial. This stimulus remained on the screen until the infant shifted gaze or 
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3 s elapsed. During baseline trials, the peripheral stimulus appeared simultaneously with 
the central stimulus disappearance. During gap trials, a 200 ms gap occurred between 
central stimulus disappearance and the peripheral stimulus appearance. During the 
overlap trials, the peripheral target appeared while the central stimulus remained on the 
screen.  The three conditions were randomly presented across 36 trials for each block. 
Trials continued until infants become fussy or the maximum 72 trials were reached. 
Primary dependent variables included (1) baseline saccade latency, (2) overlap and gap 
saccade latencies, controlling for baseline latencies, and (3) proportion of “failed” trials 
in which a saccade did not occur.  
Quantification of Behavioral and Physiological Variables 
Attention orienting. Gap-overlap task coding procedures were selected to 
parallel previously published analyses of this task in a same-aged ASIB sample 
(Elsabbagh et al., 2013; Elsabbagh, Volein, et al., 2009). During the first portion of 
coding, each trial was evaluated for acceptability using the following criteria: (1) infant 
attends to the central stimulus directly prior to the onset of the peripheral stimulus, (2) 
infant does not blink or look away while the peripheral stimulus is being displayed, (3) 
infant attends to the screen throughout the trial (spinning stimulus through balloon 
appearance). During the second phase, three series of variables were coded: (1) 
participants’ task engagement, (2) trial validity, and (3) reaction times. Saccade latencies 
for each valid trial were calculated as the difference in time (ms) between the appearance 
of the peripheral stimulus and the infant’s saccade. Consistent with previous studies 
(Elsabbagh et al., 2013; Elsabbagh, Volein, et al., 2009), latencies <100ms or >1200 ms 
were determined to be invalid. For each assessment, 5 valid trials per trial type were 
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required for inclusion in analyses, resulting in partial missing data for 12 trial-level data 
points: gap (n = 1 ASIB), baseline (n = 1 LR), or overlap (n = 10, 9 ASIBs). Notably, 
failed trials contributed to higher proportions of missing overlap data compared to the 
other trial types and were therefore analyzed as a separate variable (proportion failed 
trials). 
Data were coded offline by the first author (primary coder) and other trained 
research staff (secondary coders). Training consisted of reading training documentation, 
co-coding 2 files with the primary examiner, then coding independently until the 
secondary coder was reliable with the primary examiner on 3 consecutive files. Twenty 
percent of the secondary coders files were co-coded for reliability, and interrater saccade 
latencies correlated at r = .99. Interrater agreement for looking codes (looking versus not 
looking at screen) was 83%. 
Heart activity and heart-defined sustained attention. Procedures for editing 
heart activity and quantifying heart-defined SA were similar to Study 1. Files requiring 
greater than 5% editing were excluded from analyses (n=18; 11 ASIB). Behavioral codes 
were used to isolate portions of the task in which participants were looking toward the 
screen. These procedures are detailed in Study 1. In brief, numerical algorithms were then 
used to extract phases of heart-defined attention by comparing IBIs to the “Baseline IBI” 
for each look, calculated as the median of five IBIs preceding the participant looking 
toward the screen. Baseline IBI was reset when the participant looked away for 1.5 s. 
Unlike Study 1, participants were not required to meet a minimum looking threshold for 
SA data to be included in analyses, as the gap-overlap task required participants look for 
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stimuli to be activated. Thus, participants were engaged for a sufficient amount of time to 
calculate SA phases.  
Analyses 
Analyses were conducting using SAS 9.3 (Apex, NC) with α set to less than .05. 
Infant sibling and LR groups did not differ in number of assessments per participant, F 
(1, 44) = 0.03, p = .86, age across assessments, F (1, 97) = 0.03, p = .85, or number of 
acceptable trials, F (1, 97) = 0.95, p = .33. Normal probability plots of residuals at each 
analysis level indicated non-normal distribution of the following variables, which were 
log-transformed prior to analyses: saccade latencies (baseline, overlap, gap), overall IBI, 
overall RSA, proportion time looking toward screen, proportion time in SA, IBI SD 
during SA, average IBI deceleration during SA, and total AOSI score. 
Group Differences in Behavioral and Heart-Defined Attention  
Group differences in behavioral and heart-defined SA were examined using 
multilevel models, which were constructed using parallel procedures to Study 1. For each 
dependent variable, a series of models were constructed to determine optimal model fit, 
using (1) ICC to determine whether observations should be nested within individuals and 
(2) AIC and BIC to determine which random effects best characterize data variance and 
covariance. As detailed in Table 3.2, ICCs indicated substantial variance in dependent 
variables occurring between individuals (19-70%), and AIC and BIC statistics indicated 
observations are best modeled as nested within individuals (Model 2). Notably, modeling 
age as a random effect (Model 3) either worsened or negligibly changed model fit, 
indicating the association between age and dependent variables was relatively stable 
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across individuals. Thus across analyses, intercepts were modeled as random effects 
nested within individuals, whereas age was included as a fixed effect only.   
Analytic procedures paralleled Study 1. First, unconditional means and growth 
models were constructed to estimate level and change in attention over time. Next, group 
and cognitive ability were added to the model as time-invariant level 2 explanatory 
variables. Significant group effects indicate mean differences at the centered age of the 
sample (9 months), and significant age x group interaction indicates group differences in 
change over time. Significant age x group interactions were probed using nonparametric 
Wilcoxon signed ranked tests that tested group differences in dependent variables across 
three separate age ranges: 5-8 months, 8-11 months, and 11-14 months. The proportion of 
variance explained by conditional models was estimated using pseudo R
2
 (Table 3.2), 
calculated as the proportion of residual variance in the null model reduced by combined 
explanatory variables (Singer & Willett, 2003). To facilitate comparisons with previous 
cross-sectional studies, effect sizes for group differences were also calculated for each 
age range using Cohen’s d (Cohen, 1988). 
Correspondence between Behavioral and Heart-Defined Attention 
To determine whether cross-group and within-group differences in behavioral 
attention were associated with heart-defined attention parameters, partial Spearman 
correlations were calculated between each behavioral predictor and overall IBI, IBI SD, 
RSA, and parameters of heart-defined SA (proportion of time in SA, SD of IBI during 
SA, mean IBI change during SA). Chronological age and developmental ability were 
included as covariates in all models, and baseline latency was included as a covariate in 
overlap and gap latency models. Observations were collapsed across individuals. 
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Predictors of Clinical Autism Risk among ASIBs 
To examine whether clinical ASD risk related to abnormal behavioral and heart-
defined SA among ASIBs, multilevel models were constructed with clinical ASD risk 
included as a time-invariate predictor of each dependent variable. Model fit was tested for 
ASIB-only models and were determined to follow a similar pattern to models examining 
group differences. Thus, parallel models (intercept-only random effects) were used for 
ASIB-only analyses. Similar to cross-group models, unconditional means and growth 
models were first constructed to estimate within-group levels and change in attention 
over time. Next, clinical autism risk (AOSI total score), the interaction between age x 
autism risk, and cognitive ability were included as time-invariant explanatory variables. 
Significant interactions were probed using Wilcoxon signed rank tests across three age 
categories (5-8 months, 8-11 months, 11-14 months).  
Results  
 Descriptive data are detailed in Table 3.3 (behavioral and clinical data) and Table 
3.4 (physiological data). Although all statistical models included age as a continuous 
variable, descriptive statistics were reported across three age categories (5-8 months, 8-11 
months, 11-14 months) to inform age-related changes and facilitate comparisons with 
previous cross-sectional studies.  
Group Differences in Behavioral and Heart Defined Attention 
 Multilevel models revealed group differences in both behavioral and 
physiological variables. Unconditional models indicated significant variability in the 
mean levels of all variables except proportion of time in SA (p = .18) and average IBI SD 
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during SA (p = .10), warranting further examination of predictors through conditional 
modeling.  
Groups differed in trajectories of saccade latencies for each trial type. These 
differences are reported in Table 3.6 and depicted in Figure 3.2, which displays 
individual trajectories (light gray lines) as well as average trajectories by group (thick 
black lines) for each group and trial type. As depicted in this graph, ASIBs demonstrated 
initially slower baseline latencies that improved more rapidly with age, controlling for 
developmental abilities. Post-hoc analyses indicated significant group differences in the 
youngest age group only (<8 months; Z = -2.36, p = .009). Age related patterns of overlap 
and gap latencies also differed by group, controlling for baseline latencies and 
developmental abilities. As a group, ASIBs demonstrated initially similar overlap 
latencies that improved less rapidly with age, compared to accelerated improvements in 
overlap latencies in the LR group. This pattern was distinct from gap trials, in which the 
ASIB group demonstrated initially slower gap latencies that improved with age, whereas 
the LR group exhibited relatively stable gap latencies over time. Post-hoc cross sectional 
analyses generally corroborated these trends, with longer gap latencies in the youngest 
group only (Z = -2.47, p = .007) but non-distinct overlap latencies (p’s > .15). 
Interestingly, mean latencies generally shortened over time in all groups and trial types, 
with the exception of overlap latencies among ASIBs, which decreased between 5-8 and 
8-11 months (Z = 2.41, p = .02) but then remained relatively stable, with a slight but 
nonsignificant increase between 8-11 and 11-14 months (Z = 1.00, p = .32). Groups did 
not differ in behavioral attentiveness or proportion of stuck trials. Developmental ability 
did not relate to behavioral attention variables.  
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Group differences in physiological variables were less robust. Table 3.7 reports 
fixed effects for physiological models. To summarize, age-related patterns of IBI varied 
across groups, with initially longer IBI in ASIBs that generally decreased toward typical 
levels across age. These group differences are depicted in Figure 3.3. Post-hoc Wilcoxon 
analyses indicated significantly longer IBI in ASIBs in the youngest age group (Z = -
1.86, p = .03). Groups did not differ in other physiological variables. Across the sample, 
lower developmental abilities were associated with higher RSA and greater proportion of 
time in SA.  
Association between Behavioral and Heart-Defined Attention 
 Table 3.5 includes the full correlation matrix for the full sample, as well as ASIB 
and LR groups.  Across behavioral and physiological variables, overlap latencies positive 
correlated with proportion of time in SA across participants (partial ρ = .40; p = 002), 
controlling chronological age and developmental ability. When correlations were 
examined within LR and ASIB groups, this effect was only statistically significant within 
the LR group (partial ρ = .40; p = .03; ASIB partial ρ = .30; p =.16). Greater proportion 
of overall attentiveness correlated with higher RSA in the ASIB group only (ASIB partial 
ρ = -.37; p = .04; LR partial ρ = .07; p =.70) No other biobehavioral associations were 
significant.  
Attentional Predictors of Clinical Autism Risk 
 Among ASIBs, higher clinical ASD risk factors were associated with greater 
proportion of stuck trials and marginally slower baseline latencies. Figure 2.4 depicts 
individual and group-level trajectories of proportion stuck trials across age, separated by 
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median AOSI score (5). Data from the LR group is included for reference. These effects 
were stable across age.  
To quantify the relative change in number of stuck trials over time among ASIBs 
with high AOSI scores, rates of change in proportion of stuck trials were calculated for 
each participant [(final proportion-initial proportion)/(final age-initial age)] and ranked. 
Sixteen participants had available AOSI data and at least two assessments. The 3 ASIBs 
who received scores above the clinical cut-off for risk (>7 elevated markers) ranked 2, 
14, and 16 in rate of change over time, with a rank of 1 indicating the greatest reduction 
in stuck trials (improvement) and rank of 16 indicating some of the greatest increases in 
stuck trials. Thus, although two participants exhibited significant increases in stuck trials 
compared to other ASIBs, the third exhibited robust improvements over time, relative to 
other ASIBs.  
Discussion 
It is increasingly recognized that longitudinal surveillance is critical to mapping 
early trajectories of risk among neurodevelopmental disorders. Indeed, the two previous 
studies to  longitudinally examine orienting among ASIBs identified patterns of risk that 
were not characterized in cross-sectional comparisons alone (Elsabbagh et al., 2013; 
Zwaigenbaum et al., 2005). We, too, identified abnormal age-related changes in overlap, 
gap, and baseline saccade latencies among ASIBs, which could be conceptualized as 
increased “disengagement difficulties” over time. Our physiological data support this 
finding, with evidence of hypoarousal in our youngest participants that potentially relates 
to longer saccade latencies. However, our use of longitudinal models also unveiled 
associations that were unexpected given previous reports. Within our sample, abnormal 
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disengagement appears to be driven by group differences in general orienting – across 
trial types – that are present in our youngest participants and improve at different rates 
over time. In other words, increasing “disengagement” deficits emerged in the context of 
dampened “normalizing” of orienting latencies over time. This conceptualization 
provides an alternate interpretation to prior assumptions that aberrant disengagement 
among ASIBs emerges from overlap latencies that increasingly deviate from “typical” 
baseline trajectories. These data may suggest that group differences may be present – not 
simply emerging – around 6 months of age in ASIBs.  
Notably, this interpretation deviates somewhat from the few previous studies of 
disengagement in ASIBs, although differences likely relate, in part, to methodological 
differences across studies. Including the present study, five primary studies have 
examined gap-overlap task performance among ASIBs, each using different stimuli and 
operationalization of “disengagement.” For example, although stimuli across Elsabbagh’s 
two studies (2009, 2013) and our study used cartoons of objects and animals, Elison’s 
group (2013) used pictures of faces and objects, and Zwaigenbuam (2005) used 
geometric shapes. Task design also varied by group; Elsabbagh et al 2009 and the present 
study employed baseline, gap (200 ms) and overlap trial types, whereas Elison and 
Zwaigenbaum examined gap (250 ms) and overlap trial types only, and Elsabbagh’s 2013 
study exclusively examined overlap and baseline trial types. “Disengagement” has also 
been quantified differently across groups. Studies have examined performance across 
trial types separately (Zwaigenbaum et al., 2005), incorporated multiple trial types as 
multivariate dependent variables (Elison et al., 2013; overlap and gap only), or examined 
“disengagement effects” by controlling for baseline latencies when interpreting overlap 
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latencies (Elsabbagh et al., 2013; Elsabbagh, Volein, et al., 2009; the present study). Thus 
although each study has described abnormal attention “disengagement,” broadly defined, 
the actual stimuli and analytic approaches used by each group reflect different 
interpretations of this construct.  
The following discussion describes the present findings in relation to the prior 
literature, within the context of these cross-study differences. To facilitate cross-study 
comparisons, Table 3.10 summarizes current studies of gap-overlap tasks in ASIBs using 
calculated standardized mean group differences (Cohen’s d) for latencies across each trial 
type and age group. When not supplied by the original authors (Elsabbagh et al., 2013; 
Elsabbagh, Volein, et al., 2009; Zwaigenbaum et al., 2005), effect sizes were calculated 
using means and standard deviations reported by the original authors. Comparisons 
included ASIB versus LR groups at each age interval, as well as for ASIBs later 
diagnosed with ASD (ASIB+ASD) versus LR controls, where applicable. Although these 
effect sizes do not account for covariates (e.g. developmental abilities, age at 
assessment), they provide an approximated landscape of the current published gap-
overlap data in infants.  
Development of “Sticky Attention” in ASIBs 
Our identification of atypical orienting in very young (5-8 month) ASIBs is 
consistent with a subset of previous studies. In a cross-sectional comparison of ASIBs 
later diagnosed with ASD (ASIB+ASD) versus LR controls, Elison and colleagues 
(2013) reported longer overlap and gap latencies (baseline latencies not measured) in the 
ASIB+ASD versus LR groups. Group differences in this 6-8 month sample produced 
large effects (d=.71 for each trial type). Similarly, although Zwaigenbaum and colleagues 
 75 
 
(2005) reported nonsignificant group differences overlap and gap latencies within their 6-
7 month ASIB sample (n=25), group differences in overlap latencies produced a large 
effect (d=.47), suggesting these differences may have been statistically significant with a 
larger cohort. Together, these studies suggest that group differences may be present by 
around 6 months of age in ASIBs.  
However, not all studies have reported consistent patterns across early 
development. Although Elsabbagh and colleagues (2009, 2013) report similarly longer 
gap and overlap latencies in ASIBs relative to LR controls, they suggest these differences 
emerge later in infancy. The authors also report that baseline latencies are generally 
longer in LR controls at younger ages. In Elsabbagh and colleagues’ (2009)  initial cross-
sectional report, 8-12 month ASIBs were reported to exhibit longer gap (d=.86) and 
overlap (d=.41) latencies than LR controls, with similar baseline latencies across groups 
(LR>ASIB d=.07). Similarly, the follow-up longitudinal study (Elsabbagh et al., 2013) 
reported group differences in overlap latencies relative to baseline latencies in 12-15 
month ASIBs, but not 6-10 month ASIBs.  Again, within the 6-10 month sample, the LR 
group actually exhibited longer baseline latencies than ASIBs (d=.44), opposing our 
finding of longer baseline latencies in ASIBs (d=.96). Although this baseline effect 
becomes negligible in this sample at older ages (Elsabbagh et al., 2009, ages 8.5-12.3 
months, d=.07; Elsabbagh et al., 2013, ages 12-15 months: d=.01), the absence – and 
counterevidence – of longer baseline latencies in young ASIBs is striking, particularly in 
light of the similar stimuli and procedures used across Elsabbagh’s reports and the 
present study.  
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Several sampling and statistical considerations may have contributed, in part, to 
these divergent findings. First, each study has defined and modeled developmental 
change differently. Prior to the present study, studies of gap-overlap tasks in AISBs have 
employed categorical modeling of age groups, despite the possibility – and likelihood – 
that rates of change in orienting changes during the first year of life. Indeed, between the 
5-8 month and 8-11 month age windows in our own sample, the average baseline latency 
changed by 70.42 ms in ASIBs (16.99 ms in LR), compared to only 16.78ms (10.95 ms 
in LR) between the 8-11 month and 11-14 month age groups. As such, collapsing across 
this earlier age window in previous studies may have produced more modest, or even 
absent age effects. It is also likely that differences also emerged due to modeling choices. 
The present study employed individual growth trajectories based on exact age at 
assessment, whereas previous longitudinal reports have used categorical approaches, 
comparing two assessments nested within broad age ranges (e.g. performance at 12-15 
months compared to 6-10 months).  Although our multilevel models accounted for 
individual differences in performance over time, the linear models we employed may still 
oversimplify developmental trajectories, smoothing over brief periods of rapid, non-
linear change that may be detectable in larger, more complex models. For example, our 
within-group contrasts suggest that overlap latencies within ASIB shortened between 5-8 
month and 8-11 month groups but were stable – and even exhibited slight but 
nonsignificant increases – between 8-11 and 11-14 months. This potential nonlinear 
pattern may explain why some studies have reported longer overlap latencies among 
ASIBs across two time points (Elsabbagh et al., 2013; Zwaigenbaum et al., 2005), 
whereas we observed shorter overlap latencies across a broader age span of up to three 
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time points. This nonlinear pattern may also indicate a period of vulnerability in which 
ASIBs begin to exhibit more heterogeneous profiles, with some increasing and some 
decreasing between 8-11 and 11-14 months, resulting in nonsignificant group-level 
change. The later scenario is supported by previous reports that ASIBs who later meet 
ASD criteria exhibit longer overlap latencies over time compared to general shortening 
among ASIBs who do not meet for ASD (Elsabbagh et al., 2013; Zwaigenbaum et al., 
2005). Our data complement these previous studies by suggesting that group-level 
differences are apparent prior to this developmental juncture, warranting further study of 
these complex trajectories and the potential neurobiological substrates that sustain both 
initial group differences and potential age-related increases in heterogeneity among 
ASIBs.     
It is likely that variations in sample composition, such as ASD symptoms and sex, 
have also contributed to variations across studies. When conceptualizing participant 
groups, some have reported ASIB data regardless of outcome (Elsabbagh, Volein, et al., 
2009), others used ADOS scores alone to quantify ASD symptoms (Elison et al., 2013; 
Zwaigenbaum et al., 2005) and the remaining study interpreted ADOS scores within 
broader diagnostic criteria (Elsabbagh et al., 2013). This use of both diagnostic and 
symptom-based outcome measures reflects complementary approaches of examining both 
broader endophenotypic features – similar to the extensive adult literature on the broader 
ASD phenotype (Bolton et al., 1994; Dawson et al., 2002; Pickles et al., 2000) – as well 
as specific risk factors for ASD among ASIBs. However, due to the presence of 
subthreshold ASD features in ASIBs without ASD (Elsabbagh et al., 2013), studies that 
strictly categorize ASIBs based on the presence or absence of ASD diagnoses may 
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restrict the variability of their “clinical” sample, reducing power to detect variation 
relevant to the ASD endophenotype. Similarly, different sex distributions across studies 
likely also affect the distribution of ASD symptoms, given ASD is 4.5 times more 
common in males (Centers for Disease Control, 2014). Proportion of males in previous 
studies ranges from 40% (Elsabbagh et al., 2013) to 75% (Elsabbagh et al., 2009; Elison 
et al., 2013 = 56%; Zwaigenbaum et al., 2005 sex not reported). Thus, classification 
systems and sex distributions may cause fluctuations in findings across groups. For 
example, our predominantly male sample (82% male) may have produced more robust 
group differences than previous studies with predominantly female samples (Elsabbagh et 
al., 2013). Teasing apart these patterns of sampling differences across studies may 
contribute to our conceptualization of heterogeneous symptom emergence in ASD.  
Despite these differences across studies, our data generally converged with 
previous reports that atypical orienting may be a marker of ASD risk among ASIBS. In 
our sample, higher ASD clinical risk – as measured by a behavioral screening tool 
between 11-14 months, correlated with higher proportion of stuck trials and moderately 
longer baseline latencies (p=.06), consistent with previous findings of “sticky attention” 
in ASIBs who later meet ASD criteria (Elison et al., 2013; Elsabbagh et al., 2013; 
Zwaigenbaum et al., 2005). Interestingly, both effects were stable across ages (e.g. age 
interactions were not significant), supporting that core vulnerabilities are detectable 
among young participants. Future studies are certainly needed to examine the long-term 
outcomes associated with infant orienting in this sample, particularly to examine whether 
these markers specifically predict ASD versus other developmental concerns (Elsabbagh 
et al., 2013). However, in the interim, our findings support that (1) sticky attention 
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remains a salient feature of the ASD endophenotype, and (2) these effects may be present 
earlier than previously reported.  
Autonomic Processes in ASIBs 
In addition to clarifying the behavioral emergence of abnormal orienting in 
ASIBs, the present study contributes novel information regarding the autonomic 
correlates of these aberrant behavioral profiles. In the present sample, ASIBs 
demonstrated slower IBI at younger ages, perhaps indicating global hypoarousal that may 
relate to slowed attention shifting and disengagement. Although correlations between 
overlap latencies and overall IBI did not reach statistical significance, the ASIB group 
exhibited subthreshold associations between longer IBI and slower latencies (n=29, 
=.22, p=.29) that were not present in the LR group (n=38, =-.05, p=.78). Although RSA 
did not differ across groups, ASIBs with greater behavioral attention exhibited higher 
RSA, potentially indicating that more abnormal visual attention is associated with poorer 
parasympathetic regulation in ASIBs, consistent with studies of reduced vagal 
suppression during cognitive stressors in older children with ASD (Porges, 2013). 
Interestingly, although RSA was negatively associated with developmental ability 
(p=.01), this effect was not significant in our previous study of an overlapping ASIB 
sample during a passive viewing task (Study 1; p=.11). These differences suggest the 
association between poorer RSA suppression and lower developmental ability was more 
apparent during a more cognitively taxing task, although it is also possible that slight 
differences in samples and missing data contributed to study differences. Paired with the 
behavioral patterns of slower latencies in ASIBs versus LR groups at younger ages, these 
data support the theory that attention disengagement in ASIBs is indexed by an 
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exaggerated biobehavioral attentional profile, with generally consistent data across 
behavioral and physiological measures. Interestingly, this pattern of hypoarousal and 
poor regulation in young ASIBs parallels associations between hypoarousal and higher 
ASD symptomatology previously in young infants with fragile X syndrome, a single-
gene disorder highly associated with ASD (Roberts et al., 2012).  Together, these studies 
suggest that abnormal arousal may be characteristic of a subset of infants at risk for ASD.  
Consistent with previous studies in low-risk samples (Casey & Richards, 1988; 
Richards, 1997), behavioral orienting was grossly associated with heart-defined SA in 
infants who are typically developing. This association was less robust – and dropped 
below statistical significance – in our ASIB sample, despite similar proportions of time 
spent in SA across ASIB (sample-wide mean = 23%, SD=11%) and LR (mean =20%, 
SD=11%) groups.  On the surface, this finding somewhat contradicts our hypothesis that 
abnormal visual orienting would be indexed physiologically by greater SA. However, it is 
notable that overlap latencies and proportion of stuck trials were more closely associated 
with properties of SA – such as IBI SD --- in ASIBS ( =.23, p=.28) compared to nearly 
no association in controls ( =.00, p=.99). Thus, it is possible that the properties of SA, 
rather than the overall proportion of time in SA, more closely index abnormal orienting in 
this group. Indeed, in our previous study of heart-defined SA in an overlapping sample, 
we found that qualities of SA during a passive viewing task predicted within-group 
variability in ASD symptoms among ASIBs (Study 1), suggesting qualities of SA may 
more closely relate to ASD symptomatology in this population.  
Interestingly, although our previous study (Study 1) identified group differences 
in heart-defined SA across overlapping ASIB and LR samples, SA did not distinguish 
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groups in the present study. In addition, heart activity and heart-defined SA also did not 
predict clinical autism risk among ASIBs, unlike the robust associations between ASD 
clinical risk and numerous physiological variables (IBI, IBI SD, IBI change during SA, 
IBI SD during SA) in Study 1.We propose these divergent findings likely reflect task-
related differences. Study 1 examined a passive viewing task that involves minimal 
examiner prompts to re-engage the child, thus capturing “resting” heart activity in a non-
demanding environment. Study 2, in contrast, examined active manipulation of attention 
(e.g. the examiner was directing the child’s attention to the task and did not initiate trials 
until fixation occurred). Furthermore, trials were separated by distinct inter-trial breaks in 
which no stimuli were on the screen, potentially disrupting endogenous physiological 
patterns related to attention. These preliminary studies suggest that measures of “resting 
state” physiology and heart-defined SA may be most informative of clinical ASD risk 
among ASIBs, although it is also possible that more fluid contingent looking paradigms 
may similarly reveal more nuanced patterns.  
Limitations and Future Directions 
 Despite providing novel evidence that both attentional and physiological 
differences may be detectable around 6 months of age or earlier among ASIBs, our 
findings are limited in a number of ways. First, although similar in size to previous 
studies of attention in ASIBs (Elison et al., 2013; Elsabbagh, Volein, et al., 2009; 
Zwaigenbaum et al., 2005), our sample is insufficient to model complex, non-linear 
changes that are likely present in the attentional trajectories in young infants. Capturing 
these trends is important to identifying potential “critical periods” (Rice & Jr, 2000) of 
abnormal development that could both (1) inform neurobiological processes sustaining 
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aberrant attention in ASIBs and (2) serve as points of prevention and intervention. 
Indeed, recent concentrated longitudinal assessments of visual attention in ASIBs have 
suggested abnormalities as early as 2 month of age (Jones & Klin, 2013), supporting the 
utility and importance of integrating repeated assessments to capture developmental 
change. Although the present study focused on continuous ASD risk factors as a measure 
of the ASD endophenotype, it will also be important to continue to follow this cohort of 
children to assess long-term “endpoints” of these early, aberrant processes. Although a 
number of previous studies have associated abnormal orienting with ASD risk (Elison et 
al., 2013; Elsabbagh et al., 2013; Zwaigenbaum et al., 2005), abnormal orienting has also 
been identified among ASIBs with non-ASD developmental abnormalities (Elsabbagh et 
al., 2013). Establishing the specificity of these associations will define the clinical scope 
of aberrant visual orienting as a marker of ASD risk.  
As we continue to document the role of abnormal orienting in the ASD 
endophenotype, another important next step will be to tease apart how sampling and 
methodological differences affect findings across studies. This question is important to 
both clarifying the aforementioned inconsistencies in the ASIB literature, as well as 
informing translational efforts such as early intervention protocols. Because the sex 
distribution in our study was designed to parallel rates of ASD in the general population 
(4.5 males to 1 female; Centers for Disease Control, 2014), our sample is underpowered 
to tease apart whether abnormal orienting is similarly apparent across male and female 
ASIBs. It is likely that our capacity to detect group differences between ASIB and LR 
samples was also enhanced by the skewed sample of males, although testing this 
possibility statistically will be important for understanding sex-specific risk patterns. 
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Similarly, additional work is needed to clarify the specific variables that affect efficient 
orienting, particularly given the different stimuli and presentation timing used in current 
studies. For example, in both our and Elsabbagh’s studies (2009, 2013), the central 
stimulus during overlap trials changes properties from an animated spinning stimulus to a 
static image. Although this change was designed to increase similarity between the 
central and peripheral stimuli (a balloon that alternates between smaller and larger sizes), 
the changed central stimulus may operate as a cue that another stimulus is about to 
appear. Our own data across Studies 1 and 2 also demonstrate the capacity of different 
tasks to elicit varied performance within an overlapping sample. For example, abnormal 
looking patterns were observed during passive viewing (Study1) but not a the gaze-
contingent task (Study 2), suggesting typical gaze patterns in the presence of examiner 
and task-related prompts, but not in the absence of these supports. Continuing to examine 
the scope of orienting deficits – such as whether effects vary across social versus 
nonsocial stimuli, static versus dynamic stimuli, and cued versus non-cued stimuli – will 
provide important clues as to the attentional processes subserving abnormal orienting and 
ASD risk.  
This study also paves the way for new research investigating autonomic 
functioning among ASIBs. It has been suggested that psychophysiological variables, such 
as abnormal arousal, may provide sensitive information that may eventually result in 
biological rather than behavioral categorization of ASD (Cuthbert & Insel, 2013; 
McPartland, Bernier, & South, 2015). Our finding of hypoarousal in young ASIBs 
parallels one of the few studies to examine heart activity as a biomarker of ASD risk in 
“high risk” infants with fragile X syndrome (Roberts et al., 2012), warranting further 
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research into whether early autonomic profile may index ASD risk among ASIBs. Our 
findings also suggest that although heart-defined SA may serve as an index of attentional 
processes, the utility of this method likely varies across task designs, as associations 
emerged in our previous passive viewing study (Study 1) that were not present in the 
present gaze-contingent task. Further studies of computerized visual attention tasks may 
be designed to answer these questions. However, it will be important to examine the 
association between ASD risk and heart-defined SA during naturalistic activities, such as 
play-based assessments, as a means to inform the clinical utility of heart-defined SA as a 
marker of the ASD endophenotype.  
Conclusion 
 The present study identified abnormal visual orienting and co-occurring 
physiological functioning within the first year of life in infant siblings of children with 
ASD. Importantly, our longitudinal models suggest that commonly reported 
“disengagement deficits” observed among ASIBs may emerge due to initially abnormal 
patterns of general orienting (across trial types) that improves at varied rates over time. 
This interpretation, supported by aberrant heart activity observed at younger ages among 
ASIBs, suggests persistent orienting deficits that are present, rather than beginning to 
emerge, around 6 months of age. These deficits also relate to later behavioral markers of 
clinical ASD risk, supporting further investigation as to whether biobehavioral orienting 
patterns may index ASD vulnerability. Although additional work is needed to clarify the 
long-term clinical implications of these findings, our results suggest that abnormal 
orienting is apparent within the infant ASD phenotype and may co-occur with aberrant 
physiological functioning early in development.  
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Table 3.1. Previous Gap-Overlap Task Studies in Infant Siblings of Children with Autism 
Authors and Tasks Analyses/Comparisons  Key Findings 
Zwaigenbaum et al., 2005 
 
Sample: ASIBs assessed at 
6m (n=25) and 12m (n=27; 
20 with 2 assessments); 25 
LR assessed at 6-7m. Sex 
not reported. 
 
Outcome: At 24m, 6/25 6m 
ASIBs and 10/27 12m 
ASIBs scored ADOS+ for 
Autism/ASD.   
Cross-sectional group differences 
in Overlap and  Gap at 6m 
 
Paired t test to examine 6 vs. 12m 
Overlap and Gap within ASIBs 
 
ASIBs categorized by whether 
Overlap latency increased by 
1500ms+ 
 
Correlation between ADOS 
algorithm score and 12m Overlap 
and Gap 
Gap (p=.78; *d=0.08) and Overlap 
(p=.12; *d=0.47) ns at 6m 
 
From 6-12m, ASIB Overlap 
increased (p=.01), Gap ns (p=.78)  
 
All ASIBs with 1500ms+ increases 
in latencies were ADOS+ at 24m 
 
ADOS correlated with Overlap 
(r=.42, p <.05) but not Gap (r= -0.04,  
p =.85) 
Elsabbagh et al., 2009 
 
Sample: 16 ASIBs (4 male) 
and 16 LR (4 male), 
assessed at 8-12m (1 
assessment each).  
 
Outcome: No outcome data 
 
Group differences in Baseline, 
Overlap and Gap latencies 
 
 
Group differences in likelihood to 
orient on Overlap trials 
 
Group (2) x Condition (2) 
ANOVA 
- Model 1: Overlap vs Baseline 
- Model 2: Gap vs. Baseline 
Baseline (p>.05, *d=.07) and 
Overlap (p>.05, *d=.41) ns, ASIB 
Gap latencies slower (p=.02; d=.86).  
 
Group differences ns (p=.24, *d=.36; 
ASIB=91%, LR=84%) 
 
Relative to LR, ASIBs showed 
longer Overlap (p=.02, np
2=.17) and 
Gap (p=.02, np
2=.17) latencies vs. 
Baseline 
Elsabbagh et al., 2013 
 
Sample: 54 ASIBs (21 
male) and 50 LR (21 male), 
assessed at 6-10m (“7m”) 
and 12-15m (“14m”; 2 
assessments each).  
 
Outcome: 16 ASIBs met 
ASD ICD-10 criteria at 
36m; 12 ASIBs “atypical” 
due to ASD symptoms or 
low IQ 
Group (4) x Condition (2) repeated 
measure (Age) GLM, controlling 
developmental abilities (DA) 
- Groups=LR, ASIB+ASD, 
ASIB-Atypical, ASIB-Typical 
- Conditions=Overlap, Baseline  
 
 
Three-way interaction (p=.008) in 
which ASIB+ASD group exhibited 
longer latencies than other 3 groups 
at 14m, but not 7m. LR and ASIB-
Typical groups exhibited shorter 
Overlap latencies relative to Baseline 
from 7 to 14m, whereas 40% of 
ASIB+ASD group exhibited longer 
latencies from 7 to 14m.  
 
Slower latencies in lower DA (p=.01) 
Elison et al., 2013 
 
Sample: 56 ASIBs (31 
male) and 41 LR (24 male), 
assessed at 6-8m (1 
assessment each) 
 
Outcome: 16 ASIBs scored 
ADOS+ for ASD at 25m 
Multivariate ANOVA predicting 
Overlap and Gap latencies by 
Group(3)  
- Groups: LR, ASIB+ASD, 
ASIB-Typical 
 
ASIB+ASD group exhibited longer 
Overlap than LR group (d=.71, 
p=.03) and ASIB-Typical groups 
(d=.73, p=.01). ASIB+ASD group 
exhibited longer Gap than LR group 
only (d=.71, p=.03) 
 
ASIB+ASD group did not show 
typical associations between saccade 
latencies and radial diffusivity of 
splenium.  
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Table 3.2: Model Fit Parameters for Fixed and Random Effects, Cross- Group Comparisons  
Dependent Variable  Model 1 
No Random Effects 
Model 2 (Null Model) 
Fixed: Intercept, Age 
Random: Intercept 
Model 3 
Fixed: Intercept, Age 
Random: Intercept, Age 
 ICC 
Level 1 
R
2
 
Full Model  
vs. Null Model 
Behavior        
     Baseline Latency AIC 
BIC 
10.5 
13.1 
-10.8 
-7.2 
-9.5 
-2.1 
 .52 .11 
     Overlap Latency AIC 
BIC 
14.5 
16.9 
11.7 
15.3 
13.4 
18.9 
 .35 .13 
     Gap Latency  AIC 
BIC 
22.3 
24.8 
15.4 
19.1 
16.3 
23.7 
 .33 .18 
     % Failed Trials AIC 
BIC 
-80.0 
-77.5 
-77.1 
-73.5 
-73.9 
-66.6 
 .31 .00 
     Prop. Inattentive AIC 
BIC 
-92.3 
-89.9 
-87.5 
-83.8 
-84.1 
-76.8 
 .33 .01 
Overall Heart Activity        
     Overall IBI AIC 
BIC 
33.1 
35.4 
22.3 
25.9 
24.1 
31.4 
 .70 .11 
     Overall RSA AIC 
BIC 
61.3 
63.6 
62.0 
65.7 
59.5 
66.8 
 .52 -.02 
     Overall IBI SD AIC 
BIC 
98.8 
98.9 
94.5 
98.1 
86.0 
94.6 
 .59 -.04 
Sustained Attention 
 
       
     Proportion SA AIC 
BIC 
-129.7 
-127.5 
-123.2 
-119.5 
-124.5 
-117.2 
 .19 .08 
     SA IBI SD AIC 
BIC 
79.5 
81.7 
84.4 
88.0 
87.4 
94.7 
 .26 -.003 
     SA Mean IBI Δ AIC 
BIC 
89.0 
91.2 
86.6 
90.3 
87.4 
94.7 
 .52 -.02 
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Table 3.3. Clinical and Behavioral Descriptive Statistics by Group and Chronological Age 
  Infant Sibling (n=23)  Low Risk Control (n=23) 
  
 
n 
 
SD min max 
 
n 
 
SD min max 
Individual-Level Variables 
     n assessments  23 2.17 0.89 1 3  23 2.13 0.81 1 3 
     MSEL SS   23 97.87 14.29 60 121  23 102.48 10.68 83 119 
     AOSI Total Score   21 6.14 4.69 1 19  -- -- -- -- -- 
     AOSI N Markers  21 4.00 2.37 1 10  -- -- -- -- -- 
Assessments between 5-8 months 
     Age in months  13 6.43 0.49 5.95 7.53  12 6.38 0.63 5.65 7.82 
     Baseline Latency   13 437.49 103.05 212.5 601.95  12 349.28 79.3 241.66 513.88 
     Overlap Latency  12 578.57 121.38 385.71 747.61  11 561.13 149.82 290.47 805.55 
     Gap Latency   13 368.01 85.9 215.38 510.25  12 282.59 85.32 186.66 495.83 
     % Failed Trials  13 0.07 0.06 0 0.15  12 0.07 0.07 0 0.24 
     Prop. Inattentive  11 0.46 0.17 0.16 0.71  6 0.41 0.23 0.1 0.74 
Assessments between 8-11 months 
     Age in months  19 9.45 0.55 8.88 10.62  17 9.44 0.38 8.84 10.42 
     Baseline Latency   19 367.07 86.56 249.27 540.74  17 332.29 78.12 225 485.71 
     Overlap Latency  17 467.12 124.8 354.16 885.75  17 468.92 126.42 329.63 816.66 
     Gap Latency   19 311.73 87.21 197.5 514.81  17 288 91.16 198.48 497.22 
     % Failed Trials  19 0.08 0.07 0 0.2  17 0.06 0.04 0 0.14 
     Prop. Inattentive  16 0.49 0.18 0.09 0.8  15 0.54 0.18 0.3 0.89 
Assessments between 8-11 months          
     Age in months  18 12.49 0.58 11.7 13.78  20 12.28 0.49 11.54 13.74 
     Baseline Latency   18 350.29 81.4 229.41 526.66  19 321.34 69.6 180.57 475.43 
     Overlap Latency  12 489.36 83.98 383.33 657.14  20 461.2 132.58 287.1 799.99 
     Gap Latency   18 275.5 53.68 208.33 372.22  19 278.82 74.02 186.12 490.42 
     % Failed Trials  18 0.1 0.08 0 0.26  20 0.08 0.06 0 0.24 
     Prop. Inattentive  17 0.46 0.19 0.06 0.70  16 0.52 0.20 0.07 0.80 
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Table 3.4. Physiological Descriptive Statistics, by Group and Chronological Age 
 
  
Infant Sibling (n=23) 
 
Low Risk Control (n=23) 
  
 
n 
 
SD min max 
 
n 
 
SD min max 
Assessments between 5-8 months 
     Overall IBI 
 
11 336.36 113.80 214.58 515.21  8 239.75 78.65 190.96 430.40 
     Overall RSA 
 
11 2.71 1.37 1.31 6.13  8 2.05 0.71 1.05 3.57 
     Overall IBI SD 
 
11 19.90 15.80 7.29 59.96  8 12.51 4.00 5.55 16.42 
     Proportion SA 
 
9 0.27 0.12 0.06 0.41  5 0.31 0.18 0.12 0.55 
     SA IBI SD 
 
9 27.20 17.33 9.27 62.99  5 28.63 5.96 21.70 37.32 
     SA Mean IBI Δ 
 
9 26.30 18.54 5.77 62.76  5 25.78 6.11 17.62 31.66 
Assessments between 8-11 months 
     Overall IBI 
 
13 281.62 103.48 211.70 486.34  15 241.55 46.36 205.41 397.34 
     Overall RSA 
 
13 2.34 1.05 1.23 5.33  15 2.07 0.38 1.42 2.76 
     Overall IBI SD 
 
13 19.04 11.46 8.58 51.76  15 14.59 4.41 10.37 25.48 
     Proportion SA 
 
13 0.19 0.11 0.06 0.42  14 0.19 0.12 0.01 0.46 
     SA IBI SD 
 
13 25.59 7.04 13.80 38.24  14 28.38 12.77 16.37 62.94 
     SA Mean IBI Δ 
 
13 24.16 8.15 8.18 34.47  14 23.75 7.80 12.06 37.82 
Assessments between 11-14 months 
     Overall IBI 
 
13 283.16 85.30 214.97 440.62  16 280.36 107.63 209.12 561.19 
     Overall RSA 
 
13 2.53 0.91 1.35 4.65  16 2.57 1.30 1.64 5.82 
     Overall IBI SD 
 
13 19.01 8.28 9.17 39.24  16 17.89 10.25 9.90 43.51 
     Proportion SA 
 
13 0.24 0.09 0.13 0.37  15 0.17 0.06 0.03 0.28 
     SA IBI SD 
 
13 32.06 15.13 6.89 65.32  15 28.16 11.00 15.11 57.25 
     SA Mean IBI Δ 
 
13 26.58 10.57 5.55 43.58  15 26.30 8.42 13.42 50.69 
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Table 3.5. Partial Spearman Correlations between Behavioral and Physiological Variables, Controlling for Chronological Age, 
Developmental Ability, and Baseline Latency (Overlap and Gap Only) 
 
*Significant at p<.05 ^p=.06   
 Baseline Latency Overlap Latency Gap Latency % Stuck Trials % Inattention 
 n partial ρ n partial ρ n partial ρ n partial ρ n partial ρ 
Full Sample           
     Overall IBI 78 .14 70 -.02 77 .18 79 .14 69 -.17 
     Overall IBI SD 78 .06 70 .03 77 .08 79 .10 69 -.07 
     Overall RSA 78 .06 70 -.01 77 .03 79 .12 69 -.23^ 
     Proportion SA 71 -.08 63 .40
*
 70 -.16 72 .00 69 -.77* 
     SA IBI SD 71 -.04 63 .11 70 .09 72 .07 69 .03 
     SA Mean IBI Δ 71 -.03 63 .04 70 -.12 72 -.05 69 -.09 
ASIB Group           
     Overall IBI 37 .03 29 .22 37 -.03 37 .19 35 -.24 
     Overall IBI SD 37 .12 29 .29 37 .05 37 .12 35 .07 
     Overall RSA 37 .01 29 .23 37 -.04 37 .13 35 -.37* 
     Proportion SA 35 -.17 27 .30 35 -.27 35 .04 35 -.74* 
     SA IBI SD 35 -.02 27 .23 35 .05 35 .05 35 .15 
     SA Mean IBI Δ 35 -.03 27 .11 35 -.08 35 -.08 35 .04 
LR Group           
     Overall IBI 41 .08 41 -.06 40 .20 42 .05 34 .03 
     Overall IBI SD 41 -.03 41 -.09 40 .06 42 .05 34 .07 
     Overall RSA 41 -.00 41 -.07 40 -.01 42 .07 34 .07 
     Proportion SA 36 .02 36 .40
*
 35 -.15 37 -.03 34 -.79* 
     SA IBI SD 36 .03 36 .01 35 .15 37 .12 34 .02 
     SA Mean IBI Δ 36 .12 36 .04 35 -.14 37 .12 34 -.06 
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Table 3.6: Fixed Effects of Group on Behavioral Attention  
 
Model Component Estimate SE df t-value p 
Baseline Saccade Latency      
Intercept -1.13 0.05 44.20 -24.14 <.0001 
Age -0.01 0.01 61.60 -0.93 0.35 
Group 0.17 0.07 43.70 2.56 0.01 
Group*Age -0.03 0.01 60.00 -2.37 0.02 
Developmental ability 0.00 0.00 39.50 0.79 0.44 
Overlap Saccade Latency      
Intercept -0.03 0.11 56.80 -0.27 0.78 
Age -0.03 0.01 71.80 -2.37 0.02 
Group -0.02 0.05 38.10 -0.35 0.73 
Group*Age 0.04 0.02 71.80 2.10 0.04 
Developmental ability 0.00 0.00 35.50 1.34 0.19 
Baseline Saccade Latency 0.63 0.10 60.80 6.46 <.0001 
Gap Saccade Latency      
Intercept -0.53 0.10 47.50 -5.15 <.0001 
Age 0.01 0.01 74.10 0.55 0.58 
Group 0.04 0.04 28.90 0.83 0.41 
Group*Age -0.03 0.02 72.50 -1.98 0.05 
Developmental ability 0.00 0.00 24.50 -0.52 0.61 
Baseline Saccade Latency 0.68 0.09 52.20 7.79 <.0001 
% Stuck Trials       
Intercept 0.15 0.03 46.70 5.36 <.0001 
Age 0.00 0.01 76.70 0.04 0.97 
Group 0.05 0.04 46.80 1.22 0.23 
Group*Age 0.01 0.01 74.00 0.71 0.48 
Developmental ability 0.00 0.00 41.50 0.96 0.34 
Proportion Time Inattentive      
Intercept 0.39 0.03 47.40 13.62 <.0001 
Age 0.01 0.01 57.40 1.22 0.23 
Group -0.01 0.04 43.40 -0.32 0.75 
Group*Age -0.01 0.01 54.90 -1.06 0.29 
Developmental ability 0.00 0.00 34.10 -0.39 0.70 
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Table 3.7: Fixed Effects of Group on Physiological Variables 
 
Model Component Estimate SE df t-value p 
Overall IBI      
Intercept 5.55 0.06 38.90 87.91 <.0001 
Age 0.01 0.01 40.90 1.08 0.29 
Group 0.11 0.09 37.00 1.21 0.23 
Group*Age -0.04 0.02 38.80 -2.53 0.02 
Developmental ability -0.01 0.00 36.30 -1.54 0.13 
Overall RSA      
Intercept 2.69 0.09 37.50 29.75 <.0001 
Age 0.03 0.03 48.00 1.33 0.19 
Group 0.13 0.13 35.00 1.03 0.31 
Group*Age -0.02 0.03 44.10 -0.46 0.65 
Developmental ability -0.01 0.00 34.30 -2.44 0.02 
Overall IBI SD      
Intercept 0.79 0.07 36.50 10.74 <.0001 
Age 0.02 0.02 48.40 1.14 0.26 
Group 0.07 0.10 33.90 0.65 0.52 
Group*Age -0.03 0.03 44.10 -0.97 0.34 
Developmental ability -0.01 0.00 33.20 -1.72 0.09 
Proportion SA      
Intercept 0.19 0.02 40.10 10.08 <.0001 
Age -0.01 0.01 49.80 -2.02 0.05 
Group 0.02 0.03 37.60 0.79 0.43 
Group*Age 0.01 0.01 48.10 1.19 0.24 
Developmental ability 0.00 0.00 33.20 2.18 0.04 
Average IBI Variability during SA    
Intercept 3.18 0.11 43.50 29.45 <.0001 
Age 0.01 0.03 38.10 0.43 0.67 
Group -0.06 0.15 40.00 -0.40 0.69 
Group*Age 0.02 0.04 37.60 0.51 0.61 
Developmental ability 0.00 0.01 35.80 -0.06 0.95 
Average IBI Change during SA    
Intercept 3.31 0.10 40.10 34.71 <.0001 
Age 0.00 0.03 45.60 -0.14 0.89 
Group -0.10 0.13 37.10 -0.79 0.43 
Group*Age 0.04 0.04 44.20 1.02 0.31 
Developmental ability 0.00 0.00 32.60 -0.75 0.46 
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Table 3.8: Fixed Effects of Clinical ASD Risk on Behavioral Attention among ASIBs 
 
Model Component Estimate SE df t-value p 
Baseline Saccade Latency (R
2
=.28) 
Intercept -1.17 0.12 17.40 -9.58 <.0001 
Age 0.01 0.04 33.00 0.18 0.86 
Autism Risk 0.13 0.07 17.00 2.02 0.06 
Autism Risk*Age -0.03 0.02 32.90 -1.41 0.17 
Developmental ability 0.01 0.00 17.40 3.00 0.01 
Overlap Saccade Latency(R
2
=.18) 
Intercept -0.37 0.21 28.90 -1.79 0.08 
Age 0.04 0.04 21.20 1.07 0.30 
Autism Risk 0.03 0.06 11.30 0.55 0.60 
Autism Risk*Age -0.02 0.02 24.60 -1.16 0.26 
Developmental ability 0.00 0.00 13.80 1.53 0.15 
Baseline Latency 0.37 0.16 33.00 2.36 0.02 
Gap Saccade Latency(R
2
=-.01) 
Intercept -0.49 0.16 35.20 -3.11 0.00 
Age -0.04 0.03 34.70 -1.38 0.18 
Autism Risk 0.00 0.04 19.40 0.01 0.99 
Autism Risk*Age 0.01 0.02 34.90 0.36 0.72 
Developmental ability 0.00 0.00 19.90 0.20 0.85 
Baseline Latency 0.67 0.12 39.20 5.72 <.0001 
% Stuck Trials (R
2
=-.07)      
Intercept 0.02 0.08 14.60 0.29 0.77 
Age 0.02 0.03 33.80 0.80 0.43 
Autism Risk 0.11 0.04 14.30 2.55 0.02 
Autism Risk*Age -0.01 0.02 34.20 -0.58 0.57 
Developmental ability 0.005 0.002 15.20 2.82 0.01 
Proportion Inattentive (R
2
=.01)     
Intercept 0.46 0.08 16.30 5.89 <.0001 
Age 0.03 0.02 25.20 1.15 0.26 
Autism Risk -0.04 0.04 15.60 -1.03 0.32 
Autism Risk*Age -0.02 0.01 25.60 -1.27 0.22 
Developmental ability 0.00 0.00 16.60 0.51 0.62 
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Table 3.9: Fixed Effects of Clinical ASD Risk on Heart Activity among ASIBs 
 
Model Component Estimate SE df t-value p 
Overall IBI (R
2
=.12)      
Intercept 5.83 0.22 14.70 26.11 <.0001 
Age -0.10 0.05 18.00 -2.01 0.06 
    Autism Risk -0.08 0.12 14.30 -0.68 0.51 
    Autism Risk*Age 0.04 0.03 18.80 1.38 0.18 
Developmental ability -0.01 0.01 15.40 -1.77 0.10 
Overall RSA (R
2
=.09)      
Intercept 0.82 0.25 15.50 3.31 0.00 
Age -0.07 0.07 21.10 -1.01 0.33 
    Autism Risk 0.02 0.13 14.90 0.14 0.89 
    Autism Risk*Age 0.04 0.04 22.00 0.98 0.34 
Developmental ability -0.01 0.01 16.30 -2.01 0.06 
Overall IBI SD (R
2
=.06)      
Intercept 2.66 0.30 15.80 8.83 <.0001 
Age 0.07 0.08 20.70 0.92 0.37 
    Autism Risk 0.07 0.16 15.30 0.44 0.66 
    Autism Risk*Age -0.03 0.04 21.60 -0.72 0.48 
Developmental 
ability 
-0.02 0.01 16.70 -2.88 0.01 
Proportion SA (R
2
=.004)      
Intercept 0.22 0.06 15.80 3.54 0.00 
Age 0.00 0.02 19.70 0.05 0.96 
    Autism Risk -0.01 0.03 14.10 -0.36 0.72 
    Autism Risk*Age 0.00 0.01 20.20 -0.10 0.92 
Developmental ability 0.00 0.00 16.50 0.23 0.82 
Average IBI Variability during SA (R
2
=-.004) 
Intercept 3.03 0.32 16.10 9.51 <.0001 
Age 0.14 0.11 19.30 1.33 0.20 
    Autism Risk 0.07 0.17 14.50 0.40 0.69 
    Autism Risk*Age -0.05 0.06 19.90 -0.93 0.37 
Developmental ability -0.01 0.01 16.80 -0.97 0.35 
Average IBI Change during SA (R
2
=-.12) 
Intercept 2.96 0.43 13.80 6.85 <.0001 
Age 0.07 0.10 14.20 0.70 0.50 
    Autism Risk 0.05 0.23 12.90 0.20 0.85 
    Autism Risk*Age -0.02 0.05 14.80 -0.30 0.77 
Developmental ability -0.01 0.01 14.20 -0.63 0.54 
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Table 3.10. Standardized Mean Group Differences (d) of Raw Latencies and Proportion Stuck Trials in Gap-Overlap Studies in ASIBs 
   Age  Sample Size   Cohen’s d  
Study Groups  Mean(SD) Range  ASIB LR  Baseline Gap Overlap % Stuck 
Zwaigenbaum et al. 
2005 
LR vs. 
ASIB 
 ^ 6.36 (0.48) ~ 6-7m  25 25  -- 
0.08 
a
 
ASIB>LR 
0.47 
ASIB>LR 
-- 
Tonnsen et al (current) 
LR vs. 
ASIB 
 6.40 (0.54) 
5.65-
7.82 
 13 12  
0.96 
ASIB>LR 
1.00
 b
 
ASIB>LR 
0.13 
ASIB>LR 
0.07 
LR>ASIB 
Elison et al., 2013 
LR vs. 
ASD 
 7.04 (.95) ~6-8m  16 41  -- 
0.71 
a
 
ASD>LR 
0.71 
ASD>LR 
0.55 
ASD>LR 
Elsabbagh et al. 2013 
LR vs. 
ASIB 
 7.35 (1.20) ~ 6-10m  52 48  
0.44 
LR>ASIB 
-- 
0.13 
LR>ASIB 
0.19 
LR>ASIB 
Elsabbagh et al. 2013 
LR vs. 
ASD 
 7.35 (1.20) ~ 6-10m  16 48  
0.37 
LR>ASD 
-- 
0.10 
LR>ASD 
0 
ASD=LR 
Tonnsen et al (current) 
LR vs. 
ASIB 
 9.45 (0.47) 
8.84-
10.61 
 19 17  
0.42 
ASIB>LR 
0.27
 b
 
ASIB>LR 
0.01 
LR>ASIB 
0.26 
ASIB>LR 
Elsabbagh et al. 2009 
LR vs. 
ASIB 
 9.75m (2.73) 
8.58-
12.32m 
 16 16  
0.07 
LR>ASIB 
0.86
 b
 
ASIB>LR 
0.41 
ASIB>LR 
0.36 
ASIB>LR 
Tonnsen et al (current) 
LR vs. 
ASIB 
 12.37 (0.54) 
11.54-
13.78 
 18 20  
0.38 
ASIB>LR 
0.05
 b
 
LR>ASIB 
0.25 
ASIB>LR 
0.32 
ASIB>LR 
Elsabbagh et al. 2013 
LR vs. 
ASIB 
 13.79 (1.46) 
~12-
15m 
 52 46  
0.01 
ASIB>LR 
-- 
0.30 
ASIB>LR 
0.10 
ASIB>LR 
Elsabbagh et al. 2013 
LR vs. 
ASD 
 13.79 (1.46) 
~12-
15m 
 16 46  
0.01 
ASD>LR 
-- 
1.00 
ASD>LR 
0.32 
ASD>LR 
 
Note: LR=low risk; ASIB = All infant siblings, regardless of outcome; ASD = infant siblings later diagnosed with ASD 
^Mean for broader study sample; ages for participants with attention data not reported 
a
200ms gap, 
b
250ms gap
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 Figure 3.1: Group Differences in Saccade Latencies across Age, by Trial Type  
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Figure 3.2: Group Differences in Disengagement and Facilitation across Age 
Note: Difference scores used for display purposes only. Statistical models were 
constructed for Overlap and Gap latencies, controlling for Baseline latency. Compared to 
the LR group, ASIBs exhibited less improvement in Overlap and Gap latencies over time, 
relative to Baseline latencies.  
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Figure 3.3: Group Differences in Trajectories of Interbeat Interval across Age 
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Figure 3.4: Proportion of Stuck Overlap Trials across Age, by Clinical ASD Risk 
Note: Proportion of stuck trials across ASIBs with AOSI Total Score less or greater than 
the group median (<5 = “Low AOSI”; > 5 = “High AOSI”) versus LR controls. 
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CHAPTER 4 
CROSS-SYNDROME ATTENTION IN INFANTS AT RISK FOR AUTISM
3
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 Tonnsen, B. L., Richards, J. E. & Roberts, J. E. To be submitted to American Journal of 
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After decades of research seeking to characterize the developmental course of autism 
spectrum disorder (ASD), our field is beginning to complement reactive approaches – 
reducing symptoms that cause impairment – with proactive approaches – preventing 
debilitating symptoms before they emerge (Dawson, 2008). The first step to prevention, 
however, is fine-tuned characterization of the nature and course of atypical development. 
One of the most common techniques for identifying prodromal indicators of ASD risk is 
to prospectively examine cohorts of “high risk” infants over time. A number of 
longitudinally studies have followed infant siblings of children with autism (ASIBs), who 
exhibit 10-20 times higher rates of autism diagnoses (e.g. 19%; (Ozonoff et al., 2011) 
than the general population (1-2%; Centers for Disease Control, 2014) to establish 
endophenotypes of ASD and potential predictors of later ASD risk. However, far fewer 
studies have examined emerging autism symptoms and risk factors in other infants at 
elevated risk for ASD, such as infants with fragile X syndrome (FXS), a single-gene 
disorder highly associated with autism (Bailey, Raspa, Olmsted, & Holiday, 2008). 
Comparing aberrant pathways identified in ASIBs across multiple high-risk groups may 
establish convergent pathways of risk that indicate generalizable targets for population-
based surveillance. These comparisons may also identify sources of syndrome-specific 
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variability that could clarify etiological pathways of ASD symptoms and mechanism-
specific treatments.  
The present study employs a cross-syndrome approach to investigate attention 
orienting in infants at risk for ASD. Aberrant orienting is one of the most commonly 
reported abnormalities in ASIBs (Study 2; Elison et al., 2013; Elsabbagh et al., 2013; 
Elsabbagh, Volein, et al., 2009; Zwaigenbaum et al., 2005) and has been identified in a 
small sample of infants with FXS, as well (Roberts et al., 2011). We previously reported 
atypical patterns of attention orienting in 5-14 months ASIBs compared to low risk 
controls using a computerized gap-overlap task (Study 2). In the present study, we 
investigated cross-sectional profiles of attention orienting, as well as concurrent 
physiological arousal and heart-defined sustained attention, in 9 and 12-month infants 
with FXS contrasted our previously reported ASIB and low risk (LR) data (Study 2). The 
purpose of this work is twofold. First, we aimed to establish whether abnormalities we 
previously reported in ASIBs similarly manifest in infants with FXS, informing potential 
heterogeneity in symptom expression. Second, we sought to determine whether 
converging cross-syndrome behavioral profiles are associated with similar physiological 
substrates, informing whether shared phenotypes are potentially sustained by distinct 
biological mechanisms. By examining both shared and heterogeneous pathways of ASD 
risk across groups, this work may characterize both global and syndrome-specific 
information about the etiology and emergence of ASD risk in infants.   
A cross-syndrome approach to ASD 
Between 2010 and 2014, over 100 peer-reviewed papers were published on the 
early development of infant siblings of children with ASD (ASIBs). This body of 
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literature has identified a number of abnormal features in ASIBs, ranging from socio-
communicative symptoms to visual attentional abnormalities, which have paved the way 
for earlier ASD detection and treatment (see Jones et al., 2014; Rogers, 2009; 
Zwaigenbaum, Bryson, & Garon, 2013, for review).  A notable limitation of the “infant 
sibling” approach, however, is the likelihood that ASIBs exhibit different patterns of 
prodromal autism risk than infants diagnosed without a family history of ASD. For 
example, compared simplex families with one child affected with ASD, multiplex 
families (more than one child with ASD) exhibit less robust elevations in ASD rates in 
males versus females (Ozonoff et al., 2011; Zwaigenbaum et al., 2012), suggesting 
differing profiles of genetic risk. Similarly, sub-clinical autism features are more 
common in multiplex versus simplex families (Constantino et al., 2010; Szatmari et al., 
2000), as well as in and simplex versus adoptive families (Szatmari et al., 2000), 
indicating genetically-mediated gradients of symptoms in non-ASD samples. Infant 
siblings who do not meet ASD criteria also exhibit higher rates of subthreshold ASD 
symptoms and elevated risk of developmental and language impairments compared to 
low-risk controls (Messinger et al., 2013; Ozonoff et al., 2014; Toth et al., 2007), 
suggesting complex risk profiles among ASIBs that may not extend to non-ASIB groups. 
Thus, although the ASIB literature has been central to defining infant predictors of 
multiplex ASD and genetically-mediated symptom profiles, a critical next phase will be 
disentangling the generalizability of ASIB profiles to the majority of autism cases 
diagnosed without a family history.  
 A promising, complementary model for delineating early risk factors for ASD is 
to engage in cross-group comparisons across multiple “high risk” samples. Much like in 
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ASIBs, elevated rates of autism are reported across a number of genetic syndromes, 
including fragile X syndrome (Bailey, Skinner, et al., 2008; Farzin et al., 2006; 
Kaufmann et al., 2004; Rogers, Wehner, Hagerman, & Wehner, 2001a), tuberous 
sclerosis (Tye & Bolton, 2013), Smith Lemli Opitz syndrome (Sikora, Pettit-Kekel, 
Penfield, Merkens, & Steiner, 2006), and Down syndrome (Kent, Evans, Paul, & Sharp, 
1999). Similar to the “infant sibling” model, prospectively following children with these 
disorders from infancy through toddlerhood may inform developmental trajectories of 
risk and resilience (McCary & Roberts, 2013; Tonnsen, Malone, et al., 2013). 
Importantly, studying populations with known genetic vulnerabilities also permits 
conceptualization of complex genetic, environmental and developmental interactions not 
afforded by populations in which specific genetic biomarkers of risk are unknown (Fung 
et al., 2012; McCary & Roberts, 2013; Tonnsen, Malone, et al., 2013; Tye & Bolton, 
2013), deepening our understanding of complex genetic and epigenetic risk factors for 
ASD.  
Autism in Fragile X Syndrome 
Although the cross-syndrome approach is applicable to a number of genetic 
syndromes associated with ASD, the present study focuses on fragile X syndrome (FXS), 
a single-gene disorder that affects 1:4000 individuals (Crawford et al., 2001; Hagerman 
& Hagerman, 2002) and is highly associated with ASD (Bailey, Raspa, et al., 2008; 
Farzin et al., 2006; Kaufmann et al., 2004; Rogers, Wehner, Hagerman, & Wehner, 
2001b). “Fragile X” is caused by a CGG triplet repeat mutation on the X chromosome 
that results in methylation of the FMR1 gene and subsequent absence of fragile X mental 
retardation protein (FMRP), a protein that contributes to synaptic plasticity in typical 
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neural development (Fernández, Rajan, & Bagni, 2013). The behavioral phenotype of 
FXS is well-defined and includes elevated anxiety, inattention, hyperarousal, autistic 
symptoms, and intellectual disability (Bailey, Raspa, et al., 2008; Cordeiro, Ballinger, 
Hagerman, & Hessl, 2011; Tonnsen et al., 2014; Tonnsen, Shinkareva, Deal, Hatton, & 
Roberts, 2013). Cognitive delays in FXS generally emerge by 9 months of age in males 
(Roberts, Mankowski, et al., 2009), and females generally exhibit less severe symptoms 
due to random X-inactivation (Sobesky et al., 1996).  
Relevant to the present study, between 25% and 60% of children with FXS also 
meet diagnostic criteria for ASD, and up to 90% display ASD symptoms (Farzin et al., 
2006; Kaufmann et al., 2004; Rogers et al., 2001b). In general, co-occurring ASD 
(“FXS+ASD”) is associated with more severe outcomes including behavior problems 
(Hatton et al., 2002), receptive language delays (Rogers et al., 2001b), more severely 
impaired cognitive profiles (Bailey, Hatton, Skinner, & Mesibov, 2001; Roberts, 
Mankowski, et al., 2009), and abnromal approach and socialization (Hernandez et al., 
2009; Roberts et al., 2007; Roberts, Clarke, et al., 2009).Given the well-defined genetic 
mechanisms and behavioral profile of FXS, as well as high rates of co-occurring ASD 
symptoms, FXS may serve as a salient model for disentangling early profiles of ASD risk 
(McCary & Roberts, 2013; Tonnsen, Malone, Hatton, & Roberts, 2013b).   
The elevated co-occurrence of ASD in FXS has been conceptualized through a 
number of theoretical lenses. One perspective is that ASD features in FXS emerge from 
abnormal function of the FMR1 gene and compounding intellectual disability, thus ASD 
within FXS is quantitatively different from “true” ASD  and may be considered largely 
redundant with the broader FXS phenotype (Abbeduto, McDuffie, & Thurman, 2014; S. 
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Hall, Lightbody, & Hirt, 2010). An alternate interpretation is that a number of factors 
relevant to FXS – including FMR1 gene function, environmental contexts, phenotypic 
features, developmental change, and ASD-specific vulnerabilities – may produce 
divergent patterns of ASD within FXS that inform meaningful variability in ASD. This 
dynamic framework reflects the notion that developmental phenotypes emerge 
probabilistically rather than deterministically (Gottlieb, 2007), with genetic syndromes 
representing complex, interactive sequelae of development rather than static, 
deterministic end products (Karmiloff-Smith, 2009). Although these perspectives are not 
mutually exclusive, conceptualizing the FXS phenotype as a dynamic process treats 
variability in ASD symptom profiles as expected reflections of the complex heterogeneity 
of ASD rather than an artifact of phenotypic miscategorization or error. Within this 
framework, cross-syndrome comparisons of ASD in FXS produce a number of 
meaningful benefits, such as informing convergent risk factors, differentiating subgroups, 
and characterizing the developmental emergence of ASD. Here, we briefly summarize 
literature in the context of these benefits, focusing our discussion on infants at risk.  
Expected Outcomes of Cross-Syndrome Comparisons 
Identifying convergent patterns of risk across multiple high-risk groups such as 
FXS may inform ASD etiology and candidate mechanisms for targeted intervention. For 
example, similar patterns of “sticky” visual attention have been identified in a small 
sample of infants with FXS with elevated ASD symptoms (Roberts et al., 2011) and 
ASIBs who later meet ASD criteria (Elison et al., 2013; Elsabbagh et al., 2013; 
Zwaigenbaum et al., 2005), suggesting a potential common risk factor for later ASD 
symptomatology across groups. Similar trends have also emerged related to physiological 
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arousal. We previously identified higher autism symptoms associated with hypoarousal 
during toy play in young infants with FXS (Roberts et al., 2012), as well as hypoarousal 
in similarly aged ASIBs during an active attention task (Study 2). Thus, hypoarousal in 
young infants may be a shared vulnerability for ASD symptoms across groups. However 
given the limited extant literature on ASD emergence in FXS, extracting these types of 
similarities is complicated by a number of developmental and contextual factors, such as 
age-related shifts from hypo- to hyper-arousal across early childhood in FXS (Roberts et 
al., 2012), and apparent specificity of hypoarousal to active (Study 2) versus passive 
(Study 1) attention tasks in ASIBs. Thus, although emerging trends across studies suggest 
converging features across FXS and ASIBs, within-study, cross-group comparisons are 
needed to clarify the developmental processes and contexts in which these shared patterns 
are expressed.  
A second meaningful outcome of cross-syndrome comparisons is the likelihood of 
revealing divergent patterns of risk. Indeed, because ASD is defined by behavioral rather 
than biological symptoms, it is likely that autistic symptoms emerge secondary to a 
variety of genetic and neurodevelopmental processes (Abrahams & Geschwind, 2008; 
Pinto, Pagnamenta, Klei, & Anney, 2010). Establishing connections between specific 
phenotypic features and multiple layers of measurement – in essence, attending to 
symptoms rather than categories – is consistent with recent impetus from the National 
Institute of Mental Health that psychopathology be conceptualized across multiple layers 
and dimensions, rather than through arbitrary diagnostic categories (Cuthbert & Insel, 
2013). Symptom-based approaches have been similarly advocated to improve 
conceptualization of ASD in FXS (Abbeduto et al., 2014). From this transdiagnostic 
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perspective, profiles of symptom expression in genetic disorders such as FXS provide a 
rich context for exploring complex interactions among multiple levels of risk. Indeed, 
divergent patterns of early temperament have been identified in infants with FXS 
compared to patterns reported in ASIBs, with markers of ASD in ASIBs predicting 
anxiety, not autistic symptoms, in FXS (Tonnsen, Malone, et al., 2013). In early 
childhood, structural brain differences have also been observed in FXS+ASD versus 
ASD-only, with FXS+ASD exhibiting enlarged caudate and smaller amygdala volume 
compared to substantially enlarged amygdala volume in ASD-only (Hazlett et al., 2012). 
These behavioral and neurobiological differences in FXS+ASD may inform genetic 
pathways of symptom expression specific to the developmental neurobiology of FXS.  
Although parsing cross-syndrome variability is a complex task, capturing this 
heterogeneity may pave the way for developmental surveillance that is sensitive to 
individual differences, as well as targeted treatments that address the mechanisms, rather 
than symptoms, of impairment. 
These convergent and divergent patterns of ASD-associated features in FXS 
highlight a third meaningful outcome of cross-syndrome comparisons: clarifying the 
developmental emergence of ASD. From a practical standpoint, static, categorical 
diagnoses – such as those present in the Diagnostic and Statistical Manual for Mental 
Disorders (DSM-V (Association, 2013) – provide an organized nomenclature for 
comparing research and translating science relevant to clinical subgroups (First, 2005). 
However, current theoretical positions increasingly recognize that developmental 
disabilities do not emerge from static, modular deficits that persist over time, but instead 
evolve through complex interactions across multiple layers of development (Cornish et 
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al., 2007; Karmiloff-Smith, 1998, 2009). This perspective is apparent in ASD research, as 
a number of ASD theories specify complex interactions among genetic and 
neurobiological sequelae over time (Abrahams & Geschwind, 2008; Johnson et al., 2005; 
Keehn et al., 2013; Pinto et al., 2010), resulting in a continuous spectrum of risk rather 
than categorical impairments. Layering developmental theories with cross-syndrome 
comparisons may disentangle these pathways by holding constant a portion of genetic 
variability, as well as by revealing shared biological pathways that emerge downstream 
from initial genetic differences (Abrahams & Geschwind, 2008). These comparisons are 
particularly critical in ASD given the multitude of genetic risk factors for the disorder and 
heterogeneous presentation of symptoms across affected individuals, even among siblings 
diagnosed with ASD within the same family (Yuen et al., 2015).  
Despite this emerging popularity of a dynamic, developmental approach to ASD, 
empirical studies of ASD in FXS have largely focused on static, cross-sectional 
comparisons of symptom profiles in childhood and adulthood (McDuffie, Thurman, 
Hagerman, & Abbeduto, 2014; Roberts et al., 2007; Roberts, Clarke, et al., 2009; Sally J 
Rogers et al., 2001), likely due to the limited information about emerging ASD symptoms 
in infants (McCary & Roberts, 2013). However, a handful of repeated-measure studies 
have begun to index dynamic temporal changes that clarify complex presentations of 
ASD symptoms within FXS. For example, ASD symptoms are associated with short-term 
patterns of sustained withdrawal across the duration of an assessment (Roberts, Clarke, et 
al., 2009), as well as long-term deficits in peer relationships and adaptive socialization 
across multiple annual evaluations (Hernandez et al., 2009). Our emerging work in 
infants also suggests that longitudinal trajectories provide unique information about 
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emergent ASD predictors in FXS that is not detectable from cross-sectional profiles 
(Roberts et al., 2011) and may distinguish FXS from other high risk groups (Tonnsen, 
Malone, et al., 2013). Further clarifying these early pathways of ASD risk in FXS may 
contribute to broader understanding of ASD emergence and stability, informing questions 
of ASD expression within FXS and its generalizability to non-FXS samples.  
Taken together, these multiple benefits of cross-syndrome comparisons – 
including identifying commonalities, disentangling differences, and clarifying 
developmental profiles – attest to the utility of examining ASD profiles in FXS. 
However, few studies to date have examined prospective emergence of ASD symptoms 
in infants with FXS (Roberts et al., 2011; Tonnsen, Malone, et al., 2013). The present 
study applies this framework to examine one of the most robust predictors of ASD, 
aberrant attention orienting, in infants with FXS compared to ASIBs and low-risk 
controls. This work aims to both examine shared pathways of risk FXS and ASIB groups 
in early development, as well as disentangle potential cross-group differences in 
underlying mechanisms that may inform pathways to ASD risk.  
The Case of Attention in “High Risk” Infants 
 Aberrant attention orienting is well-defined as a predictive feature of ASD in 
ASIBs within the first year of life. Previous studies on attention in ASIBs, as well as 
methods for measuring constructs such as orienting and heart-defined attention, are 
reviewed in Studies 1 and 2. In brief, previous work suggests ASIBs display abnormal 
orienting toward social and nonsocial stimuli (Dawson et al., 1998; Landry & Bryson, 
2004; Swettenham et al., 1998) and slower saccade latencies on computerized orienting 
tasks (Elison et al., 2013; Elsabbagh et al., 2009, 2013; Zwaigenbaum et al., 2005). In 
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Study 2, we used a previously-published version of the gap-overlap task (Elsabbagh et 
al., 2013; Elsabbagh, Volein, et al., 2009) to examine both behavioral orienting and heart-
defined sustained attention in ASIBs contrasted to LR controls. We identified abnormal 
orienting in ASIBs around 6 months of age, with blunted improvement in disengagement 
latencies among ASIBs. We also identified patterns of hypoarousal in young ASIBs, 
which may be reflective of slower saccade latencies in this sample. Importantly, the 
proportion of “stuck” trials, those in which participants failed to disengage attention, was 
associated with higher clinical autism risk symptoms around 12 months of age, 
supporting previous reports that abnormal orienting predicts ASD risk among ASIBs 
(Elison et al., 2013; Elsabbagh et al., 2013; Zwaigenbaum et al., 2005). Together, these 
data support further investigation into the role of aberrant attention orienting in ASD 
symptom emergence, as well as whether orienting deficits are similarly present in other 
high-risk infant groups such as FXS. 
Orienting in FXS. Abnormal orienting is one of many attentional impairments 
reported in FXS, with others including poor inhibitory control (Cornish, Cole, Longhi, 
Karmiloff-Smith, & Scerif, 2012; Tonnsen et al., 2014), inattention (Bailey, Raspa, et al., 
2008; Cornish et al., 2012), and hyperactivity (Bailey, Raspa, et al., 2008; Wheeler et al., 
2014). Due to the early and pervasive nature of these attention problems, it has been 
suggested that early attention patterns “constrain” later developmental trajectories within 
FXS (Cornish et al., 2012).  Indeed, early attention abnormalities within FXS have been 
associated with a variety of clinical outcomes, including lower intellectual abilities, 
poorer classroom behavior, and higher autistic symptoms (Cornish et al., 2012; Roberts et 
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al., 2011; Tonnsen et al., 2014), suggesting early abnormal attention may index risk and 
warrant intervention. 
Similar to the orienting deficits reported in ASD, orienting deficits have been 
reported in FXS across the lifespan. Using a series of ocular motor paradigms, Lasker and 
colleagues (2007) identified longer latencies to disengage attention from competing 
stimuli in 7-22 year old females with FXS (n=17) and Turner syndrome (n=19), 
suggesting similarly impaired attention orienting to previous reports in ASD (Dawson et 
al., 1998; Landry & Bryson, 2004; Swettenham et al., 1998). In a small sample of infants 
with FXS (n=13), Roberts and colleagues (Roberts et al., 2011) reported higher rates of 
ASD symptoms in infants who spent more time looking at a toy at age 12 months and 
exhibited increased latency to disengage attention between 9 and 12 months. These 
results parallel findings of increased look duration and atypical disengagement in ASIBs 
(Elison et al., 2013; Elsabbagh et al., 2013; Zwaigenbaum et al., 2005)Study 2). Cornish 
and colleagues (Cornish et al., 2007) also examined orienting toward targets in response 
to cues that were either valid (cue same side as target) or invalid (cue opposite side from 
target). In this small sample of 9 toddlers with FXS (ages 14-55 months) compared to 
infants with Williams syndrome (n=8) and mental age-matched controls (n=20), similar 
saccade latencies were observed among groups during validly-cued trials, with slower 
performance on invalid trials in the Williams syndrome group only. However, the authors 
caution that nonsignificant findings in the FXS likely relate small sample size; a 
conclusion that is supported by evidence of a moderate effect (Cohen’s d=.50,  (Cohen, 
1988) between validly cued trials across FXS and mental-age matched groups (calculated 
for the present study using published means and standard deviations). Thus, orienting 
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deficits appear to be present from infancy through adolescence in FXS, although small 
samples and varied experimental designs warrant further replication and clarification of 
the nature of these deficits.   
Mechanisms for abnormal orienting in FXS.  The neurobiological mechanisms 
and longitudinal emergence of orienting deficits in FXS are also unclear, although both 
self-regulatory and visual processes have been posited to sustain these behaviors. 
Abnormal autonomic functioning is well-documented in FXS. In general, children and 
adults with FXS exhibit hyperarousal (Hall, Lightbody, Huffman, Lazzeroni, & Reiss, 
2009; Heilman, Harden, Zageris, Berry-Kravis, & Porges, 2011; Roberts, Boccia, Bailey, 
Hatton, & Skinner, 2001; Roberts et al., 2012; Tonnsen, Shinkareva, et al., 2013), which 
appears to be a chronic state in FXS rather than a state-dependent feature (Klusek et al., 
2015).  
Given these well-documented abnormalities in autonomic functioning in FXS, it 
is possible that abnormal arousal contributes to orienting deficits observed in this 
population.  In typically developing samples, behavioral orienting is closely associated 
with patterns of physiological arousal that index the attentional response (Casey & 
Richards, 1988; Richards, 1987, 1997). As attention increases, parasympathetic processes 
activate, producing HR decelerations that serve as biomarkers of attention engagement 
(Graham & Clifton, 1966; Lacey, 1959). In infants, sustained attention is the 
maintenance of decelerated HR as stimulus details are processed (Casey & Richards, 
1991; Richards & Casey, 1991; Richards, 2000). During sustained attention, typically 
developing infants are less likely to orient to peripheral stimuli, both during computerized 
attention tasks (Casey & Richards, 1988; Richards, 1997) and toy play (Lansink & 
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Richards, 1997). In the only study to examine heart-defined sustained attention in FXS, 
Roberts and colleagues (2011) identified shallower and less variable sustained attention 
during toy play in a small sample (n=12) of infants with FXS. Thus, integrating measures 
of heart-defined sustained attention may inform whether abnormal orienting reported in 
FXS is rooted in atypical physiological functioning.  
However, it is also possible that aberrant orienting in FXS is sustained or 
compounded by abnormal visual processes apparent in the disorder. Similar to a number 
of other developmental disabilities, FXS is associated with “dorsal stream deficits” 
related to processing dynamic visual information (Kogan, Bertone, & Cornish, 2004; 
Kogan, Boutet, et al., 2004). The dorsal stream is one of two primary cortical pathways 
through which the lateral geniculate nucleus transmits information from the retina to 
primary visual cortex (Felleman & Van Essen, 1991). In healthy individuals, FMRP is 
highly expressed in magnocellular pathways involved in the dorsal stream, and the 
absence of FMRP has been posited to explain observed abnormalities in magnocellular 
pathway morphology in FXS (Kogan, Boutet, et al., 2004). Psychophysiological studies 
in FXS have supported this association by identifying a number of functional dorsal 
deficits, such as maintaining identity of dynamic but not static objects when occluded 
(Farzin & Rivera, 2010) detecting temporal change and motion (Farzin, Whitney, 
Hagerman, & Rivera, 2008; Kogan, Boutet, et al., 2004), and processing multimodal 
stimuli (Scerif, Longhi, Cole, Karmiloff-Smith, & Cornish, 2012). It is possible that 
abnormal dorsal functioning contributes to orienting deficits in FXS, particularly given 
recent evidence of abnormal associations between attention orienting and dorsal stream 
connectivity, measured via radial diffusivity of the splenium, among infants later 
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diagnosed with ASD (Elison et al., 2013). Notably, abnormal dorsal stream functioning 
has been similarly reported in other neurodevelopmental disorders such as Prader-Willi 
syndrome (Woodcock, Humphreys, & Oliver, 2009), Dravet syndrome (Ricci et al., 
2015), and non-FXS associated ASD (Spencer et al., 2000), suggesting a potential shared 
biological pathway among neurodevelopmental disorders rather than syndrome-specific 
endophenotype to FXS.  
The Present Study 
Cross-syndrome comparisons may inform the early emergence of ASD by 
identifying both shared pathways of risk and sources of heterogeneity. Although ASD 
symptoms are common in FXS (Bailey, Raspa, et al., 2008; Farzin et al., 2006; 
Kaufmann et al., 2004; Sally J Rogers et al., 2001), few studies have examined early 
trajectories of ASD emergence in infants with FXS (Roberts et al., 2011; Tonnsen, 
Malone, et al., 2013), and no studies to-date have contrasted these early trajectories to 
other high-risk groups such as ASIBs. The present study examined cross-sectional 
profiles of visual attention orienting and concurrent heart-defined sustained attention in 9 
and 12-month infants with FXS contrasted to a subset of our previously published ASIB 
data (Study 2). This work aimed to establish whether abnormalities we previously 
reported in ASIBs similarly manifest in infants with FXS, informing potential 
heterogeneity in early ASD predictors and mechanisms.  
Three primary research questions were examined: (1) Do behavioral and heart-
defined patterns of attention differ between FXS and both ASIB and LR groups? (2) Are 
biobehavioral associations between behavioral and heart-defined attention similar in FXS 
versus ASIB and LR groups, and (3) Within FXS, do behavioral and heart-defined 
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attention indicators predict clinical ASD risk? In Study 2, we examined these questions in 
ASIBs and LR controls using an expanded, longitudinal sample. In contrast, the present 
study focuses on attention in FXS compared to ASIB and LR groups.  
We hypothesized that although both FXS and ASIB groups would display “sticky 
attention” (longer latencies to disengage attention, greater proportion of failed trials), 
associations between behavioral and heart-defined attention would differ across groups. 
In light of previous findings (Roberts et al., 2011), we hypothesized that infants with FXS 
would show longer latency to disengage attention but shorter and shallower SA, 
suggesting dysregulation from typical associations between slower disengagement 
indexed and greater sustained attention (Casey & Richards, 1988; Lansink & Richards, 
1997; Richards, 1997). Increased dysregulation would be associated with higher clinical 
ASD risk features. This pattern would parallel our previous reports that greater clinical 
ASD risk in ASIBs is associated with reduced IBI change during SA and IBI variability 
during a passive viewing task (Study 1) as well as greater difficulty disengaging attention 
during a gap-overlap task (Study 2). Although we did not identify associations between 
behavioral and heart-defined attention in ASIBs during the gap-overlap task in Study 2, 
we anticipated these associations would be present in FXS due to the cumulative effects 
of self-regulatory and visual processing deficits in the disorder.   
Methods 
Measures, stimuli, and behavioral coding procedures were identical to Study 2. 
Data from 113 assessments were collected from 62 participants (17 FXS, 21 ASIB, 24 
LR). The proportion of participants with both 9 and 12 assessments was similar across 
groups (X
2
(2) = 1.50, p = .47; FXS=59%; ASIB=76%; LR=63%). All participants were 
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required to be born full term (37 weeks or later, >2000 grams) and live with their 
biological mother. Fragile X diagnoses were verified with genetic report (>200 CGG 
repeats on the FMR1 gene). The ASIB and LR groups were required to have no 
diagnosed genetic or medical conditions. Infant siblings were required to be full 
biological siblings of a child with an ASD diagnosis documented by a licensed 
psychologist. Due to the lower risk for ASD in females (Bertrand et al., 2001; Nassar et 
al., 2009) and high variability in developmental skills in females with FXS (Clifford et 
al., 2007; Hatton et al., 2009), efforts were made to recruit a predominately male sample. 
Several females were permitted in each group (FXS 7/17; ASIB 6/21, LR 3/24). The 
ASIB and LR sample for the present study overlapped considerably with Study 2, with 
minor differences due to matching and age (e.g. 6m ASIB data examined in Study 2, 
additional LR female included in Study 3 to parallel higher proportion females in FXS 
sample). In contrast to Study 2’s focus on longitudinal patterns of individual differences 
in ASIBs contrasted to LR controls, the present study focuses on cross-sectional patterns 
of attention in 9 and 12 month infants with FXS. As such, differences between ASIB and 
LR groups are reported for reference but are presented in greater detail and using 
complete longitudinal data in Study 2. 
To characterize both age and developmental processes related to attention, we 
examined FXS data in relation to both chronological and mental age groups. 
Chronological age comparisons were conducted across FXS, ASIB, and LR groups at 9 
and 12 months. The FXS group exhibited mental ages approximately 3 months behind the 
LR group at each time point. Thus, to determine whether differences in the FXS group 
were accounted for by mental age, the FXS group was also compared to mental age (MA) 
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control groups by contrasting 12 month FXS and 9 month LR groups, as well as 9 month 
FXS and 6 month LR groups (6 month LR group not included in chronological age 
comparisons). Although mental age was not measured during the 6 month assessment, it 
was estimated for each participant by multiplying chronological age by the average ratio 
of mental to chronological age in the LR group at 9 and 12 months (1.07). Although 
coarse, these calculations suggested relatively similar mental ages across groups. Mental 
age contrasts were not conducted for physiological variables given expected maturation 
in autonomic functioning across age.  
Missing data were similar to previous work in similarly sized samples (Elsabbagh, 
Volein, et al., 2009). In addition to 113 assessments included in analyses, 16 additional 
assessments were conducted but excluded due technology problems (n = 13; 4 ASIB, 9 
LR) and noncompliance (n = 3; 1 FXS, 2 ASIBs) yielding 12% missing behavioral data. 
In addition, physiological data were excluded for 18 assessments (4 FXS, 8 ASIB, 6 LR) 
due to high artifacts, were not collected from 7 participants (2 FXS, 2 ASIB, 3 LR) 
during the initial battery implementation, and were not collected for 1 LR participant due 
to parental preference, yielding 19% missing physiological data. Five LR participants 
were excluded due to developmental concerns (1epilepsy, 3 suspected ASD, 1 suspected 
family history of ASD).   
Analyses 
Analyses were conducting using SAS 9.3 (Apex, NC) with α set to less than .05. 
Due to the relatively small sample and uneven number of assessments across participants, 
nonparametric techniques were used to test differences in levels of each dependent 
variable at two time points: 9 months (range 8 to 11 months) and 12 months (range 11 to 
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14 months). No participant was observed more than one time in each age range. 
Employing nonparametric analyses is appropriate for small, ordinally distributed samples 
but precludes conclusions about within-individual change over time, which we previously 
examined in our expanded longitudinal ASIB and LR samples (Studies 1 and 2).  Group 
differences in dependent variables were analyzed using nonparametric Wilcoxon-Mann-
Whitney tests, which compare dependent variable ranks across groups. Correspondence 
between behavioral and heart-defined attention variables were analyzed using Spearman 
correlations, collapsed across ages. Chronological and mental age were covaried for all 
correlations, and baseline latency was covaried for gap and overlap latencies. 
Results 
Group Differences 
 Behavioral attention. Behavioral attention differed between FXS and 
comparison groups, with greatest abnormalities within FXS. Tables 4.3 and 4.4 detail 
chronological and mental age comparisons, respectively, for behavioral and physiological 
variables. Compared to same-aged LR controls, the FXS group exhibited longer overlap 
latencies (9 and 12 months), greater proportion of failed trials (9 months), and less 
inattention (greater attentiveness; 9 months). Compared to ASIBs, the 9-month FXS 
group exhibited longer overlap latencies and greater attentiveness. These group 
differences are depicted in Figures 4.1-4.3, which portray boxplots of individual values 
across groups and chronological age categories, with significant differences indicated by 
red brackets. Only 12-month overlap latencies remained significantly different compared 
to MA controls. Together, these behavioral results suggest longer latencies to disengage, 
greater proportion of stuck trials, and increased inattention in FXS, particularly in 
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younger participants. The FXS group exhibited similar latencies to MA-controls at 9 but 
not 12 months, suggesting delays that increasingly deviated from developmental 
expectations over time. 
Physiological variables. Physiological profiles differed across groups. Compared 
to LR controls, the 9-month FXS group exhibited marginally longer IBI (p=.08) and 
higher RSA (p=.06). As depicted in Figure 4.3, the 9-month FXS group exhibited greater 
change in IBI during SA than both LR and ASIB groups, which did not differ from each 
other. The 12-month FXS group also spent a larger proportion of time in SA compared to 
LR controls. No additional group comparisons were significant at 9 or 12 months. Thus, 
physiological profiles in FXS were marked by increased depth of SA at 9 months and 
greater proportion of time in SA at 12 months, with a trend toward general hypoarousal at 
younger ages.  
Correspondence between Behavioral and Heart-Defined Attention 
Table 4.3 details correlations between behavioral and heart-defined variables for 
each group. Across groups, proportion of time in behavioral and heart-defined attention 
positively correlated. Sustained attention parameters also correlated with behavioral 
attention in the FXS and LR groups, although specific associations varied by group. 
Among infants with FXS, longer overlap latencies and greater proportion of stuck trials 
were associated with less change in IBI during SA, and longer overlap latencies were also 
associated with less variability in IBI during SA. However among LR controls, longer 
overlap latencies were associated with greater proportion of time in SA but were not 
significantly associated with change or variability of IBI during SA. Thus we observed 
paradoxical patterns of reduced SA parameters associated with increased attention in 
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FXS, versus typical associations between increased SA and increased attention in LR 
controls. Consistent with Study 2, no significant correlations between behavioral and 
heart-defined attention were observed among ASIBs.  
Correlations with Clinical Autism Risk in FXS 
 Controlling for chronological age, longer baseline latencies and greater proportion 
of failed trials predicted higher clinical autism risk in 12-month infants with FXS. The 
effects between behavioral performance and clinical markers were no longer significant 
when mental age was included as a covariate, likely reflecting the strong negative 
correlation between ASD clinical markers and developmental abilities (-.50, p = .01). 
Thus, although associations between baseline latencies and clinical ASD risk are present 
in FXS, developmental ability accounts for a large proportion of variance in risk.  
Discussion 
 Cross-syndrome comparisons may inform the etiology and developmental 
mechanisms of ASD by clarifying both shared pathways of risk and syndrome-specific 
mechanisms. The present study employed a cross-syndrome approach to investigate 
visual orienting in two samples of infants at “high risk” for ASD: infant siblings of 
children with ASD (ASIBs) and infants with fragile X syndrome (FXS). We observed 
persistent, early emerging orienting deficits in FXS increasingly deviated from 
developmental expectations and were more robust than differences observed in ASIBs. 
The magnitude of these deficits predicted clinical ASD risk in FXS, which was also 
highly associated with mental age. Importantly, we observed dissociations between 
patterns of physiology that related to global attention versus attention orienting in FXS, 
potentially indicating dysregulated intersection of attentional and physiological 
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processes. Furthermore, although behavioral abnormalities were similar across FXS and 
ASIB groups, physiological profiles differed. These distinct profiles suggest potentially 
heterogeneous pathways to abnormal attention across infant groups at high risk for ASD.  
Visual Attention in FXS 
As hypothesized, we observed early-emerging and persistent attentional deficits in 
FXS, consistent with a previous study of orienting in a small sample of infants (Roberts 
et al., 2011).  These deficits worsened over time; although overlap latencies at 9 months 
were longer than CA controls but similar to MA controls, the FXS group exhibited longer 
overlap latencies than both CA and MA controls at 12 months, suggesting increasing 
deviation from developmental norms across age. The FXS group also exhibited greater 
proportion of failed trails and abnormally increased attentiveness at 9 months, although 
these differences were not significant compared to MA-matched controls. Thus, although 
a portion of attentional deficits in FXS may reflect developmental delay rather than 
deficit, the magnitude of saccade latency differences accelerated over time relative to 
MA-matched controls, suggesting increasingly greater deficits than expected based on 
developmental abilities alone. This pattern is distinct from abnormal orienting we 
previously described in ASIBs (Study 2), as abnormalities in FXS relate to mental age, 
whereas ASIB differences persisted when MA was covaried in models 
Similar to our previous study of ASIBs (Study 2), behavioral attention also 
correlated with clinical ASD risk within FXS, suggesting attention abnormalities may 
index or contribute to ASD features. Specifically, longer baseline latencies and higher 
proportions of failed trials were associated with higher AOSI scores in FXS, paralleling 
previous reports of higher ASD symptoms in infants with FXS who exhibited 
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increasingly abnormal attention across early infancy (Roberts et al., 2011), as well as a 
number of studies linking abnormal orienting to ASD in ASIBs (Elison et al., 2013; 
Elsabbagh et al., 2013; Zwaigenbaum et al., 2005). Notably, these effects were no longer 
significant when mental age was covaried, likely due to the high proportion of variance in 
ASD risk explained by developmental ability. This differential association with and 
without controlling for MA does not necessarily suggest that orienting-ASD associations 
are insignificant in FXS, but instead may reflect the higher presence of ASD among 
individuals – with and without FXS – who exhibit lower intellectual abilities (de Bildt, 
Sytema, Kraijer, & Minderaa, 2005; Deb & Prasad, 1994; S. Hall et al., 2010). 
Examining these effects in larger FXS samples stratified by developmental ability may 
inform the impact of mental age on the attention-ASD relationship. Similarly, comparing 
attention in FXS to other groups with similar developmental delays would inform the 
specificity of impairments to FXS. Notably, sampling characteristics may have also 
tempered associations between behavioral attention and clinical ASD risk, as we included 
a high proportion of females who typically exhibit less ASD risk within FXS (Bailey, 
Raspa, et al., 2008). Thus is possible that effects may be salient in male-only samples or 
among infants with lower developmental abilities. Efforts are underway to expand the 
present FXS sample to include more male participants, increasing our capacity to 
examine whether effects differ in male-only samples.  
Heart Activity in FXS 
Physiological data also revealed unique patterns of autonomic dysfunction within 
FXS that may inform the mechanisms of abnormal attention in this population. Compared 
to ASIB and LR groups, the 9 month FXS group exhibited marginally longer IBI and 
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higher RSA, as well as greater IBI change during SA. Twelve-month infants with FXS 
also spent more time in heart-defined sustained attention than LR controls. Interestingly, 
these patterns of hypoarousal deviate somewhat from the general consensus that 
individuals with FXS are hyperaroused ( Hall et al., 2009; Heilman et al., 2011; Roberts 
et al., 2001, 2012; Tonnsen, Shinkareva, et al., 2013) and display lower RSA at rest 
(Boccia & Roberts, 2000; S. S. Hall et al., 2009; Roberts et al., 2012). This divergence 
supports emerging theories that hyperarousal may emerge secondary to a period of 
hypoarousal in infants with FXS. For example, Roberts and colleagues (Roberts et al., 
2012) reported higher autistic symptoms in FXS were associated with hypoarousal in 
young infants (<10 months) but hyperarousal in older infants (>37 months), and a 
number of additional studies in infants and toddlers failed to identify FXS-specific 
differences in arousal (Roberts et al., 2011; Tonnsen, Shinkareva, et al., 2013), perhaps 
due to shifting patterns that dilute group differences. Our finding of marginally higher 
RSA in FXS may similarly reflect reduced suppression of vagal tone in response to the 
cognitive load of the task, similar to findings of reduced vagal suppression in older 
children with FXS (Heilman et al., 2011). Thus, although somewhat inconsistent with 
findings in older samples, our results converge with emerging evidence of shifting 
arousal patterns in infants with FXS and warrant additional work in this area.  
These potentially changing self-regulatory profiles across infancy have important 
implications for early detection and intervention efforts in FXS.  First, our findings 
suggest that early self-regulatory profiles in FXS may not linearly predict later 
development, lending support to the increasingly popular conceptualization of 
neurodevelopmental disorders as developmental phenotypes that evolve over time 
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(Karmiloff-Smith, 2009). Second, although further work is needed to characterize self-
regulation among infants with FXS, it is possible that future interventions may be 
designed to capitalize on these early periods of rapid developmental change, consistent 
with the increasing impetus on preventing rather than treating developmental disorders 
(Dawson, 2008). Identifying “hot spots” of developmental vulnerability, as well as the 
neurobiological systems contributing to those vulnerabilities, may permit interventions 
that alter early neurodevelopmental trajectories and improve developmental outcomes. 
However, additional prospective, longitudinal studies of infants with FXS are likely 
necessary to inform the specific developmental landscape of infant arousal within FXS, 
as well as the feasibility and consequences of potential arousal-related interventions. 
Given the elevated behavioral attention observed in our FXS group, it is also 
possible that hypoarousal reflected increased behavioral attention rather than “resting” 
differences in autonomic functioning. Several of our findings support this conclusion: 
proportion of time in behavioral and heart-defined attention correlated across groups, 
infants with FXS exhibited the highest behavioral attentiveness, and the 9-month FXS 
group exhibited deeper decelerations in IBI during SA compared to both ASIB and LR 
samples. However, conflicting patterns emerged related to gap-overlap task performance, 
potentially suggesting different mechanisms of abnormal attention at gross (overall 
looking) versus specific (visual orienting and disengagement) levels. Consistent with 
typical associations between longer saccade latencies and greater SA (Casey & Richards, 
1988; Richards, 1997), we observed positive associations between longer overlap 
latencies and increased proportion of time in SA among our LR group. In contrast, longer 
overlap latencies in FXS were associated with less variability and change in IBI during 
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SA, despite deeper IBI decelerations in the FXS group overall. In other words, although 
overt looking correlated with proportion of time in SA within FXS, longer saccade 
latencies were associated with reduced quality of SA within FXS. These paradoxical 
patterns are consistent with previous reports of shallower SA-related IBI decelerations 
and less IBI variability during an attention toy play task in an independent sample of 
infants with FXS (Roberts et al., 2011) as well as our previous findings that decreasing 
IBI decelerations and variability during SA predicted clinical ASD risk among ASIBS 
(Study 2). These converging findings raise questions as to the biological processes 
maintaining abnormal attention in FXS. 
A possible explanation for these paradoxical findings is that abnormal attention 
orienting and attention engagement are both present in FXS yet are subserved by 
different biological processes: abnormal overall attentional engagement may relate to 
general patterns of arousal in FXS, whereas specific abnormalities in attention orienting 
may emerge secondary to neurobiological processes such as dorsal stream dysfunction. 
From this framework, disengagement difficulties in FXS may index abnormal visual 
perception of competing, dynamic stimuli rather than general “over-interest” in a primary 
stimulus. Our data can be interpreted in a manner consistent with this hypothesis. The 
FXS sample exhibited greater looking time overall, as well as deeper IBI deceleration 
during SA and greater proportion of time in SA. These patterns suggest SA is a valid 
biomarker of overall attentional engagement in FXS, which was elevated in our sample. 
This biobehavioral association was reversed in relation to overlap saccade latencies: 
participants with FXS and more typical (shorter) overlap latencies exhibited deeper SA 
than participants with FXS and more atypical (longer) overlap latencies. It is possible that 
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the more extreme overlap latencies observed in FXS indexed abnormal visual processing 
of the dynamic stimuli that “interrupted” typical physiological engagement, reflected by 
less SA (shallower decelerations) despite abnormal latencies. Participants with FXS and 
less extreme overlap latencies, on the other hand, may exhibit less dorsal dysfunction 
than other participants with FXS and therefore maintain increased overall physiological 
engagement characteristic of the FXS group, resulting in deeper IBI decelerations relative 
to controls. Of course, this cursory theory is just one possible explanation of the present 
findings. Further testing of dorsal function in FXS as related to both neuroanatomical and 
physiological functioning is needed to test these relationships empirically.  
 Interestingly, we similarly observed dysynchrony among ASIBs, who did not 
exhibit any associations between qualities of SA and either overt looking or saccade 
latencies in the present cross-sectional study or our prior longitudinal analyses of gap-
overlap data (Study 2), despite the presence of these associations in LR controls. Instead, 
elevated attention was associated with higher RSA across analyses. Again, at least two 
explanations could account for these patterns. First, it is possible that elevated behavioral 
attention among ASIBs is driven by poorer suppression of vagal activity during attention. 
Infant siblings with lower developmental abilities may be particularly vulnerable to RSA-
related over-attention, as we previously observed higher RSA in ASIBs with lower 
developmental ability (Study 2). This RSA-attention association was not significant in 
our previous passive viewing task (Study 1; p=.11), suggesting more robust associations 
may have been driven by cognitive engagement in a more complex task.  Interestingly, 
RSA was not associated with behavioral attention in FXS, which may suggest differences 
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in biological vulnerabilities across groups, with abnormal parasympathetic suppression in 
ASIBs compared to intersecting physiological and visual factors in FXS.  
Alternately, it is also possible that abnormal visuo-perceptual processes 
interrupted physiological engagement among ASIBs – similar to FXS – particularly given 
recently reported associations between dorsal connectivity and orienting among ASIBs 
(Elison et al., 2013) and the reduced associations we observed between SA and overlap 
latencies among ASIBs versus LR controls (Study 2). During passive-viewing (Study 1), 
higher clinical ASD features in ASIBs were also associated with increasingly reduced IBI 
change and SD during SA in the context of a passive viewing task, suggesting reduced 
qualities of SA that, similar to FXS in the present study, did not distinguish ASIBs but 
did predict within-group variability. Given these effects emerged during passive viewing 
(Study 1) but not gap-overlap (Study 2) tasks, additional work is needed to clarify these 
potential dissociations using systematic comparisons of autonomic functioning across 
task types (e.g. high versus low cognitive load) and stimuli-specific demands (e.g. 
requiring dorsal versus ventral functions) in further cross-syndrome studies.  Specifically 
designing studies to differentiate between autonomic and visual perceptual influences 
will be important to informing the mechanisms of abnormal attention, as well.  
A long-term goal of this work will be to inform translational science surrounding 
abnormal orienting as a risk factor for ASD. Although we observed behavioral orienting 
as a common predictor of clinical ASD risk across both ASIB and FXS groups, our 
physiological data also raise questions as to whether these behaviors undergo distinct 
developmental trajectories and are subserved by different processes. These differences 
may inform the etiology and treatment of ASD. Etiologically, if orienting is related to 
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different physiological processes, why do orienting processes still predict symptoms 
across high risk groups? Does attention compound later downstream developmental 
processes, as has been previously proposed in the ASD literature (Keehn et al., 2013)? 
Alternately, are we capturing associations between orienting and specific features of ASD 
that are common in ASIB and FXS samples? Answering these questions will both inform 
etiology and pose direct implications for treatment. Although orienting has already been 
integrated into early interventions for ASD (Rogers et al., 2014), our data suggest that 
supplementing these efforts with mechanism-specific protocols may increase treatment 
effectiveness. For example, children whose abnormal orienting is sustained by abnormal 
arousal may respond to treatments targeting self-regulation, whereas children whose 
deficits emerge secondary to abnormal dorsal functioning may instead respond to visual 
training. In other words, although abnormal orienting is associated with clinical ASD risk 
across ASIBs and FXS, reducing the downstream effects of this common process may 
require mechanism-specific interventions targeting the processes, rather than symptoms, 
of impairment.   
Limitations 
 It is important to temper these cross-group differences within the context of our 
study sample, as the more severe symptoms we observed in FXS may relate to a number 
of factors beyond the FXS phenotype. One interpretation of our findings is that the 
magnitude of effects in the FXS group, but not ASIB group, was great enough to be 
detected using coarse cross-sectional methods. Indeed, we hypothesized that 
abnormalities in FXS would be more severe given the higher presence of ASD symptoms 
in this population, greater intellectual impairment, and increased physiological and visual 
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processing vulnerabilities. However, it is also possible that group differences reflect 
diverging emergent ASD symptomatology across groups, as  between 25% and 60% of 
children with FXS generally meet diagnostic criteria for ASD (Farzin et al., 2006; 
Kaufmann et al., 2004; Rogers et al., 2001) compared to approximately 20% of ASIBs 
(Ozonoff et al., 2011). Continuing to follow these samples over time will facilitate 
differentiating between endophenotypes of ASD – features that relate to genetic risk 
regardless of diagnostic outcome – versus specific predictors of ASD diagnoses. Given 
previous evidence that abnormal attention relates to abnormal developmental features in 
ASIBs aside from ASD (Elsabbagh et al., 2013), dissociating predictors of ASD versus 
other outcomes will be particularly important as we continue to follow these samples 
over time.  
Our study is also limited by coarse cross-sectional methods, which are necessary 
due to the availability of FXS data but likely mask developmental trends that may 
differentiate groups. Indeed, the effects we identified among ASIBs in Study 2 were 
primarily longitudinal in nature and were therefore “missed” by static age comparisons in 
the present study. As such, it is likely that longitudinal characterization of our FXS data 
would reveal similarly complex age associations, particularly given previous evidence 
that developmental changes in attention and physiology relate to ASD features in infants 
with FXS (Roberts et al., 2011, 2012). Efforts to track attention in an expanded, 
longitudinal FXS cohort are underway and may further elucidate the developmental 
patterns that subserve abnormal attention in ASIB and FXS samples. Notably, this 
expanded dataset is projected to include additional male participants, permitting us to 
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also examine whether the high presence of females in the FXS group are tempering group 
differences.  
A related limitation that is reflected both in the present study and in the broader 
literature of “high risk” infants is the potential for spontaneous findings that emerge due 
to examining different variables in the same longitudinal cohort over time. Of note, the 
utility and need for controlling for multiple comparisons has been debated in the broader 
quantitative literature due, in part, to the likelihood of corrections actually increasing the 
likelihood of missing “true” effects (Rothman, 1990). Although the philosophy of 
multiple comparisons is certainly relevant to the present study, there are a number of 
practical issues in early detection research that further complicate the discussion of 
whether – and how – to control for multiple comparisons. First is the issue of non-
independence. It is common for a single infant with FXS to be enrolled in multiple 
research studies, and ASD data are often submitted to national data repositories for use 
by future researchers (e.g. National Dataset for Autism Research; Hall, Huerta, 
McAuliffe, & Farber, 2012), thus even studies published by separate labs are often not 
fully independent. Although family-wise error could hypothetically be controlled within 
certain measures or constructs, truly controlling for multiple comparisons would require 
tracing single participants’ data across all ongoing studies and evaluating significant 
findings in the context of cross-lab findings. These comparisons would create such 
stringent criteria for significance that virtually no effects – even true effects – would 
exceed the adjusted threshold. A second challenges is that high-risk samples are often 
expensive and difficult to recruit, thus it is not feasible for scientists to obtain research-
naïve samples for each study and research question. Given these challenges, we have 
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addressed issues of independence and multiple comparisons using a five-pronged 
approach: (1) use theory to guide study design and hypothesis testing rather than 
“fishing” for significant findings, (2) specify non-independence of ASIB and LR samples 
across papers, as well as cross-study differences in sampling and exclusions, (3) 
explicitly state that our FXS sample is independent from  previously published studies by 
our group examining similar constructs (Roberts et al., 2011), (4) focus on effect sizes in 
addition to traditional p values, and (5) articulate the limitations of non-independent 
samples explicitly. Although these strategies are an initial step toward increased 
sensitivity toward issues of non-independence and multiple comparisons, we would 
advocate for a broader discussion of these issues across the early detection field.  
Conclusion 
 Prospective infant studies have transformed early detection of ASD by 
emphasizing prospective surveillance of prodromal ASD features that are being translated 
to earlier detection and treatment. The present study is among the first to compare risk 
factors in ASIBs to other high risk groups, and our results provide initial evidence that 
despite similar behavior profiles (e.g. “sticky attention”), the biological mechanisms 
subserving these behaviors may vary across genetic samples.  Consistent with our 
dynamic developmental framework, these biobehavioral group differences should not be 
interpreted as counterevidence for exploring ASD in FXS due to potential FXS-specific 
mechanisms. Instead, we propose these data contribute to a growing discussion of how 
genetic disorders may inform meaningful heterogeneity of ASD symptom expression, 
complementing growing emphasis on conceptualizing psychopathology across multiple 
layers of analysis (Cuthbert & Insel, 2013). Our data also suggest that similar behavioral 
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features, such as abnormal visual attention, may emerge through multiple developmental 
processes, consistent with the notion that broader ASD profiles may reflect a number of 
heterogeneous pathways of risk (Yuen et al., 2015). Together, these findings support 
continued prospective cross-group comparisons of ASD emergence that may inform 
mechanistically-sensitive early detection and treatment efforts.
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Table 4.1 Behavioral Descriptive Statistics by Group and Categorical Age   
  
 Chronological Age Comparison  Mental Age Comparison 
 FXS ASIB LR (CA)  LR (MA) 
9 Month  n  SD n  SD n  SD  n  SD 
Age in months 13 9.36 0.63 19 9.45 0.55 18 9.43 0.37  12 6.38 0.63 
MSEL Std. Score 12 86.08 22.96 17 96.71 13.59 18 103.06 13.10     
MSEL Mental Age 12 7.48 2.92 17 9.09 1.16 18 10.15 2.41  12 6.83 0.67 
Base. Latency 11 344.77 67.69 19 367.07 86.56 18 336.23 77.60  12 349.28 79.30 
Overlap Latency 11 563.59 155.14 17 467.12 124.80 18 468.46 122.66  11 561.13 149.82 
Gap Latency  12 316.17 110.01 19 311.73 87.21 18 290.03 88.86  12 282.59 85.32 
% Failed Trials 13 0.16 0.16 19 0.08 0.07 18 0.07 0.05  12 0.07 0.07 
Prop. Inattentive 11 0.29 0.18 16 0.49 0.18 16 0.52 0.19  6 0.41 0.23 
              
12  Month               
Age in months 14 12.62 0.67 18 12.49 0.58 21 12.27 0.48  18 9.43 0.37 
MSEL Std. Score 14 83.07 21.05 17 98.65 11.65 21 101.81 11.60  18 103.06 13.10 
MSEL Mental Age 14 10.59 2.70 17 12.16 1.49 21 13.06 2.40  18 10.15 2.41 
Base. Latency 13 401.54 193.87 18 350.29 81.40 20 321.30 67.74  18 336.23 77.60 
Overlap Latency 11 601.46 214.08 12 489.36 83.98 21 464.64 130.18  18 468.46 122.66 
Gap Latency  14 333.04 156.66 18 275.50 53.68 20 278.47 72.06  18 290.03 88.86 
% Failed Trials 14 0.14 0.13 18 0.10 0.08 21 0.08 0.06  18 0.07 0.05 
Prop. Inattentive 10 0.42 0.24 17 0.46 0.19 17 0.51 0.20  16 0.52 0.19 
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Table 4.2: Heart Activity Descriptive Statistics by Group and Categorical Age   
 
 Chronological Age Comparison 
 FXS ASIB LR (CA) 
9 Month  n  SD n  SD n  SD 
Heart Activity          
     Overall IBI 11 300.98 105.94 13 281.62 103.48 16 241.45 44.79 
     Overall RSA 11 2.74 1.02 13 2.34 1.05 16 2.10 0.39 
     Overall IBI SD 11 17.67 7.50 13 19.04 11.46 16 14.77 4.32 
Sustained Attention          
     Proportion SA 11 0.27 0.15 13 0.19 0.11 15 0.20 0.12 
     SA IBI SD 11 24.69 7.38 13 25.59 7.04 15 29.09 12.61 
     SA Mean IBI Δ 11 33.16 11.49 13 24.16 8.15 15 25.23 9.46 
          
12  Month           
Heart Activity          
     Overall IBI 10 281.41 97.01 13 283.16 85.30 17 279.21 104.32 
     Overall RSA 10 2.53 0.99 13 2.53 0.91 17 2.57 1.26 
     Overall IBI SD 10 16.40 4.41 13 19.01 8.28 17 18.12 9.97 
Sustained Attention          
     Proportion SA 9 0.27 0.13 13 0.24 0.09 16 0.18 0.06 
     SA IBI SD 9 32.06 8.70 13 32.06 15.13 16 29.20 11.42 
     SA Mean IBI Δ 9 32.25 12.65 13 26.58 10.57 16 26.66 8.26 
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Table 4.3. Partial Spearman Correlations between Behavioral and Heart-Defined Attention 
 
* Significant at p<.05 
 
 Baseline Latency Overlap Latency Gap Latency % Stuck Trials % Inattentive 
 
n 
partial 
ρ 
N 
partial 
ρ 
n 
partial 
ρ 
n 
partial 
ρ 
n 
partial 
ρ 
FXS           
     Overall IBI 19 -.21 18 -.28 19 .22 19 -.20 20 -.15 
     Overall RSA 19 -.22 18 -.35 19 .27 19 -.19 20 .11 
     Overall IBI SD 19 -.26 18 -.45 19 .21 19 -.34 20 .22 
     Proportion SA 18 .003 17 .01 18 -.05 18 .33 20 -.78* 
     SA IBI SD 18 .13 17 -.65
 
* 18 .21 18 -.27 20 .23 
     SA Mean IBI Δ 18 -.27 17 -.69 * 18 .22 18 -.50 * 20 .31 
ASIB           
     Overall IBI 26 -.02 19 .05 26 -.02 26 -.02 26 -.29 
     Overall RSA 26 .08 19 .06 26 -.02 26 .07 26 -.47* 
     Overall IBI SD 26 .17 19 -.12 26 .02 26 .04 26 .01 
     Proportion SA 26 -.16 19 .36 26 -.29 26 .08 26 -.69* 
     SA IBI SD 26 .01 19 -.14 26 .04 26 .02 26 .17 
     SA Mean IBI Δ 26 -.02 19 -.27 26 .02 26 -.16 26 .05 
LR           
     Overall IBI 32 .22 32 .03 31 .22 32 .30 31 -.12 
     Overall RSA 32 .09 32 -.09 31 .06 32 .15 31 -.06 
     Overall IBI SD 32 .02 32 -.04 31 .16 32 .17 31 -.03 
     Proportion SA 30 .16 30 .48
 
* 29 -.07 30 .15 31 -.82* 
     SA IBI SD 30 .12 30 -.03 29 .28 30 .30 31 -.18 
     SA Mean IBI Δ 30 .16 30 .03 29 .01 30 .23 31 -.19 
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Table 4.4: Wilcoxon Cross-Group Chronological Age Comparisons at 9 and 12 Months 
 
 
 
 
 
FXS v LR 
 
FXS v ASIB 
 
ASIB v LR 
 
9 months 12 months 
 
9 months 12 months 
 
9 months 12 months 
Variable Z p d Z p d 
 
Z p d Z p d 
 
Z p d Z p d 
Behavior 
                  
 
 
Baseline Latency 0.25 0.4 0.12 1.53 0.06 0.40 
 
-0.65 0.26 -0.30 0.74 0.23 0.25 
 
-0.91 0.18 0.40 0.89 0.19 0.43 
Overlap Latency 1.89 0.03 0.58 1.75 0.04 0.61 
 
2.07 0.02 0.71 1.32 0.09 0.50 
 
0.02 0.49 -0.01 0.88 0.19 0.19 
Gap Latency 1.14 0.13 0.23 0.86 0.2 0.33 
 
0.06 0.48 0.05 1.27 0.1 0.35 
 
-0.88 0.19 0.24 0.23 0.41 -0.04 
% Failed Trials 1.8 0.04 0.54 1.08 0.14 0.44 
 
1.47 0.07 0.73 0.84 0.2 0.30 
 
-0.11 0.46 0.20 0.71 0.24 0.33 
Prop. Inattentive -2.89 0.002 -1.21 -0.93 0.18 -0.35 
 
-2.59 0.005 -1.07 -0.33 0.37 -0.16 
 
0.25 0.4 -0.16 0.76 0.22 -0.25 
Heart Activity 
                    
Overall IBI 1.41 0.08 0.53 0.33 0.37 0.02 
 
0.93 0.18 0.26 -0.22 0.41 -0.02 
 
0.15 0.44 0.90 0.59 0.28 0.04 
Overall RSA 1.55 0.06 0.60 0.43 0.33 -0.04 
 
1.22 0.11 0.56 -0.09 0.46 0.00 
 
0.1 0.46 0.62 0.5 0.31 -0.03 
Overall IBI SD 0.91 0.18 0.37 0.43 0.33 -0.37 
 
0.12 0.45 -0.24 -0.53 0.3 -0.31 
 
0.99 0.16 0.99 0.96 0.17 0.09 
Sustained Attention 
                    
Proportion SA 1.25 0.11 0.44 2.12 0.02 0.65 
 
1.39 0.08 0.60 0.67 0.25 0.33 
 
-0.23 0.41 -0.08 1.34 0.09 1.00 
SA IBI SD -0.73 0.23 -0.57 0.93 0.18 0.31 
 
-0.23 0.41 -0.08 0.2 0.42 0.00 
 
-0.37 0.36 -0.28 0.33 0.37 0.25 
SA Mean IBI Δ 1.66 0.05 0.65 0.99 0.16 0.41 
 
2.14 0.02 0.87 0.8 0.21 0.57 
 
0 0.5 -0.11 0.2 0.42 -0.01 
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Table 4.5: Wilcoxon Cross-Group Mental Age Comparisons at 9 and 12 Months  
  
 
9 Month FXS vs. LR 
 
12 Month FXS vs. LR 
 
Chronological Age  
(9 mo LR) Mental Age* (6 mo LR) 
 
Chronological Age  
(12 mo LR) Mental Age (9 mo LR) 
Variable Z p d Z p d 
 
Z p d Z p d 
Mental Age -- -- -- 1.13 0.13 0.21 
 
-- -- -- 0.55 0.29 0.16 
Baseline Latency 0.25 0.4 0.12 -0.09 0.46 -0.06 
 
1.53 0.06 0.82 0.98 0.16 0.32 
Overlap Latency 1.89 0.03 0.58 0.13 0.45 0.02 
 
1.75 0.04 0.40 1.69 0.05 0.59 
Gap Latency 1.14 0.13 0.23 1.01 0.16 0.29 
 
0.86 0.2 0.61 0.7 0.24 0.26 
% Failed Trials 1.8 0.04 0.54 1.55 0.06 0.54 
 
1.08 0.14 0.33 1.44 0.07 0.52 
Prop. Inattentive -2.89 0.002 -1.21 -1.16 0.12 -0.63 
 
-0.93 0.18 0.44 -0.92 0.18 -0.39 
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Table 4.6: Partial Spearman Correlations among Chronological and Mental Age, Clinical Autism Risk and Attention in FXS 
   Correlations with Clinical Autism Risk 
 CA MA  Controlling CA Controlling CA+MA 
Behavior ρ p ρ p  partial ρ p partial ρ p 
     Baseline Latency .19 .36 -.27 .20  .43 .05 .26 .26 
     Overlap Latency .09 .69 -.14 .54  -.18 .48 -.22 .39 
     Gap Latency .08 .71 -.27 .19  .14 .53 .11 .66 
     % Failed Trials -.003 .99 -.22 .28  .43 .04 .27 .23 
     Prop. Inattentive .31 .17 .10 .68  .16 .52 .01 .97 
Overall Heart Activity 
    
 
    
     Overall IBI .008 .97 -.42 .07  .30 .22 .13 .61 
     Overall RSA -.16 .48 -.33 .16  .29 .23 .10 .68 
     Overall IBI SD -.05 .81 -.13 .58  .33 .17 .18 .46 
Sustained Attention 
    
 
    
     Proportion SA .07 .76 -.07 .79  .03 .90 .18 .50 
     SA IBI SD .37 .11 .41 .08  .14 .58 .20 .44 
     SA Mean IBI Δ -.08 .75 .22 .36  .20 .43 .33 .19 
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Note. Red bracket indicates significant group 
difference 
 Figure 4.1: Group Differences in Saccade Latencies 
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Note. Red bracket indicates significant group 
difference 
Figure 4.2: Behavioral Attention: Proportion Stuck Trials and Overall Looking 
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Note. Red bracket indicates significant group 
difference 
Figure 4.3: Heart-Defined Sustained Attention 
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CHAPTER 5 
CONCLUDING REMARKS 
 
In 2008, Geraldine Dawson made the provocative claim that “[f]or the first time, 
prevention of autism is plausible. Prevention will entail detecting infants at risk before 
the full syndrome is present and implementing treatments designed to alter the course of 
early behavioral and brain development” (Dawson, 2008, p. 775). Indeed, converging 
evidence from both surveillance and treatment studies suggest that prodromal features of 
autism spectrum disorder (ASD) are emerging as early as two months of age (Jones & 
Klin, 2013), and ASD outcomes can be altered – in some cases by intervening in 
symptomatic infants within the first year of life (Rogers et al., 2014). These advances 
suggest that characterizing and treating ASD in infancy – prior to full symptom 
expression – is likely key to reducing ASD-associated impairments. However, the early 
detection field remains limited in a number of domains. It is unclear which children are 
most likely to benefit from prevention efforts, as even within “high risk” groups, many 
children exhibit non-ASD outcomes (Ozonoff et al., 2011). The mechanisms of ASD 
emergence are also still unknown. Although abnormal visual attention orienting has 
predicted ASD across a number of studies (Elison et al., 2013; Elsabbagh et al., 2013; 
Zwaigenbaum et al., 2005) and has been integrated into prevention efforts(Sally J Rogers 
et al., 2014), few studies have examined the biological mechanisms of abnormal attention 
in high-risk infants (Elison et al., 2013; Roberts et al., 2011). As a result, both prevention 
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and treatments often target ASD symptoms, rather than mechanisms, arguably reducing 
effectiveness in altering maladaptive developmental trajectories. 
 The present series of studies addressed these areas of need by unpacking the 
developmental and biological features of a commonly-reported predictor of ASD in 
infants: visual orienting. This work aimed to inform the onset, mechanisms, and 
generalizability of attention as an endophenotype of ASD. Across studies, we 
demonstrated abnormal patterns of both behavioral and heart-defined attention in infant 
siblings of children with ASD (ASIBs) and infants with fragile X syndrome (FXS), which 
emerged within the first year of life. We also provided novel evidence that although 
behavioral patterns of abnormal attention in ASIBs grossly generalize to high-risk infants 
with fragile X syndrome (FXS), the nuanced associations between attention and arousal 
systems differ across groups, potentially indicating diverging pathways to common 
behavioral features. Here, we synthesize these findings by (1) integrating results across 
studies and (2) discussing cross-study themes and implications.  
Integrating Results 
 Across studies, we examined behavioral and heart-defined attention in high risk 
ASIBs (Studies 1-3) and infants with FXS (Study 3) during both passive viewing (Study 
1) and visual orienting (Studies 2-3) tasks. The following sections integrate key 
behavioral (overall attention, saccade latencies) and physiological (global heart activity, 
heart-defined attention) findings, highlighting trends across studies. Additional discussion 
of these findings is provided within Chapters 2-4, thus the following sections provide a 
brief synopsis rather than exhaustive review. Specifically, findings are summarized in 
relation to (1) primary dependent variables (behavioral attention, saccade latencies, heart 
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activity), (2) association between behavioral and physiological measures, and (3) 
predictors of clinical ASD risk. 
 Behavioral attention. One of the most consistent findings across studies was 
abnormal behavioral attention (e.g. looking at the monitor) across high risk groups. In 
ASIBs, this effect was present during passive viewing (Study 1), during which ASIBs 
exhibited increased behavioral attention with age compared to decreased attention among 
low risk (LR) controls. Similarly, infants with FXS exhibited greater attention than LR 
controls and ASIBs at 9 months of age, with differences similar to younger LR children 
matched on MA. Two informative inconsistencies emerged in cross-study data. First, 
ASIBs’ abnormal looking patterns were elicited by passive viewing (Study1) but not a 
gaze-contingent task (Study 2), suggesting typical gaze patterns in the presence of 
examiner and task-related prompts, but not in the absence of these supports. Second, the 
abnormalities in FXS appear to relate to mental age, whereas ASIB differences persisted 
when MA was covaried in models. Thus, although both groups exhibited similar 
behavioral symptoms, the developmental nature of abnormal overall attention varies 
across groups, potentially suggesting mechanisms related to developmental delay in FXS 
compared to potential ASD endophenotype-related differences among ASIBs.  
Saccade latencies. Patterns of saccade latencies were similarly abnormal across 
both high-risk groups, although nuanced differences again emerged across samples. In 
Study 2, ASIBs exhibited distinct age-related patterns of initial abnormalities in orienting 
across trial types, which normalized (e.g. approached LR trajectories) at different rates 
over time. The increased differences between baseline and overlap latencies over time 
produced emerging “disengagement effects,” in which ASIBs displayed worsened 
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abilities to disengage from competing stimuli, compared to their ability to shift attention 
in the absence of competing stimuli. Interestingly, infants with FXS also exhibited 
orienting deficits compared to both ASIB (9 month only) and LR groups (9 and 12 
months), which persisted in relation to developmental controls at 12 months. However, 
these effects were specific to overlap trials only, in comparison to general orienting 
deficits across trial types among ASIBs. Thus, in contrast to ASIBs who exhibited poor 
orienting across trial types that was present in the youngest participants (6 months), 
deficits in FXS were initially similar to MA controls but worsened in comparison to both 
MA and CA controls with time. Thus, groups differed in both (1) the specificity of 
orienting deficits (disengagement in FXS, global orienting with particular disengagement 
deficits in ASIBs) and (2) the developmental sequaele of deficits over time relative to 
developmental abilities (present at 6 months in ASIBSs relative controlling MA, 
emerging between 9 and 12 months in FXS relative to MA controls).  Again, these 
findings suggest behaviorally similar profiles with distinct developmental trajectories.  
Heart activity. Patterns of heart activity across development varied across high 
risk groups. Young ASIBs exhibited hypoarousal during the gap-overlap (Study 2) but 
not passive viewing tasks (Study 1), whereas the FXS group exhibited marginally longer 
IBI and lower RSA at 9 months only. As discussed in Study 3, it is possible that these 
differences relate to patterns of shifting arousal across infancy, a theory that has been 
supported by preliminary data (Roberts et al., 2012) but requires increased longitudinal 
surveillance in larger samples to test empirically. However, our data lend preliminary 
support to theories of shifting arousal, as hypoarousal is present in the youngest high-risk 
samples only.  
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Both high risk groups also exhibited abnormal patterns of heart-defined attention. 
In ASIBs, these patterns were apparent during passive viewing, during which proportion 
of time in SA remained relatively stable over time, compared to age-related decreases in 
attention among LR controls. Notably, this effect was not present during the gap-overlap 
task in ASIBs, consistent with behavioral attention patterns.  However, proportion of time 
in SA (12 months) and depth of deceleration (9 month) were abnormal in FXS during the 
gap-overlap task, paralleling previous reports of reduced IBI decelerations during 
attention tasks in FXS compared to LR controls (Roberts et al., 2011). Thus, both groups 
exhibited differences in proportion of time in SA, paralleling behavioral effects. Depth of 
IBI decelerations were also abnormal in FXS, suggesting qualities – in addition to 
quantity – of SA is distinct in this sample.  
Biobehavioral Correlates 
Biobehavioral correlations indicated distinct patterns of biological processes 
potentially underpinning behavioral features. Among ASIBs, greater behavioral attention 
corresponded with higher proportion of time in heart-defined SA during the gap-overlap 
task, with less robust, non-significant correlations emerging during passive viewing. 
Similarly, higher overall looking corresponded with higher RSA in the ASIB but not FXS 
group during the gap-overlap task. In contrast, longer overlap latencies and increased 
stuck trials in FXS were associated with less IBI SD and IBI change during SA. Thus, 
although overall looking during the gap-overlap task related to heart-defined SA across 
ASIB and FXS groups, gross behavioral differences (overall looking) relate to RSA 
among ASIBs, and saccade latencies relate to qualities of SA in FXS. These patterns may 
suggest distinct underlying processes contributing to attentional deficits across groups. 
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In Study 3, we introduced a theoretical conceptualization of the association 
between longer overlap latencies and abnormal SA (shorter IBI decelerations, less IBI 
variability) in FXS to potentially account for this observed paradoxical association. 
Specifically, we proposed that longer overlap latencies observed in FXS may index 
abnormal visual processing that “interrupts” physiological patterns of engagement, 
reflected by less SA (shallower decelerations) despite abnormal latencies. We proposed 
that in contrast, less extreme overlap latencies may reflect relatively intact dorsal 
function, thus patterns of physiological engagement would be more typical of FXS as a 
group (e.g. deeper IBI decelerations). Although this pattern may similarly explain the 
lack of biobehavioral associations among ASIBs, orienting deficits in ASIBs appear to be 
more closely related to parasympatethic functioning. Of course, these theories are 
speculative in nature and should be empirically tested by contrasting dorsally-mediated 
and non-dorsally mediated task performance with concurrent physiological monitoring.  
Predictors of Clinical ASD Risk 
Behavioral correlates of clinical ASD risk were similar across groups, although 
distinct physiological predictors emerged. Across both ASIBs and FXS, higher 
proportion of stuck trials and longer baseline latencies were shared predictors of 
increased clinical ASD risk. Within FXS, longer baseline latencies were also associated 
with higher clinical risk scores. The association between global heart activity and clinical 
autism risk factors varied by group and task. Among ASIBs, higher clinical risk was 
associated with abnormal patterns of global and heart-defined attention during passive 
viewing, with decreasing age-related patterns of both global (IBI, IBI SD) and heart-
defined (IBI SD during SA, mean IBI change during SA) heart activity in ASIBs with 
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greater clinical risk. These associations only emerged during passive viewing. In contrast, 
physiological features were not associated with clinical autism risk in FXS. We proposed 
that these patterns speak to the utility of attention as a feature of the ASD endophenotype, 
with behavioral attention presenting a more global pattern of risk, versus physiologically-
indexed attention more closely relating to risk in the ASIB group. However, it is possible 
that heart activity during passive viewing would similarly reveal unique phenotypic 
information in FXS. We did not examine passive viewing in FXS as part of these studies, 
although data collection is underway to examine these associations in the future.  
Key Implications 
 The three presented studies generated a number of common themes that speak to 
the importance of this work. Two of the most compelling findings are improved 
characterization of aberrant attention in ASIBs, as well as novel information regarding 
the generalization of ASD endophenotype in ASIBs to infants with FXS. These themes 
are discussed at length throughout the previous studies thus are summarized briefly 
within the present discussion.  
Characterizing Aberrant Attention in ASIBs 
Across studies, we identified abnormal behavioral and heart-defined attention in 
ASIBs. Our identification of atypical orienting in very young (5-8 month) ASIBs is 
consistent with a subset of previous studies, although the developmental trends we 
reported differed from previous groups, likely reflecting sampling and methodological 
differences. Despite these differences across studies, our data generally converged with 
previous reports that atypical orienting may be a marker of ASD risk among ASIBs. In 
addition to potentially serving as an endophenotype of ASD, abnormal orienting also 
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predicted clinical ASD risk in our sample, consistent with previous findings of “sticky 
attention” in ASIBs who later meet ASD criteria (Elison et al., 2013; Elsabbagh et al., 
2013; Zwaigenbaum et al., 2005). Interestingly, effects were stable across ages, 
suggesting differences may be detectable as early as 6 months of age. Future studies are 
needed to examine the long-term outcomes associated with abnormal orienting, as well as 
whether orienting differentiates ASD from other developmental concerns (Elsabbagh et 
al., 2013). However, in the interim, our findings support that (1) abnormal orienting is a 
salient feature of the ASD endophenotype, and (2) detectable effects may emerge earlier 
than previously reported.  
Cross-Group Differences in Orienting and ASD risk 
 Our findings also provide novel evidence of distinct cross-group differences, as 
well as within-group predictors of clinical ASD risk, across ASIB and FXS groups. 
Chapter 4 discusses the implication of these cross-group findings in detail. In brief, 
developmental differences in symptom trajectories differed across groups, suggesting 
different etiological pathways to aberrant attention: ASIBs exhibited initial impairments 
that changed at differential rates over time, whereas abnormalities in FXS were specific 
to attention disengagement and increased in intensity with age, relevant to developmental 
controls.  Given these differences, we proposed that abnormal attention orienting and 
attention engagement are both present in FXS and ASIB groups yet may be subserved by 
different biological processes. In FXS, disengagement difficulties in FXS may index 
abnormal visual perception of competing, dynamic stimuli rather than general “over-
interest” in a primary stimulus. In contrast, elevated attention was associated with higher 
RSA in ASIBs, possibly indicating that abnormal elevations in attentional engagement 
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are driven by poorer suppression of vagal activity during attention. These differences 
highlight the heterogeneity of developmental processes related to ASD risk and the 
potential presence of similar behavioral profiles with distinct biological signatures. 
Future Directions 
 Chapters 2-4 propose a number of compelling future directions for this work, 
particularly related to cross-syndrome investigations of ASD, employing 
developmentally-sensitive research designs, and integrating biomarkers to inform 
symptom profiles. In brief, our findings support further investigation of ASD emergence 
in non-ASIB samples, contributing to a growing discussion of how genetic disorders may 
inform meaningful heterogeneity of ASD symptom expression (Abrahams & Geschwind, 
2008). Specifically, our data suggest that “risk factors” for ASD may be subserved by 
different biological mechanisms and developmental processes across infants with varied 
genetic risk factors, despite shared behavioral features that are similarly predictive of 
ASD risk. These findings are consistent with the increasingly popular notion that broader 
ASD profiles may reflect a number of heterogeneous pathways of risk (Yuen et al., 
2015), supporting continued prospective cross-group comparisons of ASD emergence 
that may inform mechanistically-sensitive early detection and treatment efforts.  
Our data also suggest that developmental surveillance – rather than age-related 
contrasts – are essential for teasing apart nuanced risk factors for ASD. Indeed, repeated 
assessments across short time periods are increasingly employed in ASIB studies (Jones 
& Klin, 2013; Ozonoff et al., 2010, 2014; Sacrey et al., 2013) but have not previously 
been applied to examining visual orienting and physiology.  Indeed, Studies 1 and 2 
unveiled patterns of abnormal attention previously unreported in the literature, which 
 151 
likely reflect, in part, our use of longitudinal modeling rather than categorical age 
comparisons. In particular support of developmental surveillance, a number of our 
longitudinal findings were not duplicated in cross-sectional analyses of the same sample 
(Study 3), highlighting the importance of quantifying individual change rather than 
simply group-level data.   
Finally, our integration of biomarkers clarified group differences and supported 
theoretical developments that would not have been possible with behavioral data alone. 
Indeed, although FXS and ASIB groups exhibited grossly similar behavioral orienting 
deficits, cross-group differences were most apparent when physiological data were 
integrated. Although biomarkers are arguably more difficult to translate into common 
practice, their integration into clinical research may inform heterogeneity of clinical 
features that are undetectable using standard observational methods. Establishing 
subtypes of mechanism-driven symptoms may, in turn, promote more sensitive and 
specific clinical tools that reflect the heterogeneity of ASD. For example, our results 
suggest that although visual attention in FXS is subserved by different biological 
processes in ASIBs and FXS, behavioral factors were similarly related to clinical ASD 
risk in both samples, warranting future study of whether behaviorally modifying orienting 
responses may have beneficial downstream effects across samples. However, it is likely 
that given distinct physiological underpinnings of shared behavioral features across 
groups,  response to attention-related treatments may be more efficient if tailored to 
mechanisms of change. For example, efforts to improve dorsal function may improve 
orienting in FXS, whereas self-regulatory interventions may be more effective in ASIBs, 
given hyperarousal in FXS is a chronic state that does not predict clinical ASD risk and 
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physiological variables related to clinical ASD risk in ASIBs only. Although these 
theories must be tested empirically, our data support further study of the use of 
biomarkers in informing mechanism-informed early detection treatment protocols.  
Conclusion 
As rates of ASD diagnoses continue to increase, research methods for predicting 
and treating ASD must similarly be refined with time. Data from the present three studies 
suggest that cross-syndrome comparisons, developmentally-sensitive surveillance, and 
biomarker integration may offer novel glimpses into the emergence and etiology of ASD 
in infancy, potentially informing the complex heterogeneity of ASD that continues to 
challenge current science in this field. In addition to promoting earlier identification and 
treatment of ASD, this work supports an individualized, multifaceted approach to 
unpacking developmental differences, framed in the assumption that developmental 
disorders are emerging phenotypes rather than static outcomes of linear development 
(Karmiloff-Smith, 2009). Thus, our work provides novel contribution to both the 
emergent features of ASD and improved methods for studying this complex 
developmental process.  
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